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Patients commencing new medications, particularly those that are high risk such as non-
vitamin K oral anticoagulants (NOACs), require counselling to ensure safe, effective and 
empowering use of the medicine. Pharmacists are well placed to provide this counselling, but 
they require an underpinning ability to do so. Training on NOACs is unstandardised and 
variable. A virtual patient (VP) educational tool on the topic of NOACs has been developed to 
help develop counselling skills relating to NOAC use in atrial fibrillation. VPs have been used to 
provide training for undergraduate students, but they are largely uninvestigated for use by 
qualified healthcare professionals. This study aims to evaluate the VP application and explore 
perspectives of pharmacists and pre-registration trainees on its use and potential.  
Methods 
The study followed a sequential exploratory mixed methods design using a sample of 
pharmacists and pre-registration trainees from sites across England. The participants 
completed a questionnaire pre and post-VP use. Following an interim analysis, a sample of the 
respondents were selected to undertake a follow-up semi-structured interview. Questionnaire 
results were analysed using a mixture of descriptive and inferential statistics; qualitative 
results were analysed using the Framework approach to thematic analysis. Results were then 
integrated via triangulation and corroborated to give an overall interpretation of the findings.   
Results and discussion 
NOAC training appears to be an under provided for area with many participants lacking in 
confidence in conducting NOAC patient counselling. There was a significant average increase 
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in self-reported counselling ability across the respondents pre- to post-VP which suggests a 
benefit to VP use. The exact nature of the benefits were wide ranging and included changes in 
knowledge, confidence, contextualisation of content and an opportunity to practice. Some 
participants also cited effects of VP use on their practice, including using the learning as part of 
continuing professional development. Well recognised benefits to VP use were also further 
demonstrated including mobility and safety. 
The VP was largely well liked, usable and acceptable as a learning resource, but some 
improvements could be made prior to wider implementation. This includes changes to the 
delivery of feedback and increased flexibility in responses within the VP. The study considered 
how VP use maps to the theory of experiential learning to provide a learning opportunity 
routed in andragogical theory. There was a discussion around different VP users with no single 
ideal group identified but rather multiple groups that could all benefit from VP use; pre-
registration trainees and newly qualified pharmacists were the most favoured. 
Implementation of the VP needs to be more well thought-out with a clear strategy and 
considerations for the required supporting infrastructure. This supporting infrastructure needs 
to be developed to support sustained and useful use of the VP application. 
Conclusion 
This research has demonstrated value of the VP, both from an individual user and wider 
educational perspective. A number of improvements, developments and further 
considerations have been identified including things to be addressed prior to any further 
implementation. The VP application is a useful additional resource which should be considered 
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Over fifteen years ago the Keele University School of Pharmacy developed its first virtual 
patient (VP). Initially these used remarkably limited technology based on still images of 
patients using inhalers, the technology evolved into more realistic computer-generated 
animations that respond to inputs of data to interact with users. The VP which formed the 
basis of this evaluation was commissioned by Bayer AG with the brief of using VPs to educate 
pharmacists on patient counselling for those with atrial fibrillation (AF) and taking non-vitamin 
K oral anticoagulants (NOACs), specifically rivaroxaban. Bayer AG, as the manufacturer of 
rivaroxaban (Xarelto©), commissioned and funded the development of the VP, they had no 
part in this evaluation.  
Overview of the research 
This research study evaluates the VP application using a sequential mixed methods design. 
This firstly involved a questionnaire which was mainly quantitative, using Likert scales. This 
was followed by a second semi-structured interview phase to further explore participant’s 
perspectives on the VP. All participants took part in the questionnaire phase and then a 
sample of respondents were selected to take part in a follow-up interview. The two phases 
were connected in an intermediate phase where the questionnaire data were used to sample 
and recruit participants for interviews. Additionally, at the end of the study, the data from the 
two phases were integrated to give an overall interpretation. 
Thesis structure  
Each of the following chapters focuses on a particular aspect of the study as outlined below.  
• Chapter 1 presents a background to the topic of the research study. This includes AF and 
NOACs, VPs and the educational context for the study.  
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• Chapter 2 presents an overview of the relevant literature of this study. This includes an 
exploration of VP definitions, the range of technologies used within multiple health 
professions, and various VP purposes and applications.  
• Chapter 3 further reviews the literature specifically on the use of VP technology in 
pharmacy to teach communication or counselling skills. The review uses a narrative 
approach with a systematic search strategy. 
• Chapters 4 and 5 explore the methodology and methods of the study respectively. The 
philosophical research paradigm, the instruments used and how this affected the study 
were key discussion points.  
• Chapter 6 presents the questionnaire results with a brief discussion of the relevance of the 
findings.  
• Chapters 7-9 present the interview findings, each focusing on one category of themes. 
Chapter 9 also includes a supplementary analysis focusing on the implementation of the 
VP. Each qualitative chapter includes a brief discussion of the interview findings relative to 
the study aim and objectives.  
• Chapter 10 concludes with a wider discussion of the findings and an integrated 








Within this chapter the topics of AF, NOACs, patient counselling, and pharmacist education 
and training are discussed. The VP technology and the VP development process are also 
discussed. This includes the educational foundations of the VP and technological design. 
Definitions and assumptions relevant to the study are also highlighted.  
1.2 Atrial fibrillation 
AF is the most common sustained cardiac arrhythmia worldwide (National Institute for Health 
and Care Excellence 2014) and despite advances in treatment and management, AF remains a 
major cause of stroke, heart failure, sudden death and cardiovascular morbidity worldwide 
(Kirchhof et al. 2016). The prevalence of AF is increasing (National Institute for Health and Care 
Excellence 2014) and it has been identified that the lifetime risk for AF at 40 years of age is 
approximately 1 in 4 people (Heeringa et al. 2006). AF poses a massive public health burden, 
especially considering that some risk factors for AF are also increasing in prevalence, such as 
survival post-myocardial infarction (Lloyd-Jones et al. 2004). The overall prevalence of AF is 
5.5%, increasing with age to 17.8% in those over 85 years. Prevalence is slightly higher in men 
than in women (Heeringa et al. 2006); it is estimated that an average patient with AF visits a 
doctor between 8 and 11 times annually regarding their condition (Heeringa et al. 2006). 
Doctors have rated AF as the second most difficult condition to manage in practice and the 
third most demanding (Aliot et al. 2010). This was for a number of reasons including the 
demand on time and the complexity of explaining AF to patients; more than one in four 
doctors stated that they did not have enough time to fully explain AF to patients (Aliot et al. 
2010). 
  1. Background 
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 Pharmaceutical treatment of atrial fibrillation 
AF is a significant risk factor for stroke and one aim of treatment is to reduce this by 
anticoagulating patients (National Institute for Health and Care Excellence 2014). The choice of 
anticoagulant can be complex due to their associated increased bleeding risk, but there are 
two board categories used in AF: non-vitamin K antagonists (NOACs), the focus of this study, 
and Vitamin K antagonists (VKAs), such as warfarin (National Institute for Health and Care 
Excellence 2012). 
The choice of anticoagulant resides with the patient and prescriber but, in the U.K., The 
National Institute for Clinical Excellence (NICE) recommends treatment with one of apixaban, 
dabigatran etexilate, rivaroxaban or a VKA (National Institute for Health and Care Excellence 
2014). Edoxaban, a more recently licensed NOAC, is also recommended for use in the 
European guidelines (Kirchhof et al. 2016) and by NICE in a separate technology appraisal 
(National Institute for Health and Care Excellence 2015a). Increasingly NOACs are being used 
as an alternative to VKAs, such as warfarin, due to a more desirable dosing regimen, less 
monitoring, and less medication and food interactions (Verdecchia et al. 2016). 
 Patient counselling  
Detailed patient education incorporating medication and lifestyle advice is required in AF 
(Davis 2013) and NICE recommends providing patients with a personalised package of care 
with regards to their AF (National Institute for Health and Care Excellence 2014). This 
encompasses providing education on various aspects of AF including anticoagulant treatment. 
Anticoagulant education should detail: how to use the anticoagulant; the duration of 
treatment (where applicable); possible side effects of treatment and what to do if side effects 
occur; effects of other medications, food or alcohol on treatment; monitoring requirements; 
effects on dental treatment; pregnancy advice; effects on other activities, for example, sports 
  1. Background 
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and travel; and when to seek medical help. All patients should receive an anticoagulant 
information booklet and an alert card (National Institute for Health and Care Excellence 2012).  
The European Society of Cardiology (ESC) highlighted the need for patients to undergo 
education at each AF visit, including the need to discuss adherence and what to do in the case 
of missed doses (Kirchhof et al. 2016). Several practical implications of education around 
NOACs have been identified; as well as repeated education, there should be a specified follow-
up schedule for patients starting NOACs, which can be shared between healthcare 
professionals (HCPs), including pharmacists (Heidbuchel et al. 2015). One study demonstrated 
that following counselling by pharmacists, patients had greater knowledge regarding warfarin 
treatment (Collins et al. 2014). The study demonstrated the importance of ongoing patient 
counselling and education regarding warfarin and despite not incorporating NOACs specifically 
it demonstrates a benefit of warfarin specific counselling by pharmacists.   
1.3 Education and training of pharmacists 
In the U.K. to become a registered pharmacist, students must complete an accredited four 
year Master of Pharmacy degree followed by one year of structured pre-registration training 
that encompasses meeting defined competencies and passing the pharmacist registration 
assessment (General Pharmaceutical Council 2011). After meeting these requirements an 
individual can join the pharmacist register and start to practise as a pharmacist.  
There are many providers of post-registration pharmacy education and training and many 
pharmacists go on to do further qualifications such as independent prescribing or a post-
graduate diploma. In addition to this, pharmacists are required to undertake a continuous 
process of education and training to better their practice and contribute to continuing 
professional development (CPD) (General Pharmaceutical Council 2018a). One of the main 
providers of educational resources is the Centre for Pharmacy Postgraduate Education (CPPE) 
who provide resources for pharmacy education and training (Centre For Pharmacy 
  1. Background 
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Postgraduate Education 2017). Many employers or organisations also organise and provide in-
house education and training but, ultimately pharmacists are responsible for their own 
competence and practice in line with requirements set by the General Pharmaceutical Council 
(GPhC) to conduct CPD and revalidation annually.  
 Continuing professional development 
It was anticipated, during the conception of the VP, that the VP application could have a role in 
CPD as well as the general education and training of pharmacists. The GPhC state that CPD 
must reflect the context and scope of a pharmacist’s personal practice and must contribute to 
the quality or development of such (General Pharmaceutical Council 2010). 
It was demonstrated in one study that over 90% of pharmacists were in favour of undertaking 
CPD to better their practice (Bell et al. 2001), with many citing that undertaking CPD would 
make them more confident and professional when interacting with patients (Bell et al. 2001). 
Despite this, a key obstacle found was the type and lack of resources available (Bell et al. 
2001), signifying the need for a wider range and availability of CPD resources. 
 Communication and counselling skills 
The GPhC states that one of the four main responsibilities of a pharmacist is ‘’advising patients 
about medicines, including how to take them, what reactions may occur and answering 
patients' questions’’ (General Pharmaceutical Council 2018b). It is on this basis that a 
pharmacist must be appropriately trained to conduct medication counselling. Learning the 
principles of patient interactions and counselling is undertaken at undergraduate level, and in 
many cases this includes related assessments (General Pharmaceutical Council 2011). As these 
skills need to be constantly developed, they need reinforcing to be maintained (Burnard 2005). 
Pharmacists need a high counselling ability and with new medications constantly being 
  1. Background 
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brought to the market it is essential they can apply the generic skills of patient interactions 
and counselling to new scenarios and drug-specific content.  
There are few studies considering long-term counselling ability in pharmacists; one study 
investigated the longevity of pharmacist inhaler counselling and demonstration techniques, 
concluding that pharmacists need effective tools and encouragement to maintain their 
competency in inhaler counselling in order to best provide patients with the information that 
they need (Basheti et al. 2009). Another study from Finland found that a continuing education 
programme that promoted counselling was of benefit to pharmacists, particularly concerning 
approaches to, and implementation of, counselling (Kansanaho et al. 2003). Although these 
findings have not been established in the context of anticoagulant counselling it is suggested 
by the authors that resources to teach and reinforce particular counselling skills may be 
beneficial (Kansanaho et al. 2003, Basheti et al. 2009). 
 AF and NOAC training 
Few anticoagulant and AF specific training or resources are available: CPPE provides online 
training for anticoagulant and antiplatelet medications intended to relate to the New 
Medicines Service (NMS) (Pharmaceutical Services Negotiating Committee 2013). Bayer AG, as 
the manufacturer of rivaroxaban, provide information for pharmacists on its use which 
includes some patient counselling requirements, but again this focuses on the NMS 
requirements (Bayer 2017). The two cited resources both provide factual information and do 
not give any indication as for the use of this information in real-life consultations other than 
meeting the NMS requirements. Other tools available include local-level resources, formal 
teaching sessions, journal pieces, and publications by organisations such as The Royal 
Pharmaceutical Society (The Royal Pharmaceutical Society 2012, 2017). These resources 
appear to vary immensely by location, method of delivery, and audience with no widely 
recognised ‘gold standard’ for NOAC counselling training, this is further explored in section 
  1. Background 
6 
 
6.3. No resources using VPs have been identified to train pharmacists on the use of NOACs 
(chapters 2 and 3). 
1.4 Educational context 
 Pedagogy, andragogy, and learning 
Pedagogy, by definition, concerns the teaching of children (Holmes and Abington-Cooper 
2000, Chan 2010), whereas, andragogy specifically concerns the teaching of adults or the 
process of helping adults learn (Clapper 2010, Zigmont et al. 2011). The latter term was first 
detonated by Knowles in the 1960s (Clapper 2010) and the discussion of pedagogy versus 
andragogy is debatable as some believe that there is no difference educationally between 
adults and children but others dispute this (Knowles 1980, Holmes and Abington-Cooper 2000, 
Chan 2010). Zigmont et al. (2011), argued that there is a distinct difference between child and 
adult learners on the basis that adults are: self-directed and regulated, intrinsically motivated 
to learn, and have previous knowledge and experiences that are a resource for learning. 
According to the author, these are not applicable to child learners. This is in line with other 
works by Clapper (2010). Furthermore, it has been suggested that when teaching adults 
compared to children, an educator moves away from being a ‘teacher’ to a ‘facilitator’ 
(Zigmont et al. 2011). Within this study, for the purpose of consistency, andragogy will be the 
term used as the VP is aimed specifically at adult learners. Some studies use the term 
pedagogy; this will be discussed where relevant.   
A challenge for educators when creating a meaningful learning resource for adults is that 
learning should activate relevant previous experiences and knowledge, in order to allow the 
exploration of new and old alike (Zigmont et al. 2011). One way of doing this is through 
reflective based learning where experiences are recognised to play a significant role in learning 
(Zigmont et al. 2011). Using this method of learning it is not during the experience itself where 
the learning occurs but afterward during reflection and debriefing which are keys stages in the 
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learning process (Zigmont et al. 2011). For adults to change their daily practice on the basis of 
learning, the learning methods and the working environment must support the change and 
incorporate principles of life-long experiential learning (Zigmont et al. 2011). On the basis of 
this, it is clear that any new educational resource, including VPs, need to have a strong 
foundation in educational theory so that they can become useful learning experiences for the 
users.   
 Experiential learning and simulation 
There are many different educational theories associated with both teaching HCPs and using 
technology to do so. A brief description of one of the most commonly used educational 
theories regarding experiential learning is presented below, this is adopted throughout the 
study. 
Experiential and exploratory learning involves learner-driven investigations, this is often in 
pursuit of a real or simulated task (Rieman 1996). This is the opposite of more traditional 
methods of learning involving precisely determined tasks and resources that control learning 
(Rieman 1996). It is the incorporation of real tasks that makes simulation particularly well 
suited to this type of learning. Simulation and experiential learning are also well matched 
because users are in an active learning environment where they are able to formulate their 
own learning through inquiry, problem-solving and discovery (Njoo and Jong 1993).  
Learning using simulation, compared to lecture-based or teacher-led learning, requires the 
application of knowledge to a situation, this puts users in control and can help refine mental 
models of a task or experience (Zigmont et al. 2011). Simulation also allows the user to self-
regulate their own learning and there is a focus on personal learning objectives (Zigmont et al. 
2011). But, in order for simulation to be a useful experience, a level of knowledge regarding 
experiential learning is required by the simulation facilitators and designers (Zigmont et al. 
2011). 
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Kolb’s experiential learning cycle (Figure 1.1) (Kolb 1984) lends itself to learning using 
simulation because the stages of the cycle fit well with stages and principles of simulation. This 
includes concrete experiences to help identify knowledge gaps, and, reflection and debriefing, 
thus allowing reflection and preparation for learning to occur (Zigmont et al. 2011, Poore et al. 
2014).  
 
Figure 1.1 Kolb's experiential learning cycle taken from Zigmont et al. (2011) 
 
Poore et al. (2014), directly mapped the stages of simulation to Kolb’s learning cycle (Figure 
1.2). The study specifically considered interprofessional education (IPE) in nursing but the 
general stages of simulation are the same across health professions and applications. Concrete 
experience is the point at which the initial simulation occurs. This is followed by reflection and 
abstract conceptualisation of the experience which helps to bridge learning to future 
experiences. At this stage, the learner’s mental models can be changed on the basis of what 
has been learned. Finally, active experimentation involves the learner testing their new mental 
model this can either be by repeated simulation or a different experience such as experiences 
occurring in practice (Zigmont et al. 2011, Poore et al. 2014). It is using Kolb’s theory of 
experiential learning and the map of this to simulation-based interventions that the VP 
educational application in this evaluation is based. 




Figure 1.2 Kolb's experiential learning cycle mapped to the stages of simulation  
(Poore et al. 2014) 
 
 Mobile learning 
Mobile devices are increasingly common and many researchers and educators are 
incorporating the use of mobile devices into teaching and learning environments (Park and 
Tech 2013). Similar to the use of simulation as an educational technique, learning using mobile 
devices needs to have a solid foundation of learning theory in order to become a useful 
learning experience (Park and Tech 2013). 
Mobile learning can be defined as using a mobile or wireless device for the purpose of learning 
(Park and Tech 2013). Using this definition, this can include mobile phones, tablets, and 
laptops which are the three platforms that the VP of this study can be accessed through. 
Multiple studies have considered mobile learning to be an extended or more sophisticated 
version of e-learning which is broadly any learning using an electronic medium (Traxler 2005, 
Park and Tech 2013). Mobile learning is recognised to be able to both provide uniquely 
situated or context-aware learning, and also conventional learning through a different 
medium, a named example being delivering learning to remote or inaccessible learners 
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(Traxler 2005). Other advantages of mobile learning are that it can be used by users who are 
on the move (Sharples et al. 2005).  
Mobile learning embraces that a significant amount of learning is already taking place outside 
of classrooms and formal teaching establishments, and so it utilises this to deliver education 
(Sharples et al. 2005). This education is also often delivered in a more convenient way and 
mobile learning can bridge the gap between a learning environment and the environment 
where the learning is applied such as clinical practice (Sharples et al. 2005). 
One study explored how the characteristics of learning and technology converge together to 
make learning useful (Sharples et al. 2005). In order for learning to be useful it should be 
personalised, learner-centered, situated, collaborative, ubiquitous and lifelong. Mapping 
almost directly on to this, the authors stated that technology can be: personal, user-centered, 
mobile, networked, ubiquitous and durable (Sharples et al. 2005). This is key, as it 
demonstrates the relevance of technology for learning as many of the characteristics overlap 
and thus it is logical to utilise technology for learning. Sharples et al. (2005), further explored 
the theory behind mobile learning and suggested asking five key questions of mobile learning 
resources (Figure 1.3). This is something that will be considered in the evaluation as the VP is a 
mobile-simulation learning resource. Sharples et al. (2005) discussed that it is the user who is 
mobile rather than the technology and learning should be interwoven as part of daily life, 
learning can generate as well as satisfy goals, and finally, mobile learning can both 
complement and conflict with formal education (Sharples et al. 2005). These ideas will be 
incorporated into this evaluation.  




Figure 1.3 Five questions to evaluate mobile learning resources (Sharples et al. 2005) 
Mobile learning is relevant to simulation-based learning as a common theme within the two is 
context (Sharples et al. 2009). Mobile learning allows learning to occur in a relevant 
environment by providing a virtual, but stable, context for learning. This can make the learning 
more relevant for the user as stability is still present but in a more contextualised manner 
(Sharples et al. 2009). Experiential-based learning is also interlinked to this as mobile learning 
can provide experiences for learning that are more closely related to practice as part of the 
learning cycle (Sharples et al. 2009). Importantly mobile learning does not take away from 
more traditional methods but as summarised by Sharples et al. (2009): ‘’Mobile learning offers 
new ways to extend education outside the classroom, into the conversations and interactions 
of everyday life.’’ (Sharples et al. 2009). Mobile learning is important to this study as the VP 
can be accessed through a range of mobile devices and the implications for this will be 
considered within this evaluation.  
1.5 The virtual patient 
The VP application uses an animated patient within an interactive computer programme to 
simulate a pharmacy consultation. The patient, ‘Henry Gentle’, has been newly started on 
− Is it significantly different from current theories of classroom, workplace 
or lifelong learning?
− Does it account for the mobility of learners? 
− Does it cover both formal and informal learning? 
− Does it theorise learning as a constructive and social process? 
− Does it analyse learning as a personal and situated activity mediated by 
technology? 
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rivaroxaban, a NOAC, for AF and he presents to his community pharmacy with his new 
prescription. The user takes on the role of the pharmacist to interact with the patient. The 
case progresses with the intention of providing a realistic representation of a NOAC 
consultation. The VP aims are to teach pharmacists how to counsel patients on NOACs for AF, 
to improve their own knowledge and ability and to contribute to their professional 
development. The development of the VP was previously reported (Richardson et al. 2018) 
and the design of the application is discussed below. 
 The technology 
Broadly speaking, the VPs that are developed at Keele School of Pharmacy are designed 
around a clinical decision pathway with integrated visual effects. A virtual character responds 
to the user’s decisions, with personalised user feedback at the conclusion of the case to 
enhance clinical decision making and counselling skills. This VP consists of computer-
generated, animated, VP videos that depending on the decision made, trigger a relevant 
animation. The systems use Hypertext Mark-up Language (HTML), cascading style sheets (CSS) 
and JavaScript resource accessing video renders that allow the VPs to work on smartphones, 
tablets, and desktop devices (Figure 1.4 and Figure 1.5). This is in line with a previous research 
recommendation for VPs using more sophisticated graphics and animations (Jabbur-Lopes et 
al. 2012). 




Figure 1.4 The VP interface accessed from a laptop running Google Chrome 
 
 
Figure 1.5 The VP interface from a smart mobile phone 
The VP is accessed via a purpose-built website that can be used on an electronic device 
connected to the internet, the interface adapts to screen size of the device being used. The VP 
team at Keele University stated that the chosen technology had benefits based on the 
technology’s ability to be updated, its adaptability and looking to the future, the technology’s 
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potential for incorporating aspects not achievable in reality. These characteristics are 
supported by other studies that discussed the advantages of VPs (Bracegirdle and Chapman 
2010, Tan et al. 2010, Douglass et al. 2013).  
 The avatar 
Each avatar, or visual character, for each VP application, is carefully constructed to a specific 
design. Characteristics that can be tailored to create a unique character include facial features, 
age, gender, expressions, hair, clothes, and ethnicity. For some VP cases, patient 
characteristics will impact the case outcome and they need to be carefully considered.  
In this case, Henry Gentle is described as a 67-year-old man and this was in keeping with the 
visual appearance of the avatar, his age and ethnicity are not specific to the outcome of the 
case but reflect common demographics of patients with AF. The VP’s verbal responses are 
audio-recordings utilising the skills of a voice actor. The chosen voice actor is usually a close a 
match to the avatar’s characteristics; Henry’s voice actor was a similar age and ethnicity to 
him. 
 Application development  
Every VP application is individually designed for a particular purpose and client and application 
details are precise; this can include elements such as the patient characteristics and script to 
the type and nature of feedback. Five proposed phases for VP development were loosely 
adopted during the development of this VP (Guise, Chambers, Conradi, et al. 2012). Phase one 
involved explicitly defining learning outcomes; phase two concerned concepts and designs; 
phase three technical design aspects and; phases four and five a cycle of evaluation and 
improvement (Guise, Chambers, Conradi, et al. 2012). The technology-orientated VP 
development team at Keele University led a three-way approach where the development 
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team, client, and a steering group informed VP development as part of the development 
process. 
Development of the VP first involved the concept of the VP being discussed with the 
development team who developed a prototype using a basic script with stationary and 
incomplete characters. Following the modification and approval of this, a functional prototype 
was developed to test the script and scenario further. After approval of this, a fully functional 
version was developed.  
 Learning outcomes 
The VP team requested the client to outline the VP’s indented learning outcomes, this was to 
‘learn how to counsel a new patient on rivaroxaban’ (Figure 1.6). There was a further list of 
topics required to be covered in the scenario to ensure an application was created that 
included particular elements, a named example being, specific drug information such as, how 
to take the medication. The learning outcome and topic list helped with the development of 
the scenario script to meet the specific requirements of the client. The script was developed 
by the design team in conjunction with the client so that the application met both the client’s 
expectations and the technological abilities of the software. This was particularly important 
when the client suggested ideas that were not possible or were difficult to achieve technically. 
The learning outcomes and topic list were rewritten a number of times during development to 
facilitate this.  




Figure 1.6 The VP application introduction as presented to the user  
 
 Decision tree and script 
Once the scenario had intended learning outcomes, a decision tree of the script was 
developed. This simplified the case, detailing it from start to finish, helping to establish key 
points and decisions. Each question and/or action was carefully incorporated into the decision 
tree, with considerations for how individual elements could impact the case pathways moving 
forward within the application and also how decisions affect user feedback. The decision tree 
had approximately 40 questions and 90 elements that were highlighted as ‘good’ and ‘bad’ 
decisions relevant to the intended learning outcome. Each decision was categorised as more 
or less favourable compared to the optimum case pathway. The optimum pathway through 
the case was developed first before the addition of alternative routes, this is in keeping with 
the usual method for developing a decision tree (Guise, Chambers, Conradi, et al. 2012). The 
decision tree also highlighted the points within the case when additional information became 
available to the user, for example, access to the patient’s medication record. The decision tree 
evolved throughout development until feedback in the development process suggested that 
the case pathways were ready for use; this process was an iterative development process led 
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by the expertise of the development team and steering group. No specific verification 
processes were used and this could have introduced bias from the developers in to the 
decision tree. Although this is a limitation of the development process this evaluation has 
taken place outside of the original development team and so any limitations identified can be 
reported to the developments; further specific considerations for bias within the decision tree 
may be required but is outside the scope of this evaluation.  
 Question design 
The type of questioning within the VP case was also considered in some detail. VPs, generally, 
use either multiple choice questions or free text questioning. The former allows the user to 
select the most appropriate option from a list of a few, this appeared to be a commonly 
adopted approach and it was the method used in this VP (Pereira and Cavaco 2014, Moule et 
al. 2015, Zlotos et al. 2016). The later design appeared to be less common; it was used in the 
work by Stevens et al. (2006). A third questioning design makes use of both methods: the user 
types a keyword and a selection of related questions appear. This has been used in the 
medicines use review (MUR) work by Keele School of Pharmacy (Keele School of Pharmacy 
2017) and the work by Bracegirdle and Chapman (2010).  
This VP used multiple-choice questioning and although this can be less flexible for users it 
made the case technologically easier to develop. Additionally, multiple-choice questioning is 
recognised to be suited to narrative VPs with andrological influences of reflection-based 
learning through practice (Bearman et al. 2001), such as in this VP where users are encouraged 
to reflect on their performance. 
 User feedback 
User feedback can vary depending on the design and purpose of the particular VP (Guise, 
Chambers, Conradi, et al. 2012). Examples include verbal or written feedback and some 
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systems give comprehensive feedback whereas others intentionally limit it for educational 
purposes (Zary et al. 2006). VP programmes can also grade the user’s attempt or incorporate a 
pass/fail system as the design requires (Douglass et al. 2013, Taglieri et al. 2017). 
Actions within this specific VP scenario triggered positive and negative feedback and at the 
end of the case personalised feedback was collated. Henry verbally delivered this feedback to 
the user, giving the impression that the patient was talking to the user, as the pharmacist, 
detailing what they did well and what could be improved (Figure 1.7 and Figure 1.8). Feedback 
was instantaneous after case completion which was intended to contribute to usability. The 
VP did not incorporate a user assessment such as a test because this was not in keeping with 
the exploratory and reflective purpose of the VP.  
 
Figure 1.7 Feedback at the end of the application, Henry verbally provides feedback 
alongside subtitles 
 




Figure 1.8 Downloadable and printable feedback at the end of the application 
 
1.6 Research design 
This research study aims to evaluate the use of the VP educational application described 
across section 1.5. VPs, although not a completely novel technology, are still being established 
in health professions and the purpose of this study is to evaluate this specific pharmacy VP 
application. As part of this, there is an emphasis on considerations for pharmacy practice and 
the future use of the VP. As already discussed, AF is one of the most difficult conditions to 
manage in practice (Aliot et al. 2010) and the VP may have consequences for patient 
education. There are few VPs are currently integrated into practice or education (chapter 2) 
and so this evaluation may help to encourage the integration of novel technologies into 
healthcare. 
 Assumptions and limitations 
The study assumes that the participants, as pharmacy professionals, are competent to carry 
out patient consultations generally and to a degree on the topic of NOACs. A core premise of a 
pharmacist’s role is to counsel patients on their medications and thus a degree of training and 
experience has been assumed. Pharmacists are responsible for their own competence and 
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professional development and so it is their own responsibility to ensure that they are 
competent to conduct medication counselling. The same is true of pre-registration trainees 
but to a lesser degree.  
Pre-registration trainees are included throughout the study in addition to pharmacists; they 
are an individual in the interim year between graduating from university and joining the 
pharmacist register. During this year students are an intermediary between qualified HCP and 
student with the intention of further in-practice training and education. They should be 
equipped with general knowledge and skills of consultations but as they are still in a teaching 
and learning role, they may have less drug-specific knowledge and experience in practice. A 
level of generalisability between pharmacists and pre-registration trainees is assumed within 
the study as although the latter are not yet fully qualified, they are still governed by the GPhC 
and a code of conduct. Relevant differences and similarities between the two groups will be 
highlighted throughout the study.  
The study also assumes that participants have some prior knowledge of NOACs. There will 
have been varying degrees of knowledge, partially due to different roles and experiences, 
nevertheless, the VP assumes a low knowledge level. 
Non-vitamin K oral anticoagulants (NOACs) until recently, were also known as novel oral 
anticoagulants so may be referred to as such in the literature. They may also be referred to as 
direct oral anticoagulant or DOACs (Heidbuchel et al. 2015). In this study, the term NOAC is 
used as this appeared to be the more well-used term and the one adopted in the European 
and NICE guidelines (National Institute for Health and Care Excellence 2014, Heidbuchel et al. 
2015).  
 The research team 
This research contributes to a Ph.D. thesis in pharmacy education. The author, CR, completed 
a four-year Master of Pharmacy degree at Keele University graduating with First class honours 
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in 2016. Following this, they completed pre-registration training at The James Cook University 
Hospital, Middlesbrough and qualified as a pharmacist in 2017. The author started their Ph.D. 
in September 2017 and they also worked as a locum pharmacist in this time. In the last year of 
the research study the author worked as a lecturer of pharmacy practice and work-based 
learning at Newcastle University School of Pharmacy. 
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 Overview of the literature 
2.1 Introduction 
Patient counselling has a pivotal role in allowing pharmacists to identify and solve drug-related 
problems and can empower patients to adopt positive self-management of their medical 
conditions and medicines (Pereira and Cavaco 2014). Counselling has also been shown to 
increase patient satisfaction and optimise patient quality of care (Pereira and Cavaco 2014).  
This chapter presents an overview and background to the body of literature detailing the uses 
of VPs in healthcare, VP characteristics, and VP purposes. There is a discussion of simulation 
technology as a wider concept, followed by dialogue around VPs specifically, focusing on their 
design and theoretical foundations. This chapter aims to provide context for the systematic 
narrative review that follows. The role of the proposed research is continuously conferred 
considering gaps and inconsistencies in the literature to identify where the VP evaluation will 
provide new insight.  
2.2 The simulation spectrum in health education 
Simulation as a means of education was first conceived in aviation where it is well ingrained 
within the sector to improve safety and quality (Lin et al. 2011). Simulation in healthcare is a 
newer concept but one that has been growing, it can be defined as:  
‘’an educational technique that allows interactive, and at times immersive, 
activity by recreating all or part of a clinical experience without exposing 
patients to the associated risks’’ (Maran and Glavin 2003).  
Simulation has many recognised advantages which include reduced undesired interference 
from external influences; the ability for scenarios to be created to demand; the ability for skills 
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to be repeated and practiced; the capability to tailor training to individuals; and enhancement 
of the transfer between the classroom and clinical environments (Maran and Glavin 2003). A 
further advantage is that of patient safety, as the use of simulation removes or reduces risks to 
the patient (Maran and Glavin 2003). Simulation can be used to build confidence and it has 
been shown to help achieve a faster time to competence than traditional methods (Lin et al. 
2011). It is not intended to replace learning in clinical environments but it can be used to 
prepare for and enhance clinical experiences (Maran and Glavin 2003).  
There are some disadvantages to simulation which include, depending on the specific 
technology: limited realism; limited humanistic features such as emotion; the need for spatial 
and financial recourses; a questionable return on investment; and the requirement for full 
user participation and engagement (Lin et al. 2011). Some simulation technologies have also 
reported difficulties in recreating facial expressions and subtle clinical clues (Maran and Glavin 
2003). 
Simulation encompasses a spectrum of technologies which can be separated or categorised in 
a number of ways. One of the most common methods of categorisation is on the basis of 
fidelity, which is the ability of the system to replicate a task or scenario. Maran and Galvin 
used this to discuss the range of simulation in health. This included: high fidelity mannequins 
or task trainers such as Harvey; computer-based systems; virtual reality systems; VPs; 
simulated environments and integrated combinations of multiple methods (Maran and Glavin 
2003). The remainder of this narrative will focus on VPs as one sub-type of simulation, where 
relevant references to other sub-types will be made.  
2.3 Virtual patient technology 
Within healthcare simulation, VPs are one sub-type of simulation and their use, until recently, 
has largely been peripheral (Ellaway et al. 2009). VPs have only entered mainstream medical 
education in recent years and this may be due to some of the previous barriers to VP adoption 
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having been overcome (Ellaway et al. 2009). Named examples of this include an increasing 
awareness of the ability of VPs to pose scenarios that are obscure or missed during practice or 
placements; a better understanding of the underlying technology of VPs; and an increasing 
appreciation for the pedagogical and andragogical value of alternative educational modalities 
(Ellaway et al. 2009). This is suggested to have contributed to a somewhat increased 
implementation of VPs (Ellaway et al. 2009). Conversely, there does appear to be a lack of 
consistency that allows VPs to be reused outside of their original context, consequently 
generalisability is an increasingly significant factor when evaluating VPs (Georg and Zary 2014).  
VPs are thought of as an alternative to more traditional simulation techniques, particularly 
standardised patients, which are actors used to simulate patient-professional interactions. 
Some literature suggests that VPs are as effective or have benefits over standardised patients 
(Stevens et al. 2006, Ellaway et al. 2009, Baumann-Birkbeck et al. 2017), and additionally 
standardised patients have some distinct disadvantages which can be overcome or reduced by 
using VPs. They are expensive, in terms of time and resource, and variability has been shown 
regarding training and outcomes (Stevens et al. 2006), a phenomenon known as performance 
drift (Baumann-Birkbeck et al. 2017). VPs, especially when used for assessments, can be more 
standardised than standardised patients and they have the ability to replicate scenarios that 
are difficult to duplicate with standardised patients (Stevens et al. 2006). Notable examples of 
this include aggressive patients or paediatric consultations. VPs allow for repetition and 
mistakes without consequence, even more so than with standardised patients (Stevens et al. 
2006).  
VPs specifically have a number of advantages, including their potential to deliver education to 
large numbers and at a relatively low cost (Bateman et al. 2013); they can easily incorporate 
assessments and they have an efficient delivery that can be anywhere, anytime and is learner-
centred (Tan et al. 2010). Despite this, VPs are not without disadvantage: using VPs can be a 
learning curve for users and facilitators; VPs require a level of technology or equipment to be 
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available and functioning in order to be beneficial; and costs can be significant to develop and 
set up a VP; VPs are a rapidly evolving technology and programmes have to be kept up to date 
with a level of constant maintenance (Tan et al. 2010).  
 Classifications 
VP definitions vary remarkably, and this can result in confusion and so some authors use 
classification systems rather than overt definitions. Cook and Triola (2009) suggested that VPs 
are made up of all or a combination of the following: interactivity, clinical requests and 
responses, case progression, feedback and instruction, learner collaboration, curricular 
integration, and assessment. Although this is a vague description that could encompass many 
simulation technologies not solely VPs.  
One review sought to clarify the confusion by classifying VPs into categories based on their 
purpose: education, clinical procedures, clinical research and eHealth (Kononowicz et al. 2015). 
From the searches, around 500 studies were retrieved. Educational VPs were the most 
common group (62%); with interactive patient scenarios accounting for 37% of this group, 
followed by high fidelity simulations and virtual standardised patients (a VP by definition of 
this study, as discussed in section 2.3.2). Less frequent categories included VP games. The 
categories relevant to this study were interactive patient scenarios and virtual standardised 
patients, which have the predominant competencies of clinical reasoning and communication 
skills respectively. A drawback of the classification was that some types of VP could not be 
classified and so were excluded, somewhat limiting the inclusion criteria. The review used a 
deductive approach to analyse the programmes, this included descriptive statistical analyses. 
The findings indicated that the quantity of VP technologies increased between 1991 and 2013; 
interactive patient scenarios increased rapidly but virtual standardised patients were lower 
and more constant, this suggests that ‘virtual standardised patients’ or VPs, were not as widely 
researched in this time frame (Kononowicz et al. 2015). 
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A similar research study to the one previously discussed also attempted to define and 
categorise VPs, 185 definitions of VPs underwent inductive-deductive analysis to establish 
definition categories: patient, teacher, VP, curriculum, and learner (Hege et al. 2016). Sub-
groups were defined, and notable examples included interactivity, feedback, and authenticity; 
these were visualised in a concept map which presents a comprehensive view of VPs (Figure 
2.1). This framework is simpler than work by Kononowicz et al. (2015) but it presents some 
new and alternate ideas, such as the patient being a stakeholder in VP development. This does 
not appear to be discussed elsewhere in the literature, but it is something to be considered in 
the future. The authors suggest the need for further research investigating the perceived 
authenticity of VPs and how this affects learner engagement (Hege et al. 2016). 
 
Figure 2.1 A concept map of a framework for VP design. The colour coding represents the 
different layers of VP descriptions where the five orange descriptors represent the five types 
of VP as concluded by Hege et al. (Taken from Hege et al. 2016) 
 Definitions 
The definition of VPs can vary remarkably and, for the purpose of this study, three of the most 
cited definitions are critiqued before discussing the study’s adopted definition. The American 
Association of Medical Colleges (AAMC) define a VP as:  
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‘’A specific type of computer-based program that simulates real-life clinical 
scenarios; learners emulate the roles of health care providers to obtain a 
history, conduct a physical exam, and make diagnostic and therapeutic 
decision’’ (Association of American Medical Colleges 2007). 
Numerous studies have adopted this definition including Kononowicz et al. (2015), but it is 
most relevant to the medical profession as the definition states that a VP must incorporate 
four components of history, physical exam, diagnosis, and therapy. This may not always be 
applicable to all VP applications, especially those aimed at pharmacy professionals. The AAMC 
definition is not adopted because of this. 
A second definition is that of Ellaway et al. (2007), who state a VP is:  
‘’An interactive computer simulation of real-life clinical scenarios for the 
purpose of medical training, education, or assessment. Users may be learners, 
teachers, or examiners.’’ (Ellaway et al. 2007).  
This definition is more relevant to this study as it is less restrictive and could include VPs which 
are used to train HCPs a range of skills and knowledge. It does not stipulate a profession, 
design or andragogical intent. A planned Cochrane review also adopted this definition 
(Kononowicz et al. 2016). 
A final definition is that of Bracegirdle and Chapman (2010), who defined a VP as:  
‘A computer generated programmable patient, or avatar to simulate a clinical 
scenario in a three dimensional environment. The character or avatar responds 
to the decisions made by the learner’ (Bracegirdle and Chapman 2010). 
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The work by Thompson et al. (2016), adopted this as did Cavaco and Madeira (2012). Similar 
to Ellaway et al. (2007), there is no restriction on the nature of the technology and the 
definition is broad.  
The definition by Bracegirdle and Chapman (2010) was adopted in conjunction with that of 
Ellaway et al. (2007) to create a specific definition but one that retained its design and 
andragogical freedom. This was used throughout this research.   
''A virtual patient is an interactive computer simulation of a computer programmable 
patient (or avatar) in a real-life clinical scenario for the purpose of health training, 
education, or assessment that will respond to learner decisions.'' (The adopted study 
definition of a VP, adapted from Ellaway et al. 2007, Bracegirdle and Chapman 2010). 
 Theoretical considerations  
VPs have been cited as lacking a theoretical foundation which can make it difficult for 
researchers to build on previous work and create a well-established and significant literature 
base for their use (Georg and Zary 2014). For this reason, it is important that VP’s educational 
foundations are considered and incorporated into designs from the offset, although VP 
designs need to be tailored to their specific contexts and intended purposes (Ellaway et al. 
2009). Depending on, for example, if the case is for self-directed learning or problem-based 
learning; or is to teach communication skills or clinical reasoning, the design will vary 
significantly (Ellaway et al. 2009). Most VPs stem from pedagogical and andragogical rationales 
of experiential or problem based learning with narrative VPs especially using theories of 
reflective learning through practice (Bearman et al. 2001).  
A grounded-theory study explored optimal VP designs considering educational theories 
(Bateman et al. 2013). The themes identified were used as a basis for a VP framework with 
one element of the framework being ‘VP construction’. This category, in part, consisted of 
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pedagogical properties (Bateman et al. 2013). This was one framework addressing VP designs 
to understand how and why the design and delivery of VPs influence learning. From the 
identified categories it is key that pedagogical and andragogical properties have a role to make 
VPs educationally worthwhile. 
The use of simulation, and more specifically of VPs, allows for repetition and the opportunity 
to practice fine-tune skills (Crea 2011). ‘Traditional’ learning methods such as didactic lectures 
are one step in developing competence often via repetition, but by using simulation there is 
an opportunity to practice, build confidence and increase accuracy (Crea 2011). This stage of 
‘deliberate practice’ is recognised to be one stage in the path to mastery in health education 
(Scalese et al. 2008). When using simulation, it is also important to provide feedback and/or 
assessment, this acts as a method of debriefing, a key stage in the learning process (Crea 
2011). This is also in line with Kolb’s experiential learning cycle (Kolb 1984) as discussed in 
section 1.4.2. Feedback in VP scenarios, due to current designs, can be limited but in 
traditional methods there are equally no guarantees that this is comprehensive or coherent 
but if done well can be extensive. This is an area of ongoing development and evaluation in 
VPs to provide useful and structured feedback without completely loosing variability between 
individuals.   
A pertinent statement which summarises the significance of VPs and learning is that VPs:  
‘’are not merely an object/tool but rather a learning activity’’ (Georg and Zary 2014). 
This embraces the idea that VPs are a learning activity and consequently need a strong 
educational foundation, they are not simply a method of delivery. This stance has been 
adopted throughout this research study in an attempt to ensure that the VP under evaluation 
is evaluated considering educational theory and learning.  




There are many VP designs which are, in part, reflective of the definition range (section 2.3.2) 
and by the progression of the technology over time. Early designs, such as the one discussed 
by Stevens et al. (2006), were especially limited due to the abilities of the technology. VP 
technology can incorporate various technological modalities named examples being voice 
recognition, eye-tracking software, animations, videos, and written information. VPs vary in 
design but features include: the level of interactivity; the ability of the system to track 
performance; the method by which information is requested and provided; the type and 
delivery of feedback; the type and delivery of assessment (if incorporated within the system); 
integration of other multimedia and; how the technology is structured, developed and 
maintained (Guise, Chambers, Conradi, et al. 2012).  
The two main types of VP design are linear and branched (narrative). Branched VPs are the 
focus of this dialogue, but some linear VPs are also included. Linear designs, such as the one by 
Pereira and Cavaco (2014) do not allow progression within a case on the basis of an incorrect 
decision. If an incorrect decision is selected, the programme will return the user to reattempt 
the question. Some systems will allow a maximum number of attempts or a time limit (Pereira 
and Cavaco 2014). 
Branched VPs have alternative routes through the case and can potentially have several 
conclusions. The cases do not correct mistakes and allow the user to complete the case before 
giving feedback. They focus on decision making and emphasise patient-centered approaches, 
encouraging users to reflect on their performance and the case outcomes in line with 
reflective learning (Guise, Chambers, Conradi, et al. 2012). Although branched designs can be 
more expensive to produce than linear, as each pathway has to be carefully designed and 
there is limited opportunity to use a case template (Bearman et al. 2001).  
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The designs of a branched and a linear VP to teach communication skills to medical students 
were compared in one study in an attempt to establish the preferred design (Bearman et al. 
2001). Although conducted almost 20 years ago (1998-1999), the results appear to still be 
pertinent as narrative VPs were shown to be favourable for teaching communication skills, 
something that is still referred back to and discussed today (Huwendiek et al. 2009, Saleh 
2010, Guise, Chambers, and Valimaki 2012). In the original study, the student participants 
were assessed via an standadised patient interaction at baseline and after using the VP. This 
outcome may have been limited by outside confounders due to possible subjectivity between 
standardised patients (Bearman et al. 2001), but as an exploratory study, it was a pioneering 
evaluation of VP design. 
Guise, Chambers, Conradi, et al. (2012), suggested that when designing a branched VP, the 
‘ideal’ case pathway case should be developed first before alternative pathways based on 
other choices and decisions are created. This method was also adopted by Bracegirdle and 
Chapman (2010) and Shah et al. (2012). The primary pathway helps mark important stages in 
the case and aids the development of feedback linking to each decision (Guise, Chambers, 
Conradi, et al. 2012). Within Guise, Chambers, Conradi, et al's. (2012) review, five phases for 
the development of VPs were established. Understanding educational needs and learning 
goals, which includes the integration of the VP case into a wider curriculum with specific 
learning outcomes. This stage is echoed to be important in multiple other studies (Edelbring et 
al. 2011, Pereira and Cavaco 2014, Hege et al. 2016, Baumann-Birkbeck et al. 2017). The 
second stage concerns Conceptualising and designing, this concerns the transition of the 
learning outcomes into a task and the third and fourth stages of design and construction of 
multimedia components, or the technical aspects of development, and usability and 
evaluation, which can incorporate content validity assurances. The final stage is improving the 
design, which further refines the designs following feedback in the previous phases. Aspects of 
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this were adopted in the development of the VP under investigation as discussed in Section 
1.5.3.  
The VP discussed by Bracegirdle and Chapman (2010) was similar in design to the VP of this 
study as it followed a branched design using decision trees to map the case pathways. The 
system did not make the user aware that they had made mistakes and the VP itself provided 
feedback at the end of the scenario. The authors discussed how experiencing the 
consequences of clinical mistakes is a learning tool supplementary to the programme’s overt 
intentions of improving communication skills. The system was stated to be adaptable to a 
range of settings such as individual or group use and could include both formative and 
summative assessments. It was used to teach undergraduate pharmacy students but, the 
authors highlighted the potential of the technology to teach qualified pharmacists (Bracegirdle 
and Chapman 2010).  
2.4 Virtual patient use 
The next part of this chapter summarises the use of ‘VPs’ in various health professions. 
Throughout this section, VPs are made reference to but there are a range of VP designs and 
definitions, this is highlighted where relevant. Many of the technologies are referred to as VPs, 
but they may not be completely in keeping with the adopted definition of this research, they 
are presented to give an overview of health ‘VP’ technologies.  
 Medicine 
In medicine, some of the most common VP applications appear to teach communication skills, 
clinical reasoning, and history taking. High fidelity mannequins appear to be particularly 
common in medicine and nursing to teach practical skills, such as cardiopulmonary 
resuscitation (CPR) (Lin et al. 2011). A well-adopted medical VP is Harvey, a cardiology patient 
simulator. This is a high-fidelity VP, but despite this, the research evidences mainstream 
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integration of a simulation technology. Harvey was designed in the USA but has now been 
adopted to multiple U.K. medical schools for undergraduate teaching, suggesting a degree of 
generalisability. Harvey has also proved popular on student satisfaction surveys and was rated 
highly at the end of course monitoring for assessing academic standards (Issenberg et al. 
2003).  
One study provided an overview of the use of ethical VPs in medical students in multiple U.K. 
universities, this demonstrated an extended role of VPs outside of the initial clinical domain. 
The authors stated that the VPs were popular, increased enjoyment of learning, and 
potentially improved ethical decision making by creating relatable ethical scenarios; there was 
limited evidence presented to support this conclusion (Hooper 2015).    
Botezatu et al. (2010) developed a framework for VP design and evaluated VP use in medical 
students, identifying that their main purpose was to develop critical reasoning skills. This is 
something that has been identified as the main purpose of medical VPs but appears to be less 
investigated in other professions. It was suggested that VP use possibly has a regulatory-effect 
on a personal level as VPs can help students to plan their learning (Botezatu et al. 2010). This 
looks to be absent elsewhere in the literature but appears to be an evidenced conclusion. In 
the study particular importance was placed upon including the user’s perspective to 
successfully develop VPs. The main themes identified were learning, teaching, assessment, 
authenticity, and implementation (Botezatu et al. 2010). Qualitative methods were used, and 
another area discussed was that VPs aided the development of critical reasoning through a 
combination of ‘’developing transferable skills, knowledge retention and enhancement, and 
highlighting the importance of making mistakes’’. The students identified that the VPs were 
useful across all clinical specialties, particularly to support the learning of topics not seen 
during clinical rotations, an already recognised advantage of VPs (Ellaway et al. 2009). The 
students thought that communication skills fell outside of the scope of VPs, but, this may be 
because the VP was linear with case study characteristics; no animations or avatars were 
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incorporated (Botezatu et al. 2010). The authors identified some limitations with their system 
and stated that to reach its educational goal, a VP must meet a level of authenticity and 
overcome implementation barriers (Botezatu et al. 2010). 
Psychiatry has made use of VPs, for example, Shah et al's (2012) work evaluated the use of a 
VP in medical students to teach and assess student’s abilities to identify major depression 
symptoms. Results had favourable opinions on VP use: it was enjoyable, simulated real life and 
was a good educational tool (65.4%, 24.1%, and 65.8% agree it was good/excellent on a five-
point Likert scale respectively) (Shah et al. 2012). Likewise, a rheumatology-based 
phenomenology study in a sample of Swedish medical students, found that VPs promoted 
clinical reasoning and helped student’s transition from textbook to ‘actual patients’ (Edelbring 
et al. 2011). Still, VPs were found to lack emotional interactivity and the complexity of real 
patients. This VP also lacked a level of technological sophistication as the VP cases were 
presented by video clips, images, and text; there were no animations or direct user interaction 
with a patient. The students reported that despite the absence of external pressures, they did 
not want to lose face in the situation and wanted to appear knowledgeable. A concluding 
statement was that VP use was not yet conceptually established and that additional research 
could add to the conception of VPs and their uses (Edelbring et al. 2011), highlighting 
requirements for further research.  
Tan et al. (2010) discussed three examples of VPs used in geriatric medicine, including some 
which were peer-reviewed and well established in U.S. medical schools. The evaluation was 
not detailed but the VPs were suggested to be effective, well-liked and successful. Further 
research requirements included considerations for different users, assessment integration and 
curriculum development (Tan et al. 2010). Similarly, a small pilot study of medical students 
trialled the usability, accessibility, and acceptability of one VP aiming to develop clinical 
reasoning skills (Patel et al. 2011). Findings suggested that VP users required little instruction 
on the use of the software but that performance when using a VP could be adversely affected 
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by technological barriers, these must be overcome before the technology becomes a useful 
learning experience (Patel et al. 2011). This highlights the need for functional, effective 
technology to be available before any learning can occur. 
There has been less research conducted regarding the use of VP in qualified doctors. One 
planned study incorporated a VP into a CPD programme on smoking cessation for doctors. It 
was hoped that the programme would improve smoking cessation consultations by creating 
an opportunity for practice and performance feedback, disappointingly results are not 
available (Ruiz 2011).  
The literature concerning medical VPs showed varied research. There was a reasonable 
quantity, but studies were individualised and did not merge easily into a body of evidence. 
Many of the technologies were unique with wide-ranging purposes and evaluations, there is a 
clear gap regarding the use of VPs in qualified doctors. This is something echoed in other 
professions (sections 2.4.2, 2.4.3 and 2.4.4) and evidences the need for research into VP use 
by qualified professionals.  
 Nursing 
Nursing appears to be second to medicine in the volume of VP related research. Research has 
shown nursing students find it difficult to apply theoretical knowledge in a clinical context and 
VPs have been trialled to bridge theory and practice (Georg and Zary 2014). Similar to 
medicine, VPs to develop clinical reasoning have been assessed in nursing. One study found 
that VPs were engaging and they supported the development of clinical reasoning skills, 
although review methods were not discussed (Georg and Zary 2014). 
Another study initially developed a framework for VP design, before the authors created, 
evaluated, and implemented a VP in qualified mental health nurses. The study was cross-
European and rigorous validity testing was undertaken. Findings focused on the design and 
implementation of the VP and the authors stated that the VP had good feedback but did not 
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elaborate; the exact aesthetic of the VP was unclear (Guise, Chambers, Conradi, et al. 2012). It 
was stated that in-depth evaluative research into narrative VPs was required and, as this study 
is one of only a handful that used VPs in qualified HCPs, it shows a need for more research in 
this area.  
A further study that used qualified nurses as participants, considered the use of VPs for 
formative assessment to develop clinical reasoning skills (Forsberg et al. 2016). Using 
deductive content analysis of participant self-evaluations, the authors reported that there was 
a progression of clinical reasoning throughout the course. The course involved three VP 
assessments hosted on Web-based Simulation of Patients, a well-evaluated VP system (Zary et 
al. 2006, Forsberg et al. 2016). Evaluation tools were based on Kolb’s Learning Cycle (Kolb 
1984), a key part of which is reflection to gain experience in a deeper way. Over time, the 
participants moved through the cycle and became more aware of the clinical reasoning 
process. Generalisability to other scenarios was limited, as stated by the authors, due to the 
sample size (n=14) (Forsberg et al. 2016).  
One study targeted a specific area of clinical practice that requires additional levels of nurse-
led patient counselling as the basis of a VP (Moule et al. 2015). The branched VP trained 
nurses in prostate cancer counselling, and it was developed to be part of CPD; participants 
included qualified nurses and students. A mixed methods evaluation was employed, and most 
users recommended the VP to others, some indicated that it would positively impact their 
practice. A negative aspect of the VP was that the VP was an isolated learning opportunity, as 
there was little opportunity for peer-based learning. The authors responded by stating that a 
blended learning programme may be most appropriate to integrate this VP into practice. 
Within the scenario, a novel design feature was that the nurses were interrupted and had to 
decide if to carry on the consultation or if to deal with the distraction, this added to case 
authenticity (Moule et al. 2015).  
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In nursing, VPs appeared to be well-liked and usable but there is still a need for wider 
investigation and integration, especially using qualified staff. 
 Multi-disciplinary applications  
The use of VPs has been applied to a range of multi-disciplinary settings and some studies 
have used several types of HCP as participants. VPs were used to complement a CPD course 
normally involving standardised patients, and findings showed that VPs were equivalent to 
standardised patients for improving performance and diagnostic ability (participants in the 
intervention group experienced a greater increase in their ability to diagnose when compared 
with the control group, P=0.054). This was not significant but the authors stated there is a 
potential place in training for qualified healthcare professionals (HCPs) using this technology 
(Triola et al. 2006). The HCPs involved were mostly nurses and doctors with a proportion of 
‘other providers’, with no elaboration (Triola et al. 2006). 
A Cochrane review was planned to evaluate the use of VPs for HCP education. It aimed to 
evaluate VP effectiveness versus traditional learning, other types of simulation and other types 
of e-learning, the review disappointingly has now been withdrawn with no reason provided 
(Kononowicz et al. 2016). The review had hoped to consider the education of both pre-
registration and post-registration HCPs and a range of HCPs, including pharmacists. The review 
protocol acknowledged that those already trained have equally important continuing 
educational needs as those unqualified or in training and that VPs may help to meet these 
needs. The review was only to include randomised controlled trials (RCTs) and cluster RCTs 
which may have limited eligibility (Kononowicz et al. 2016).  
A meta-analysis considered the use of VPs across health education against either no 
intervention or another form of education (Cook et al. 2010). The analysis involved six 
databases and included all types of HCP. A mixture of qualitative; quantitative-intervention 
controlled and non-controlled; and comparative studies were identified and analysed. It was 
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cited that comparisons between this range of method were difficult and only limited 
conclusions could be drawn. Qualitative studies were excluded from the meta-analysis. When 
compared to no intervention VPs were consistency associated with higher learning outcomes 
(pooled effect sizes >0.80 for outcomes of knowledge, clinical reasoning, and other skills); 
there were small and insignificant findings when VPs were compared with other non-
computer based interventions (pooled effect sizes -0.17 to 0.10 and non-significant). The 
review concluded that VPs were non-inferior to other methods but an advantage was that 
they may remove logistical barriers for providing education (Cook et al. 2010).  
A similar review found that, although the nature and use of VPs vary widely, VPs are well 
suited to the development of history taking, examination, communication skills, and 
procedural skills to name a few examples (Cook and Triola 2009). But, in order to become 
competent in these skills there are three components to master: understanding the principals 
involved; using the skill efficiently and; performing the skill effectively. The latter two principles 
are particularly where VPs are useful especially as they may help transfer knowledge into 
practice (Cook and Triola 2009).  
A  review of studies incorporating multiple professions stated that virtual simulation, including 
VPs, holds promise for CPD but that this requires in-depth research as well as considerations 
for placement within a particular curriculum (Duff et al. 2016). The authors also stated that 
regardless of profession, virtual simulation programmes are more effective in the earlier 
stages of training (Duff et al. 2016), but only three studies supported this finding and only one 
included qualified professionals: six medical doctors. These studies had small sample sizes and 
limited significance. The review stated that virtual simulation has been shown to be as 
effective, and in some cases superior to traditional educational approaches and their use for 
qualified professional’s CPD should be investigated (Duff et al. 2016).   
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The evidence for the use of VPs in a range of health professions shows the efficacy of some VP 
technologies, but the body of literature is still lacking and multiple studies have signalled the 
need for more research, especially in qualified HCPs. Ultimately, there were vast differences 
between the studies, their technology, and designs.  
 Pharmacy 
VPs in pharmacy have been investigated using a range of VPs designs, methods, and 
participants. This will be explored in more depth in chapter 3, a brief overview is presented 
below.  
A review by Jabbur-Lopes et al. (2012), highlighted that there were few relevant studies on 
VPs in pharmacy, only seven at the time. Most of these involved participants, mostly students, 
interacting with a VP followed by an evaluation. Evaluation methods all included an element of 
user satisfaction, typically via a questionnaire. Five of the seven studies also assessed some 
form of competency such as clinical ability; all the studies used quantitative methods. VPs 
were used as a method of practising either clinical or communication skills or both; some 
involved an assessment; others were purely learning resources. But, in all seven cases, the 
authors reported a high level of user satisfaction. Some of the studies did not discuss their 
limitations and most were not able to generalise beyond their original samples. The review 
stated the need for more studies into VP use, using broader populations. This is true for 
graduate and undergraduate applications and the use of VPs needs to be tested 
internationally to authenticate uses (Jabbur-Lopes et al. 2012). The authors discussed the lack 
of validated instruments to evaluate VPs and this was something also found in this study 
during the questionnaire design process (section 5.4.1). Furthermore, most studies in the 
review were conducted in the U.S, which highlights that the U.K. and Europe are lagging 
behind in being VP pioneers; all of the studies were conducted on students. The need for more 
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sophisticated graphics and animations are required according to the review recommendations 
(Jabbur-Lopes et al. 2012). 
VPs in pharmacy have been used for a range of applications. One review considered the use of 
simulation to teach pharmacy-practice to pharmacy students and investigated how this 
translates to patient care (Kane-Gill and Smithburger 2011). Results found that the most 
common applications were in therapeutics, communication, physical examination, patient 
safety and care for populations not exposed to in practice. This review included all types of 
simulation; only two out of 17 studies used VPs, most were high fidelity mannequins. Other 
technologies included standardised patients, simulation goggles, and a ‘dispensing and 
counselling’ simulation. The lack of VP-specific research adds to the growing evidence for 
further VP investigation. The review stated that simulation has established value in teaching 
pharmacy students but this has not been transmitted to CPD for qualified pharmacists (Kane-
Gill and Smithburger 2011); a key area that this research will address. 
Multiple studies have been conducted into the use of VPs for undergraduate pharmacy 
students (Battaglia et al. 2012, Cavaco and Madeira 2012, Al-Dahir et al. 2014, Bindoff et al. 
2014, Pereira and Cavaco 2014, Smith et al. 2014, Menendez et al. 2015, Smith and Benedict 
2015). Many of these used designs incorporating a mixture of pre and post-tests, and 
satisfaction surveys, often using Likert scales (Douglass et al. 2013, Al-Dahir et al. 2014, Bindoff 
et al. 2014, Smith et al. 2014, Zlotos et al. 2016). Most of the studies investigated the possible 
change in knowledge immediately after using the VP; only one study considered long-term 
outcomes (Bindoff et al. 2014), this is a drawback when evaluating VP literature.  
Several studies had similar results: comparing the use of VPs and paper-based learning, VPs 
were found to be superior and improve knowledge and counselling skills and were more fun 
and engaging (Battaglia et al. 2012, Douglass et al. 2013, Bindoff et al. 2014, Smith et al. 2014, 
Zlotos et al. 2016). A study simply evaluating VPs without a control also had positive results, 
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suggesting the need for increased VP technology (Smith and Benedict 2015). Positive user 
feedback, satisfaction, and change in confidence have also been reported.  
It appears that the vast majority of the studies evaluating VP use in pharmacy were conducted 
on students rather than qualified professionals and there is a need for further research in this 
area. Battaglia et al., (2011) trialled their VP on almost 50 pharmacists in addition to pharmacy 
students and measured changes in knowledge and confidence. It was reported that 
participant’s confidence significantly increased after VP use (pharmacist change -0.4, P=0.03; 
student change -0.7, P=0.01, where a negative score is an improvement in confidence). 
Overall, there were greater benefits reported in the pharmacist group compared to students, 
this suggests the potential significance of educational interventions aimed at pharmacists 
(Battaglia et al. 2012). No studies focused on VP educational interventions in qualified 
pharmacists, this further enforces the need for this piece of research.  
VPs in pharmacy appear to have shown themselves to be effective tools for undergraduates 
but, what is still absent from the literature is evidence for the use of VPs in qualified 
pharmacists, which is the main topic of this study.  
2.5 Research needs 
Due to increasing economic pressures, raised expectations and reduced resources, the training 
of HCPs is increasingly under pressure and it has been suggested that VPs may offer a step to 
resolving some of these issues (Cook and Triola 2009), especially as they are unique in their 
almost unlimited design potential (Stevens et al. 2006). VP software has demonstrated distinct 
advantages in healthcare, particularly for those in the process of becoming qualified HCPs. 
Advantages include versatility, mobility, and accessibility to maximise scenario realism with a 
low level of risk (Douglass et al. 2013). This is relevant as it has already been discussed that 
one area needing further research is authenticity and learner engagement of VPs (Hege et al. 
2016).  
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Many studies do not clearly discuss VP design (Guise, Chambers, Conradi, et al. 2012) and few 
studies use sophisticated technology with some using now out-dated video-based technology 
as opposed to animation (Stevens et al. 2006, Shah et al. 2012). This suggests a gap in the 
literature involving more recently developed VP technology (Edelbring et al. 2011). As already 
discussed, some studies had limited sample sizes and limited generalisability both from the 
point of view of the study designs and of the technologies to be used outside their original 
applications. Jabbur-Lopes et al. (2012) highlighted the relevance of limited generalisability 
and the need for research in wider populations to validate VP use. Most studies cited 
originated in the U.S and few were conducted in the U.K. or Europe; there is a gap in the 
literature considering the use of VPs in additional localities. There is also a large amount of 
research in medicine but this appears to be less true of other professions and similarly, VPs 
account only for a small proportion of research into the wider concept of simulation (Vyas et 
al. 2013, Kononowicz et al. 2015). This suggests that VPs may not be as conceptually 
established as other types of simulation which is in keeping with findings by Edelbring et al. 
(2011). A number of the discussed research needs have been incorporated into this study with 
the intention to investigate a clearly and recently designed VP.  
VPs have been suggested to be non-inferior to traditional teaching methods and they can 
potentially remove some logistical barriers associated with providing educational 
interventions (Cook et al. 2010). But, despite evidence for VP use, no study has primarily 
focused on qualified pharmacists as VP users. This is especially relevant as those already 
trained as HCPs have equally important continuing educational requirements as students and 
VPs may potentially be one way to meet these needs (Kononowicz et al. 2016). The possibility 
to teach qualified HCPs including pharmacists has been highlighted as a future research area 
by multiple studies (Bracegirdle and Chapman 2010, Kane-Gill and Smithburger 2011, Duff et 
al. 2016, Thompson et al. 2016a, 2017), further demonstrating the need for this evaluation 
which includes qualified pharmacists as participants.  




This chapter presented an overview of the use of VPs in healthcare. This included VP designs, 
definitions, educational foundations, and purposes, as well as evaluations of VPs in the 
literature. The wider spectrum of simulation was highlighted along with the position and role 
of VPs within this. The advantages and disadvantages of VPs were debated as well as 
considerations for the potential implications of VP use. VP roles in practice were also 
considered, including how they compare to alternative modalities and how VP use may 
overcome barriers associated with other resources. Some current applications of VPs in a 
range of disciplines were conversed. An overview of pharmacy-specific research was 
presented to understand the systematic review that follows. Research needs and 
recommendations have been emphasised throughout. This dialogue has provided insight into 
VP research and has indicated where this study will provide well-needed evidence regarding 
the use and integration of VPs into clinical pharmacy practice.  
3. Systematic Narrative Review 
44 
 
 Systematic narrative review 
3.1 Introduction 
This chapter follows on from an overview of the literature on the use of VPs across a range of health 
settings, including a discussion of their designs and purposes. In this chapter, this will be further 
explored through a systematic narrative review of VP use specifically in pharmacy education. The 
review methods will be presented, which includes the search terms and databases used, as well as 
the eligibility criteria, and how the quality of the literature was assessed. There is an explanation of 
the searches undertaken and the resulting literature retrieved. The studies are critiqued relevant to 
the wider VP evaluation to identify gaps and inconsistencies in the literature. This review has been 
published in The BMJ Simulation and Technology Enhanced Learning (Richardson et al. 2019). 
3.2 Objective 
The focus of this review was VPs as a sub-type of simulation. The objective was to establish and 
evaluate the literature on the use of VPs in pharmacy, where ‘VPs’ are clearly defined. This included 
VPs that were used to develop or contribute to, communication or counselling skills, in pharmacy 
undergraduate students, pre-registration pharmacists, and registered pharmacists. Communication 
and counselling skills were chosen as there had not been a previous review which investigated this 
specifically, despite this being recognised as a purpose of VPs (Kane-Gill and Smithburger 2011). 
Secondary outcomes were to gather information on the evaluation methods of the studies. 
3.3 Methods 
Chapter 2 presented an overview of VP literature and it was clear from this that VP uses in various 
professions were varied as were the designs, definitions, and evaluation methods. On the basis of 
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this, the use of VPs within pharmacy needed to be established with a focus placed upon technology 
identifiable with that of the wider study, either in design or purpose.  
A systematic narrative review attempts to collate literature using pre-defined criteria to meet a 
specific objective (Liberati et al. 2009). This includes a clearly defined search strategy with 
considerations for study validity and quality with the systematic presentation of the characteristics 
and findings into one narrative (Thomas and Harden 2008, Liberati et al. 2009). A systematic 
narrative review is useful to collate literature that is unsuitable for meta-analysis (Popay et al. 2006, 
Cochrane Collaboration 2018). This method was chosen because the VP studies used varied VP 
designs, evaluation designs, methods, and outcomes. This meant that meta-analysis was not 
plausible, a cited problem in another VP review (Cook and Triola 2009). 
The PICOS (population, intervention, comparison, outcomes, and study design) approach for 
determining eligibility criteria and elements of the PRISMA guidelines (Liberati et al. 2009, Moher et 
al. 2009) were used in the reporting of this review.  
 Eligibility criteria 
The inclusion and exclusion criteria used PICOS to identify studies that were suitable for the review 
(Table 3.1) (Moher et al. 2009), although, there were some limitations to this method as some VP 
evaluations did not use a control as the focus was on the technology. Therefore, the PICOS 
framework was not ideal and was used only broadly to provide structure for the eligibility criteria. 
Ultimately, the eligibility criteria did not discriminate between study designs or outcomes but rather 
focused on the VP designs and purposes (Table 3.1). This maximised eligibility on the basis of the VP 
technology although studies had to include VPs that incorporated communication or counselling 
skills. The review did not exclude studies on the basis of their design or outcomes. If the nature of 
the VP technology was unclear and could not be established the study was excluded as this was the 
highest priority assessment in deciding eligibility. Grey literature was also excluded as this is 
recognised to have not been formally published and in some cases peer-reviewed (Jesson et al. 
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2011). It was also unlikely to be returned by the search engine used. All types of participants were 
included provided some aspect involved pharmacy students, pre-registration trainees or qualified 
pharmacists. 
PICOS Inclusion Exclusion 
Participants  Studies that used pharmacists, 
pre-registration pharmacists, and 
pharmacy students. 
Studies not using qualified pharmacists, pre-
registration pharmacists or student 
pharmacists. Where studies used more than 
one type of participant, provided part of this 
met the inclusion participant criteria the study 
was included. 
Intervention Studies evaluating, using or 
developing a VP that is in keeping 
with the definitions of this study 
or one that teaches, develops or 
contributes to counselling, 
communication or consultation 
skills. This had to include direct 
patient interaction. 
Studies incorporating a VP that is not in 
keeping with the definition of this study or 
with the purpose of the VP in this study. This 
included high-fidelity programmes and case 
studies. Where studies involved multiple 
technologies provided at least one was a VP 
the study was included. If the nature of the VP 
could not be established the study was 
excluded.  
Comparisons Studies using, evaluating or 
developing a VP with or without a 
control. 
Studies were not excluded on the basis of the 
presence or absence of a control.  
Outcomes All VP-related outcomes were 
considered including knowledge 
and confidence, perspectives, 
thoughts, and implications.  
Studies were not excluded on the basis of the 
presence or absence of particular outcomes 
provided the VP and population were relevant.  
Study Design All designs were included 
provided the nature of the VP 
was appropriate.  
Studies were not excluded on the basis of their 
design. Conference abstracts, pilot studies, 
descriptive studies and ‘grey-literature’ were 
excluded.  
Table 3.1 Eligibility criteria for inclusion of a research study in the systematic review 
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 Databases  
The EBSCO search engine was used to undertake the literature search. This enabled a selection of 
health, pharmacy, and educational databases to be screened; Medline, AMED, CINAHL, and ERIC as 
summarised below (Health Education England and NICE 2018). Searches used a comprehensive 
series of search terms selected from Medical Subject Headings terms and combined using Boolean 
operators. Similar to Peddle et al. (2016), only studies from post-2000 were included as initial 
searches revealed that the majority of VP literature was from this timeframe. Electronic databases 
searches were accompanied by manual searches of the reference lists of eligible studies. 
• CINAHL - Cumulative Index to Nursing and Allied Health Literature. This includes allied 
professionals and is also cited to include health education studies. It was anticipated that multi-
disciplinary studies may be retrieved.  
• Embase - Excerpta Medica Database. Consists of three smaller databases and includes specific 
pharmacy or pharmaceutical studies covering many aspects of health.  
• Medline. A general medical database, interests include continuing education.   
• ERIC - Education Resources Information Center. A database of educational literature and 
resources.   
 Search terms and strategy 
A combination of 'virtual patient', avatar, 'computer simulation', education, counselling, 
communication, pharmacist, pharmacy, ‘pharmacy student’, ‘Pharmacy Undergraduate’, ‘Pre-reg’, 
and ‘Pre-registration’ were used. Synonyms of the terms were incorporated to make the strategy as 
comprehensive as possible. It appeared that relevant technology was most commonly referred to as 
a virtual patient but for completeness ‘avatar’ and ‘computer simulation’ were also included. Other 
terms trialled were ‘pharmaceutical’ and ‘serious gaming’, but these were found to be too broad and 
too restrictive respectively. Different variations of words were considered, for example, programme 
versus program. The search was re-run frequently to update the findings, the last being in May 2019.  
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((('Virtual patient' OR avatar OR 'computer simulation' OR 'programmable patient' OR 
‘programable Patient' OR ‘computerised patient’ OR ‘computerized patient’) AND 
(pharmacist OR pharmacy OR 'pharmacy student' OR 'pharmacy undergraduate' OR 'pre reg' 
OR 'pre registration') AND (education OR training OR counseling OR counselling OR 
consultation OR communication))). [The adopted search strategy for the systematic review]   
 Study selection 
Study selection was based on the work by Moher et al. (2009) to search for and screen potential 
studies using the approach of identification, screening, eligibility, and inclusion (Figure 3.1) (Moher et 
al. 2009). Mendeley reference management software was used throughout. The search was 
undertaken, and duplicates removed before the titles were screened. Only studies that were 
obviously unrelated to the review topic were excluded, this accounted for the majority of exclusions. 
Study abstracts were then screened with those that did not meet the criteria being excluded. The 
remaining studies underwent an in-depth screen with an emphasis on the methodological quality 
and findings (Table 3.2). Where a foreign language study was found, a search for an English version 
was conducted or Google Translate was used to translate the title; no foreign language studies were 
involved past title screening. Similarly, if the nature of the VP was unclear, for example, VPsim 
technology (https://let.pitt.edu/vpsim/) was repeatedly cited but this was not always accompanied 
by a description, a Google search established the nature of the technology. If the technology was still 
unclear the study was excluded. The findings of the studies were thematically analysed and this is 
reported in section 3.4.3. A thematic approach was used due to difficulties in making direct 
comparisons between studies as suggested by Thomas and Harden (2008). 
 Assessment of quality 
The main quality assessment instrument that was used was an appraisal tool which was designed to 
evaluate educational interventions (Morrison et al. 1999). The instrument asks nine key questions of 
a study including: is the nature of the intervention clear and, are the outcomes chosen to evaluate 
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the intervention appropriate? This tool was the main instrument used to evaluate the quality of the 
studies included in this review, although the critical skills appraisal skills programme (CASP) tools for 
qualitative research, cohort studies and randomised controlled trials (Critical Appraisal Skills 
Programme 2018a, 2018b, 2018c) were also used to supplement the tool by Morrison et al. The 
quality of the studies is summarised in Table 3.3. 
In addition to the nine questions covered by Morrison et al.’s appraisal tool, other factors which 
were considered in the quality assessment concerned the quality of the study design and reporting. 
Named factors included the study setting and participants; recruitment and sampling; ethical 
approval; study instruments; quality measures and limitations; and the outcomes measured. These 
were decided upon after reviewing the content of the tools.  
3.4 Results 
Liberati et al. and Moher et al. (2009) discussed that a review flowchart should include information 
concerning study identification, initial screening, and eligibility assessment, this was adopted and is 
presented in Figure 3.1 (Liberati et al. 2009, Moher et al. 2009).  The 490 studies initially identified 
reduced to 57 after exclusions and after full reviews, 8 studies remained. Most exclusions occurred 
in the first phase, the most common reason being that the studies did not relate to VPs or pharmacy; 
a noticeable volume of studies related to medicine and nursing. The most common reason for 
exclusions after an abstract review was that the technology did not meet the definition of the VP 
adopted in the wider research. A large proportion of the excluded studies, despite describing a ‘VP’, 
did not include direct patient contact such as questioning or counselling. Five reviews on VPs or 
simulation technologies more broadly were excluded because they were not identifiable with the 
aim of using VPs as previously discussed and in pharmacy populations. Each review was screened for 
relevant individual studies.  
  










Studies remaining n = 393 
Screening of titles on basis of 
inclusion and exclusion criteria  
Second Screening 
Studies remaining n= 111 
Review of abstract for relevance 
Studies for inclusion in review 
Exclusions 
282 studies excluded due 
to eligibility criteria - not 
VP related or pharmacy 
based.   
Exclusions 
49 studies excluded 
Not VP n=38  
(Standardised Patient n=3, 
no patient interaction 
n=16, online learning 
package n=1, physical 
system or resource n=2, 
dispensing only n=1, email 
interaction n=1, other 
n=14)  
Descriptive n=5 
News piece n=1 
Review n=5 
Full Screen 
Studies remaining n= 57 
Review of full study for relevance  
Exclusions 
54 studies excluded - 
not VP related or 
pharmacy based.   
Search Terms  
((('Virtual patient' OR avatar OR 'computer simulation' OR 'programmable patient' OR 
‘programable Patient' OR ‘computerised patient’ OR ‘computerized patient’) AND 
(pharmacist OR pharmacy OR 'pharmacy student' OR 'pharmacy undergraduate' OR 'pre 
reg' OR 'pre registration') AND (education OR training OR counselling OR counselling OR 
consultation OR communication))) 
Studies included n= 8 
Exclusions 
97 duplicates removed  
Figure 3.1 Systematic literature review flowchart 
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 Study characteristics  
The studies were screened to establish the nature of, and characteristics of each (Table 3.2). 
Particular importance was placed upon the VP technology and purpose. The studies all used 
different technologies and applications, further highlighting the difficulty in comparing them. VP 
purposes included improving subject-specific knowledge (Fleming et al. 2009, Douglass et al. 2013, 
Zlotos et al. 2016), clinical care (Zary et al. 2006, Shoemaker et al. 2015), and communication skills 
(Taglieri et al. 2017). In relation to participants, four studies used pharmacy students (Loke et al. 
2011, Douglass et al. 2013, Bindoff et al. 2014, Taglieri et al. 2017), one study used pre-registration 
pharmacists (Zlotos et al. 2016), and three used various healthcare professional (HCP) students (Zary 
et al. 2006, Fleming et al. 2009, Shoemaker et al. 2015). The latter was included as it incorporated 
pharmacy perspectives and results were available for specific types of HCP. The studies used 
different evaluation methods, with the commonest being questionnaires before and after using the 
VP; some studies used randomisation (Fleming et al. 2009, Bindoff et al. 2014, Shoemaker et al. 
2015, Taglieri et al. 2017). 
All of the review studies evaluated VPs within formal educational programmes, the majority being 
undergraduate courses. Each VP was specific to its own application and evaluation thus direct 
comparisons of the educational values or of the evaluation outcomes are limited. The studies were 
selected based on their technology, but studies could have been excluded due to an unclear 
description. To minimise this, whole papers were closely scrutinised where clarity was lacking. 
 Quality of studies  
Half of the studies (n=4) did not report whether they had received ethical approval (Zary et al. 2006, 
Loke et al. 2011, Douglass et al. 2013, Taglieri et al. 2017) and none of the studies discussed 
considerations for sample sizes, although one did acknowledge that their sample was too small to 
statistically assess changes (Fleming et al. 2009). Where statistical analysis was used, the studies 
reported P values and significance.  
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Shoemaker et al (2015), and Fleming et al (2009), each randomised two groups and were medium 
and high quality studies respectively. The randomisation process was not detailed in either study, 
but both took measures to standardise outcomes and to address the quality and reliability of their 
findings. In both studies, the particular VP’s educational contexts were not discussed. In contrast, 
two other studies used randomised controlled designs (Bindoff et al. 2014, Taglieri et al. 2017). 
Bindoff et al. detailed their instrument design but used a small sample (n=33) which limits the 
findings, especially as some results were not statistically significant (Bindoff et al. 2014). In the other 
randomised study by Taglieri et al., some VP cases were compulsory and some were not, possibly 
skewing the sample. Additionally, the demographics of the two groups are not known (Taglieri et al. 
2017). There was some discussion of the VP’s educational context, but this was not comprehensive. 
Participation also declined throughout the study, and whilst it was not clear by how much, this could 
have affected results (Taglieri et al. 2017). 
Two studies used before and after tests as a comparison without a control group (Douglass et al. 
2013, Zlotos et al. 2016). Douglass et al., presented the VP’s educational context clearly, but there 
was limited discussion of potential bias within the study or of how the questionnaire was developed 
(Douglass et al. 2013). The study was of medium quality. Similarly, Zlotos et al., provided a limited 
discussion of the VP’s underpinning educational theory and its place within a curriculum. The 
evaluation was high quality but the study lost 43.4% of participants in the six months follow up, 
although this is not uncommon in longitudinal studies (Zlotos et al. 2016). 
Finally, the qualitative exploratory study by Loke et al. was of low quality. Sampling was not reported 
and there was limited information on the methods, but the study did report reliability, validity, and 
trustworthiness. Despite limited information on the study methods, the educational principles of the 
VP were detailed (Loke et al. 2011). In the work by Zary et al., which was also low quality, the VP 
evaluation was part of a wider study (Zary et al. 2006). The evaluation methods did not confer much 
depth and there were limitations due to the small-scale evaluation, although the description of the 
VP design was detailed (Zary et al. 2006). 
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Authors, Year of Publication 
and Study Title 
Study Setting Participants VP Design or Description 
Outcomes and 
Study Purpose 
Methods Findings Limitations 
Bindoff I., Bereznicki L., 
Westbury J., et al. 
2014 
A Computer Simulation of 
Community Pharmacy Practice 









A computer simulated 
community pharmacy, using 
Unity3D game development. 
Users select patient dialog 
resulting in text responses 
and animations 
















The VP group had 
improvements in knowledge 
(P=0.059;  computer-based 
group mean change 0.6; SD 0.3 
vs paper-based group mean 
change of -0.2; SD 0.3). 
Improved history 
taking (P=0.029)  and 
counselling (P=0.008) and the 
simulation being more fun 
(P=0.006) also reported; no 
further data. The VP was as 
effective as paper-based 
alternatives 
Limited sample 
size due to 
limited access 
to students 
Douglass M.A., Casale J.P., 
Skirvi, et al. 
2013 
A Virtual Patient Software 
Program to Improve Pharmacy 
Student 
Learning in a Comprehensive 










TheraSim, a web-based 
simulation software for 
HCPs. Simulations for clinical 
training. Identify and resolve 
drug-therapy problems 
including patient education 
To consider the 
impact of a VP 





There were significant 
improvements (P<0.001) in 75% 
of the competencies post-VP 
use. Mean score difference and 
CI are reported for each 
invidiual competency. The VP 
allowed for student assessment  
Not discussed 
Fleming M., Olsen D.E., Stathes 
H., et al. 
2009 
Virtual Reality Skills Training for 
Health Care Professionals in 
















shelf’ virtual reality 
simulation. Based on 
SIMmersion. Questions to 
ask the VP, to conduct 

















Demonstrated an increase in 
the alcohol screening and brief 
intervention skills of HCPs. 
Significant increases in the 
scores of the VP group at 6 
months compared to the 
control for screening  (mean 
change 14.44; SD 16.17; 
p=0.003) and brief intervention 
(mean change 5.82; SD 20.13; 
p<.04) 
Volunteer 









this. Not clear 
how many 





Loke S.K., Tordoff J., Winikoff 
M., et al. 
2011 
SimPharm: How pharmacy 
students made meaning of a 







SimPharm, a web-based 
simulation platform with a 
time-sensitive, persistent 
world where students are 
pharmacists. Users ask 
patients questions to live 
through the consequences 
of their actions 
To investigate 
how students 
made meaning of 














Findings identified differences 
in four areas: framing of the 
problem; problem-solving steps 
and tools used; sources and 
meaning of feedback; and 
conceptualisation of the 
patient. These can be used in 











Shoemaker M.J., De Voest M., 
Booth A., et al. 
2015 
A virtual patient educational 
activity to improve 
interprofessional competencies: 












A case representing a 
patient with diabetes via the 
VirtualPT and DxR Clinician 
internet-based virtual 
patient software. Team to 
complete history and 
examination and then 
develop a management plan 










RCT. VP IPE vs 
control 
The VP group had significantly 
(P<0.05) greater odds of 
improving 4 out of 5 IPEC 
competencies and 3 out of 9 
RIPLS items (see study for 
individual odds ratios). The IPE 
activity resulted in greater 
awareness of other professions 
scopes of practice, what other 
professions have to offer 
patients and how different 
professions can collaborate 
The effect of 















Taglieri C.A., Crosby S.J., 
Zimmerman K., et al. 
2017 
 
Evaluation of the Use of a 
Virtual Patient on Student 
Competence and Confidence in 
Massachusett






The Shadow Health VP 
program. Aim to improve 
student communication 
performance and 
confidence in mock clinic 
visits 
Assessment of 
VPs in a pharmacy 
skills lab. Effects 
on competence 
and confidence to 





VP before a 
clinic visit, 
control used it 
after. Pre- and 
post-
Higher performance reported in 
the VP group (asked over 4 
questions, all P<0.001) there 
was no change in confidence 
(56.6 to 55.3, P=0.206). 
Increased scores for the ease of 
use (26.6 to 76.2, P<0.001) and 
case realism (40.2 to 60.7, 
The study only 
considered one 
course in one 
pharmacy 
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decreased 84.8 to 73.8, 









some were for 
extra credits   




and pilot evaluation of a Web-
based Virtual Patient Case 










Web-SP: simulated patient 
encounter, students gather 
and analyse data to 
diagnose and treat a VP, 
including asking questions 
to gather information.  















Pilot evaluations using 1-6 
Likert in HCP courses showed 
that students regarded Web-SP 
as easy to use (median 5, !RQ 4-
5), engaging (median 4, IQR 3-5) 
and of educational value 
(median 4, 3-5). The system 
fulfilled the aim of providing a 
common generic platform for 
creation, management, and 







Zlotos L., Power, A., Hill D., et al. 
2016 
A Scenario-Based Virtual Patient 









Computer animations using 
computer graphics 
technology with dubbed 
voice actors. Educate on 
injecting equipment and 
opiate substitution therapy 
 
Develop and pilot 













Perceived knowledge increase 
pre (median 14, IQR 12-16) to 
post (median 19, IQR 17-20) 
and at 6 months (median 16, 
IQR 14-17). Also, confidence 
increased (varied questions). 
There was a loss of knowledge 











Table 3.2 The characteristics of the research studies included in the systematic review. IQR – interquartile range. 
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Authors, Year of Publication 
and Study Title 
Recruitment Strategy Sampling and sample size 
appropriate? 
Ethical approval Instrument 
development 
Quality measures and 
significance of findings 
Overall 
quality  
Bindoff I., Bereznicki L., 
Westbury J., et al. 
2014 
A Computer Simulation of 
Community Pharmacy Practice 
for Educational Use 
Volunteer students 
that met criteria 
regarding their level 
of study and year 
group 
33 participants (16 
intervention, 17 control) 
The Social Sciences Human 
Research Ethics Committee at 




The VP scenarios were 
piloted. Discussion of 
statistical tests: P values and 
standard deviations 
presented. Results discussed 
significance 
Medium  
Douglass M.A., Casale J.P., 
Skirvi, et al. 
2013 
A Virtual Patient Software 
Program to Improve Pharmacy 
Student 
Learning in a Comprehensive 
Disease Management Course 
Participation 
occurred 
automatically as part 
of a pharmacy course 
135 participants took part in 
various aspects of the study 
Not discussed Limited information 
on knowledge 
questions and 
survey. Pre- and 
post-tests were non-
identical 
Pre-defined VP definition in 
the questionnaire to 
attempt to ensure 
consistency. Explanation of 
statistics and P values 
presented but limited 
discussion relative to results 
Medium  
Fleming M., Olsen D.E., Stathes 
H., et al. 
2009 
Virtual Reality Skills Training for 
Health Care Professionals in 
Alcohol Screening and Brief 
Intervention  
Recruitment via 
email and screened 
via phone. Monetary 
payment for 
participation 
102 participants over two 
groups (n=51 in each). No 
calculation, states sample 
too small to assess some 
statistical changes 
The UW Madison Health 
Sciences Human Subjects 
Committee 
Detailed description 





Univariate analysis assessed 
effect of demographics. 
Mean scores before and 
after intervention with t-
tests and P values 
High  
Loke S.K., Tordoff J., Winikoff 
M., et al. 
2011 
SimPharm: How pharmacy 
students made meaning of a 
clinical case differently in paper- 
and simulation-based 
workshops 
Not discussed 20 participants. Fourth year 
BPharm students 
Not discussed Discussion of VP. 
Study used 
recordings and 




reliability, and triangulation. 
Analysis not detailed due to 
qualitative approach 
Low  
Shoemaker M.J., De Voest M., 
Booth A., et al. 
2015 
A virtual patient educational 
activity to improve 
Not discussed 72 fifth semester pharmacy 
(n=33), fourth-semester 
physician assistant (n=27) 
and fourth-semester 
physical therapy (n=12) 
The Human Research Review 
Committees at Grand Valley 




of self-designed and 
recognised but no 
further exploration 
Chi-squared tests, odds 
ratio, and P values reported. 








A randomized trial 
graduate students. No size 
calculations 
Taglieri C.A., Crosby S.J., 
Zimmerman K., et al. 
2017 
 
Evaluation of the Use of a 
Virtual Patient on Student 
Competence and Confidence in 




automatically as part 
of a pharmacy course 
Control n=140 Intervention 
n=5 141. No further 
comments on sampling 
Not discussed Order of labs, clinics, 
and VP use 
presented. 
Explanation of 
assessment and the 
survey 
Peer review of study 
instruments and protocol. 
Statistical significance 
considered, results 
discussed relative to 
significance and P values 
presented 
Medium  




and pilot evaluation of a Web-
based Virtual Patient Case 
Simulation environment – Web-
SP 
Students from the 
Karolinska institute 
Pharmacy students n=90. 
Focus on development of 
software rather than 
evaluation  
Not discussed Focus on VP design, 
evaluation tools not 
discussed 
No considerations for 
measuring significance and 
no explanation of evaluation 
Low  
Zlotos L., Power, A., Hill D., et al. 
2016 
A Scenario-Based Virtual Patient 
Program to Support Substance 
Misuse Education 
Participation was 
part of a mandatory 
educational program 
Interviews of 20 trainees (11 
control, 9 VP), with 4 
trainees having used both 
case studies 
The NES research governance 
group considered the study. 
Guidance was sought from 
the Chief Scientist Office for 
NHS Scotland 
Explanation of nature 
of the questionnaire 
Pilot of study instruments. 
Friedman’s test indicated a 
significant difference 
between the three 
assessments. 
High  
Table 3.3 Quality assessment of the research studies included in the systematic review. Study quality was categorised based on the content and 
reporting of the studies across the items of tables 3.2 and 3.3. This used a double review process with study supervisors. Low studies were typically 
small scale or brief in their reporting with a focus away from evaluation but on the technology; medium quality studies were more useful studies that 
were largely complete in their report with some limitations of methods or quality; high quality studies met all of the quality assessment criteria and 
were clear in the reporting of their findings.  
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 Thematic analysis  
The results of the eight studies were thematically analysed, with the aid of NVIVO 11. Four 
themes all relating to VP outcomes were identified in the findings of the studies: knowledge 
and skills (including competency and ability); confidence; engagement with learning; and, 
satisfaction. 
Knowledge and skills 
All of the eight studies incorporated some knowledge and/or skills assessment. Zlotos et al., 
measured knowledge changes after VP use by overtly measuring students knowledge. Findings 
established a significant change post-VP (median scores across two topics were 14 pre-test, 
interquartile range (IQR) 12-16 and 19 post-test, IQR 17-20; P<0.001). This decreased after six 
months, but was higher than pre-VP (median at 6 months 16, IQR 14-17; P<0.05) (Zlotos et al. 
2016). In contrast, the study by Bindoff et al., found an insignificant knowledge improvement 
between intervention groups and pre- and post-VP use (Bindoff et al. 2014). Although there 
was a significant increase in self-measured counselling competency between groups (mean 
difference in pre- and post-self-rated competencies computer vs paper group 0.9, 95% CI 0.3-
1.6; P=0.005) and the VP may have increased perception of counselling ability (Bindoff et al. 
2014). These studies reported conflicting knowledge outcomes although Bindoff et al.’s, 
participants still percieved a value in VP use. This is similar to Zary et al., who reported that the 
VP helped students to identify knowledge gaps and motivated them in the acquisition of 
knowledge, although this was not measured (Zary et al. 2006).  
In the work by Taglieri et al., participant performance in conducting mock patient interactions 
was an outcome and participant performance improved after VP use (control 45.18%, 
intervention 53.19%; P<0.001) (Taglieri et al. 2017). The authors discussed that a purpose of 
their VP was to enable reflection on performance and to apply skills and knowledge (Taglieri et 
al. 2017). This juxtaposes the participants who themselves did not perceive the VP as helpful 
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for improving performance. Participants did find the VP useful for understanding how to ask 
patients questions (Taglieri et al. 2017). Similarly, Douglass et al., assessed clinical-competency 
skills in drug-therapy problems post-VP use using standardised patient interactions. There was 
rigorous development of a competency checklist which included a quality assurance process. 
Student performance improved by 12% across the study (Douglass et al. 2013). This outcome 
was a useful measure, possibly more so than overtly testing knowledge as a clear value was 
demonstrated, although like in the study by Taglieri et al., participant perspectives may have 
also helped to contribute to further establishing the VP’s worth. 
Further considering participant performance, Fleming et al., showed significantly greater 
performance in excessive alcohol consumption screening and referral after VP use over six 
months (improvement in screening, control 3.7%; standard deviation (SD) 19.2 vs 
experimental 14.4%; SD 16.2). Whilst the VP may have statistically improved participants’ 
screening skills there is no evidence of an improvement in problem-solving, communication, 
and professional skills, as eluded to by the authors (Fleming et al. 2009). 
The work by Shoemaker et al. used a VP to facilitate an interprofessional educational activity, 
it measured competency using elements of two recognised scales (Interprofessional education 
collaborative and Readiness for Interprofessional Learning Scale) to consider interprofessional 
competency and communication. Results favoured the VP compared to a control 
(improvement on four out of five questions measuring communication: OR=20.18, P=0.000; 
OR=7.22, P=0.002; OR=4.64, P=0.012; OR=3.60, P=0.027) (Shoemaker et al. 2015). Although 
the value of the VP to the user is unknown.  
Confidence 
Two studies assessed confidence among particular elements of participant knowledge and/or 
competence (Zlotos et al. 2016, Taglieri et al. 2017). Zlotos et al., reported increased 
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participant confidence immediately after using the VP (Wilcoxon’s signed rank Z=8.6, 
P<0.0001), which appeared to be maintained after six months albeit self-assessed (Zlotos et al. 
2016).  
In the study by Taglieri et al., results were varied as both increased and decreased confidence 
were identified across different VP cases. Confidence decreased after initial pulmonary 
modules (P=0.001) but increased to baseline after later cardiovascular modules (no significant 
change pre to post, P=5.209). This is also true for particular elements of the cases, for 
example, confidence in conducting a drug history (Pre-VP 85.8, post-pulmonary VP 79; 
P<0.001. Post all VPs 85.3; P=0.88). Despite this, participant numbers also declined by over 
40% across the study (296 to 122) and changes in confidence were ultimately not significant 
(P=0.209) additionally SD of results were not reported across this study (Taglieri et al. 2017). In 
this case, a quantitative measure of confidence resulted in confusion and participant 
perspectives may have helped to explain statistical findings. 
It is not clear if VPs are better than alternatives, but some knowledge and confidence changes 
may occur, and VPs may lend themselves to skill-based applications. It is worth highlighting 
that measuring confidence can be conflicting and a new approach to this may be required. This 
may be because confidence can be subjective with no recognised measurement. 
Engagement with learning 
Elements of experiential learning occurred throughout the studies; Zlotos et al., demonstrated 
that VPs can test clinical and ethical decision making, and allow users to see the consequences 
of decisions (Zlotos et al. 2016). Similarly, Loke et al, stated that students can ‘’live through the 
consequences of their actions’’ (Loke et al. 2011). Students identified with the VP as a real 
patient, felt responsible for the outcomes of the case and were able to see the consequences 
of actions (Loke et al. 2011). This was similar to Zary et al., who discussed VP use for the 
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repetitive and deliberate practice of skills in a safe and less stressful environment than with a 
real patient (Zary et al. 2006). Likewise, Zlotos et al., identified that VPs allow for an 
opportunity to appreciate challenges associated with interacting with patients which students 
would not necessarily interact with in practice. Their simulation involved substance misusers 
(Zlotos et al. 2016).  
Educational uses of the VPs varied by the designs of the VP and by the participants of the 
studies. Bindoff et al., highlighted VP use for contexualisation of learning and further 
supported VP use to learn from mistakes, this included experiential learning around how to 
frame questions (Bindoff et al. 2014). The study by Loke et al, supports this as participants 
were driven to complete the case by the tasks presented rather than by generic, pre-defined 
steps (Loke et al. 2011). A novel discussion within the study by Taglieri et al.’s, concerned time 
limits for VP use. This appeared to be counterproductive to learning and demonstrated the 
closely linked nature of VP design and educational outcomes, it is not clear if this was rectified 
when the time limit for VP use was removed (Taglieri et al. 2017). The study also suggested 
that increased familiarity with the technology can improve learning (Taglieri et al. 2017). This 
is reasonable given the interwoven features of the technology.  
All of the studies of this review evaluated VPs within formal educational programmes, the 
majority being undergraduate courses. Each VP appeared to be specific to its own application 
and thus direct comparisons of the educational value of the applications are limited.   
Satisfaction  
A third of the studies identified that VPs need to be available without specialist computers or 
software (Zary et al. 2006, Bindoff et al. 2014, Zlotos et al. 2016) and VPs should be accessible 
‘‘anytime anywhere’’ (Zary et al. 2006). But, across the studies, a number of technical 
difficulties which impacted outcomes were reported.  
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In the studies by Zlotos et al., Bindoff et al., Taglieri et al., and Douglass et al., significant 
technical difficulties were reported by the users. Technical difficulties and issues with technical 
design appear to limit use, these studies demonstrated the need for usable technology from 
the user’s perspective. Technological issues included ‘glitches’ that potentially impacted 
performance and competency (Douglass et al. 2013), and problems with game navigation 
(Bindoff et al. 2014). 
Two studies discussed VP accessibility. Shoemaker et al., stated that they had actively chosen 
technology so that the VP could ‘’run on a wider variety of computer specifications without 
the need for the latest graphics card technology’’ (Shoemaker et al. 2015). Bindoff et al., 
identified an advantage of their system was its accessibility and usability on the most common 
web-browsers (Bindoff et al. 2014). These designs were not evaluated in either study and 
there are no data to support these decisions. 
Three studies explicitly measured or addressed technology satisfaction, and all reported 
positive findings (Douglass et al. 2013, Bindoff et al. 2014, Taglieri et al. 2017). Douglass et al., 
had clear results concerning pharmacy student enjoyment when using the VP (85% support) 
(Douglass et al. 2013). Two studies commented on VP use compared to paper-based 
alternatives (Zary et al. 2006, Bindoff et al. 2014), although the findings by Bindoff et al.,  
varied across different pharmacy student cohorts which made it difficult to interpret if the VP 
was truly more enjoyable (Bindoff et al. 2014). The participants in the study by Zary et al., 
found the VP more engaging than paper-based alternatives (I found the cases in Web-SP 
engaging 1= strongly disagree, 6 = strongly agree, mean=4 IQR 3-5; n=10) (Zary et al. 2006).  
Finally, Taglieri et al., discussed that their technology, despite being easy to use and realistic, 
had a decrease in its perceived helpfulness by students across the study (84.8 and 78.4 pre-
study and 73.8 and 58.2 post-study for two helpfulness questions; P<0.001, no SD reported) 
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(Taglieri et al. 2017). This suggests that even when the developers believe that the technology 
is useable the users may have different perceptions. 
3.5 Discussion 
The key findings of this systematic narrative review are that although the VPs in the studies 
had varied applications there were similarities in that they were found to improve users’ 
knowledge, confidence, skills, and competency. The majority of the studies were not high-
quality evaluations and thus should be interpreted with caution especially as a number of 
studies reported conflicting findings within their own results (Fleming et al. 2009, Bindoff et al. 
2014, Taglieri et al. 2017). Some studies did not demonstrate that VP use resulted in 
statistically significant changes in performance but the VPs still appeared to be useful, with 
user benefits. 
Multiple studies commented on a VP purpose as allowing an opportunity for practice, an 
advantage of VPs well discussed in the literature (Maran and Glavin 2003, Cook and Triola 
2009, Crea 2011, Georg and Zary 2014). Whatever the purpose of VPs, two particular benefits 
are that they can provide richly contextualised learning applied to practice, but in such a way 
that the user can safely learn from mistakes. This is in line with ideas of experiential learning 
where the focus is on learner-driven investigations, often in pursuit of a real or artificial task 
(Rieman 1996). Similarly, when using VPs as an experiential learning resource users are in an 
active learning environment where they are able to formulate their own learning through 
inquiry, problem-solving and discovery (Njoo and Jong 1993). This was explicitly referred to in 
some of the review studies (Zary et al. 2006, Loke et al. 2011, Bindoff et al. 2014). This also 
links to ideas concerning reflective based learning and the importance of experiences within 
learning (Zigmont et al. 2011). VPs are able to provide new and safe experiences for users and 
putting learners in control helps users to refine mental models of a task or experience 
(Zigmont et al. 2011). VPs can also allow the user to self-regulate their own learning and focus 
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on personal learning objectives. But, in order for new VPs to be a useful experience, a level of 
knowledge regarding experiential learning is required by the facilitators and designers 
(Zigmont et al. 2011). By using VP there is an opportunity to simulate a clinical scenario and for 
the user to practice, build confidence and increase accuracy (Crea 2011). Accessible, 
standardised, safe and reliable practice opportunities are the benefits of VPs reported in some 
manner consistently across all of the studies. 
The majority of studies reported positive satisfaction with VPs, despite some limited delivery 
and usability. This was important to the outcomes of the studies and some studies cited 
technological difficulties; this needs to be considered in future VP development and 
implementation. The technology must be accessible, and easy to use and maintain, as 
discussed in one study that concluded there should be a level of functional technology in order 
for VPs to be beneficial (Tan et al. 2010). Similarly, there may be increased VP utilisation and 
implementation when more applications are developed due to a better understanding of the 
technology (Ellaway et al. 2009). The place of the VP within a curriculum should be carefully 
considered in future evaluations. It is important throughout the VP design process that 
educational principles are applied to ensure that the VP is of high educational value. This has 
been suggested in other VP studies including those for other purposes and use in different 
professions (Guise, Chambers, Conradi, et al. 2012, Shah et al. 2012, Bateman et al. 2013, 
Georg and Zary 2014).  
As delivery issues can distract from learning (Patel et al. 2011), technological delivery of VPs 
should be well thought out with justifications for decisions which have consequences for user 
satisfaction and learner outcomes. It is important that functional technology is incorporated 
into further evaluations alongside robust outcomes. There also needs to be greater detail 
provided regarding the development of evaluation instruments as this was lacking. The review 
suggests that VPs are a useful resource for experiential learning, particularly for 
undergraduates but their role in clinical practice or for pharmacists cannot be inferred.  
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All of the studies in this review focused on establishing the use of the VPs by measuring set 
outcomes, similar to the review by Cook et al., who established VPs were useful versus no 
intervention (Cook et al. 2010). There are difficulties with this approach and the subjectivity of 
measuring outcomes such as confidence; what appears to be absent is research addressing the 
user-value of such tools. Some qualitative research has been conducted on VPs but these 
studies have not focused on exploring the user’s perspectives and experiences (Zary et al. 
2006, Loke et al. 2011, Thompson et al. 2016a). In this way, users may provide a perspective 
different from that collected when measuring ability and provide valuable insights into the 
apparently contradictory findings from quantitative studies. 
None of the studies included qualified pharmacists, demonstrating a gap in the literature for 
evaluating VP applications for pharmacists. In the eight review studies, the users, despite not 
being qualified pharmacists, took on the role of the pharmacist when using the VP. This 
suggests that VPs are well-suited to simulate a pharmacist’s role but VP use has not been 
directly tested to train qualified pharmacists (Triola et al. 2006), this is explored in this 
research. A previous review highlighted the potential of VPs in graduate settings but this does 
not appear to have occurred (Jabbur-Lopes et al. 2012). An opportunity to use a VP for CPD 
was discussed in one study and in medicine rather than pharmacy, (Fleming et al. 2009). The 
use of a VP for pharmacy CPD purposes does not appear to have been investigated.  
 Review limitations and bias 
The studies were selected based on their technology, but studies could have been excluded 
due to an unclear technological description. As already discussed, to minimise this, whole 
papers were closely scrutinised where clarity was lacking. The review also made every effort to 
establish the exact nature of the technologies in order to credibly include or exclude studies 
on the basis of their technology.  
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To minimise the possibility of missed eligible studies the search strategy was repeated 
regularly and all studies included in the review had their references screened for additional 
appropriate studies. Additionally, of the studies included, there was a limited opportunity for 
direct comparison of findings due to variation in the VP technologies and evaluations.  
 Implications of the findings 
Considering the wider study, the review findings are significant in multiple ways. Firstly, as 
alluded to across section 1.5, the need for functional technology is essential. The functionality 
of the VP under evaluation is incorporated into the results in chapters 6 and 7. Additionally, 
none of the studies focused solely on qualified pharmacists, which supports the need for this 
VP evaluation study, as it is aimed, in part, at qualified pharmacists. Confidence as an outcome 
appears to have been as investigated as knowledge and skills, it is important that variation in 
outcomes are incorporated into further evaluations. 
Some VPs testing communication and counselling have proven effective, but this study goes 
one step further to investigate a VP using more sophisticated technology. There also needs to 
be more transparency and detailed reporting of the development of instruments used for VP 
evaluations. Furthermore, the ability to perform a task or skill was a common VP purpose, this 
will be incorporated into this study as the VP explores NOAC counselling as a skill. The review 
suggests that VPs are a useful resource for experiential learning, particularly at the 
undergraduate level but their role in clinical practice or for training qualified pharmacists 
cannot be inferred from the literature.   
A number of the studies included in the review helped to inform the design of the VP 
evaluation. Only one of the studies linked their findings back to practice (Zlotos et al. 2016) 
which provides a gap in the literature which this study aims to contribute to. Furthermore, as 
already discussed all of the studies in some way addressed technology satisfaction. As each VP 
application is highly individualised it appears to be important that each VP evaluation 
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incorporates a level of satisfaction testing. Considering the methods of the study, the content 
of a number of studies’ instruments were examined for inclusion in this study (Zary et al. 2006, 
Douglass et al. 2013, Zlotos et al. 2016, Taglieri et al. 2017). This was largely the wording and 
design of questions particularly ‘satisfaction’ questions and Likert designs; these are further 
discussed in section 5.4.1. Furthermore the study by Bindoff et al. (2014) provided thematic 
results of question responses, these themes were identified as potentially being relevant to 
this evaluation and so these areas were incorporated in to the questionnaire and interview 
guide (section 5.5.1). Named examples of these themes included ‘’difficult to use’’, ‘’feedback 
lacked guidance’’ and ‘’bad graphics’’. In one of the review studies, some qualitative methods 
were used where class discussions were recorded and analysed retrospectively. On the basis 
of these findings there was evidence that users were using the particular VP in different ways 
(Loke et al. 2011). This result appeared to be a novel finding and one which this study aimed to 
consider. This was included as a discussion point in the interview guide (section 5.5.1).  
The results of this review have indicated that there are gaps in understanding around VP use 
concerning the following which will be addressed within this evaluation. 
• User perspectives on the usability and functionality of the VP technology and design; 
•  The use of the VP by qualified pharmacists as a previously scarcely investigated 
population; 
• How the VP can be educationally beneficial to users particularly around confidence, 
knowledge and NOAC counselling as a skill. 
3.6 Conclusion 
This chapter systematically reviewed VP use in Pharmacy from this it is clear that important 
features in VP use are the usability of the technology, the VP purpose, and audience. VPs 
testing communication and counselling skills have been shown to be effective for use by 
pharmacy students, but despite this, individual applications still require evaluation due to the 
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individuality of the technologies. VPs are an additional valuable resource to develop 
communication and counselling for pharmacy students; use in other pharmacy populations 
has not been established. The design of this review was also conversed, including the rationale 
for the search terms, eligibility criteria, and how research quality was established. Finally, the 






This chapter follows on from an in-depth evaluation of the literature on VP use. This chapter 
discusses the methodology of the research study, particularly the underpinning philosophy 
and research paradigm. It includes a discussion of reflexivity, validity, and reliability. This 
chapter aims to provide an overview of the methodology that underpins the research as well 
as the philosophy of the researcher.  
4.2 Study aim and objectives 
The aim of the study was to investigate the learner-reported value and acceptance of the VP 
application (as discussed in section 1.5) for pharmacists and pre-registration trainees. The 
study objectives were to: 
- Explore pharmacist’s and pre-registration trainee’s reported satisfaction in the usability of 
the VP. 
- Explore and measure the perspectives of pharmacists and pre-registration trainees on the 
ability and usefulness of the VP to teach NOAC counselling. 
- Explore participant’s perspectives on how the VP can be incorporated into the education, 
training and continuing professional development of pharmacists and pre-registration 
trainees.  
- Determine participants’ perspectives on the ways in which the VP can be improved.  
 Summary of the research methodology 
The study followed a sequential exploratory mixed methods design using a pragmatic 
methodology where a sample of pharmacists and pre-registration pharmacists completed a 




respondents from the questionnaire group were selected to undertake a follow-up interview 
based on the questionnaire results. The results of the two sequential phases were also 
integrated at the end of the study, this will be further discussed in section 4.4.5. 
4.3 Research philosophies and methodologies 
 Research paradigms 
Philosophical stances or paradigms are important in research because differences in beliefs 
influence our interpretations of reality, our values and our research methodology (Doyle et al. 
2009). Ultimately, this affects the research questions we ask and the methods selected to 
answer particular research questions (Morgan 2007). There are multiple definitions and uses 
of the word paradigm to describe alternative philosophical aspects of research. In this study, a 
paradigm is defined as a ‘worldview’ which is made up of a mutually exclusive formulation of 
reality (ontology), knowledge (epistemology), and how best to learn about the world 
(methodology) (Guba and Lincoln 2004, Shaw et al. 2010). 
 Quantitative and qualitative research 
Broadly, there are two main approaches to research: qualitative and quantitative, and each 
has distinct beliefs underpinning their use. Quantitative researchers tend to think in terms of a 
single objective reality and this view underpins their whole approach to quantitative research 
as they focus on understanding the ‘truth’ regardless of context, which is also known as 
positivism (Nicholls 2009a). Conversely, qualitative research tends to be underpinned by the 
belief that reality is subjective and dependent on context, which can be referred to as 
constructivism or interpretivism (Nicholls 2009a). There are many other philosophies along the 
spectrum between these two approaches with many additional sub-types and variations 




Qualitative research is generally distinct from quantitative research not only by the 
underpinning ontological beliefs of the researchers but also in the purpose of the research. 
Quantitative research focuses on measuring and understanding quantifiable measures 
whereas qualitative research focuses away from quantifiable measures and particularly helps 
understanding of people’s views and perspectives (Dew 2007, Nicholls 2009b). Broadly 
speaking, qualitative research can include research that is not determined by statistical 
procedures or means of quantification (Hoepfl 1997). It is recognised to be particularly useful 
to seek insight, understanding, and exploration; it cannot examine causal determination 
(Hoepfl 1997). On the other hand, quantitative research is able to address these issues but it is 
not generally recognised to be able to explore the depth and complexity of phenomena, 
especially social inferences (Hoepfl 1997). On this basis, it is important that when choosing a 
research methodology the researchers consider the aims and purpose of the research 
alongside worldviews and ontological beliefs. 
 Pragmatism 
Pragmatism is an approach to research that incorporates aspects from both quantitative and 
qualitative paradigms. The worldview of pragmatists tends to be problem-centered, 
considering the consequence of actions and real-world implications. Rather than focusing on 
methodology, it emphasises the significance of the research problem and the need to use any 
available approach to understand the research question (Johnson and Onwuegbuzie 2004).  
Pragmatism follows a pluralistic approach to derive knowledge as it draws on many different 
philosophies and approaches including both quantitative and qualitative paradigms. When this 
occurs however there should be a rationale for mixing and merging paradigms that considers 
the particular research question (Johnson and Onwuegbuzie 2004, Denzin 2010).  
When using pragmatism, researchers focus on finding practical solutions to problems within 




that all research occurs in context and this is where a practical approach to epistemology 
comes in to play (Morgan 2007, Shaw et al. 2010). Johnson and Onwuegbuzie (2007), discuss 
that a pragmatic philosophy partners well with mixed methods, stating that pragmatism is 
‘’cognizant, appreciative, and inclusive of local and broader socio-political realities, resources, 
and needs‘’.  
Historically, the debate between the paradigms has focused on differences between 
qualitative and quantitative philosophies rather than similarities, for which there are multiple 
(Johnson and Onwuegbuzie 2004, Onwuegbuzie and Leech 2005). In one extreme, it has been 
argued that ‘pure’ methodologies are theoretical illusions and that all methodologies have a 
degree of being mixed (Onwuegbuzie 2010).  
Considering in further detail the potential conflicting methodologies which are to be mixed in 
this study. In using pragmatism, the underlying methodologies typically associated with the 
chosen methods are not dismissed as dichotomous but rather can be described as 
dimensionally different (Johnson and Onwuegbuzie 2007). Willems and Raush (1969), accessed 
via Onwuegbuzie and Leech (2005), discuss this in terms of the research using a bi-focal lense 
whereby pragmatic researchers are able to zoom in to microscopic detail or to zoom out to 
indefinite scope (Willems and Raush 1969). The use of pragmatism and mixed methods can be 
used a philosophy and method which aims to merge together the insights provided by 
qualitative and quantitative research into a ‘’workable solution’’ (Johnson and Onwuegbuzie 
2004); they should be seen as complimentrary rather than as rivals (Jick 1979). 
 Mixed methods 
Teddlie and Tashakkori (2009), are two pragmatic researchers using mixed methods and they 
state that most mixed methods researchers work primarily within a pragmatic paradigm. This 
is the case for this research team as a pragmatic, mixed methods methodology was adopted 




There are many reasons for using mixed methods including where a single approach is 
inadequate to provide data on multiple perspectives and with the understanding desired 
(Doyle et al. 2009). Furthermore, researchers may want to contextualise findings, view 
problems from multiple perspectives, or provide complementary or illustrative context 
(Meissner et al. 2011). Another strong reason for mixed methods research is so that one data 
set can build on another in a sequential fashion (Meissner et al. 2011), which was the 
approach adopted in this study.  
Recognised disadvantages of mixed methods include that the research team requires an 
appropriate level of knowledge of the methods that are to be mixed and also the familiarity of 
how to merge them (Doyle et al. 2009). To minimise this mixed methods research should 
combine qualitative and quantitative elements so that the strengths of the two disciplines are 
complementary with nonoverlapping weaknesses (Johnson and Onwuegbuzie 2007). In this 
study the lead investigator (CR) underwent research methods training to gain knowledge and 
understanding of conducting mixed methods research.  
Mixed methods research can address a range of questions both confirmatory and exploratory 
in nature and there is a greater opportunity for a larger assortment of divergent views than 
with some single method approaches (Teddlie and Tashakkori 2009). The use of two or more 
methods, such as questionnaires and interviews can give stronger understanding as one type 
of data provides insight into the extent of views and variables, and the other provides depth 
into understanding more of the variables, and together they yield useful results that would not 
be established with a single method (Teddlie and Tashakkori 2009), this approach is adopted in 
this evaluation. Johnson and Onwuegbuzie (2007), summarise this stating that mixed methods 
is a powerful choice that will often ‘’provide the most informative, complete, balanced, and 




A further reason that some researchers may choose to use mixed methods is becuase the 
method can offer the chance to triangulate data. Triangulation can be defined as:  
‘’The use of more than one method or source of data in the study of a social 
phenomenon so that findings may be cross-checked.” (Bryman 2016). 
Commonly multiple methods are used in triangulation for the purpose of producing a more 
accurate, comprehensive and objective representation of a study (Silverman 2014). It can also 
be used as a technique for ‘confirming’ results or in mixed methods as a way of merging data 
(Mays and Pope 2000, Teddlie and Tashakkori 2009). Additionally, triangulation can help to 
identify patterns of convergence in order to corroborate findings and gain a better overall 
interpretation of study data (Mays and Pope 2000).  
Triangulation closely links with ontology as qualitative researchers tend to not believe in a 
single objective reality, in this study this meant that close attention was paid to context when 
using triangulation, in line with a pragmatic methodology. This involved using multiple 
methods to measure and address different elements of the research objectives and 
triangulating to establish a more comprehensive overview of the research topic. This approach 
to triangulation is supported by Morse (2015), who argued that as multiple methods use 
different perspectives this will not necessarily give the same results but, as different 
understandings can be gained through the use of different methods, the overall scope and 
depth of the study is enhanced. This method is also supported elsewhere in the literature 
where it has been suggested that triangulation not be used solely for testing validity but rather 
to encourage comprehensive research via allowing unexpected results to be addressed as to 
strengthen and merge findings (Teddlie and Tashakkori 2009, Morse 2015).  
Triangulation can help contribute to the validity of research but it is not a measure of validity 




and encourage reflexivity by the researchers (Mays and Pope 2000, Cameron 2009). This was 
adopted in this study and further discussed section 4.5.2.  
4.4 Mixed Methods in this study 
This research used mixed methods as its adopted methodology using a pragmatic approach 
and research paradigm. Due to the nature of the study aim and objectives, a single method 
alone was not appropriate to answer the research question and because of this, mixed 
methods and pragmatism was a well-suited research methodology and paradigm to adopt.  
 Sequential exploratory mixed methods 
There are broadly two variations of mixed methods: convergent and sequential. Convergent 
(or parallel) designs include independent simultaneous management of two types of data or 
methods until integration at the end of the study. Conversely, sequential designs use one type 
of data or method as the basis for another that follows (Cameron 2009). This study used the 
latter of these designs, specifically, a sequential exploratory design in which qualitative and 
quantitative phases had equal standing (QUAN → QUAL) (Teddlie and Tashakkori 2006). The 
quantitative phase used questionnaires and the qualitative phase used interviews as their 
methods. Considering the sequential nature of the study design, QUAN → QUAL was decided 
upon as the use of a qualitative design for the latter phase allowed further exploration of data 
collected in the first quantitative phase. This would have not been possible had the qualitative 
phase come first followed by the quantitative phase. 
Advantages of a sequential explanatory design include the straightforwardness of the design 
and the opportunity for further exploration of findings, particularly unexpected results. 
Studies using this design typically unfold at a slower rate and more predictably than 
convergent designs and so they can be easier to manage (Teddlie and Tashakkori 2006). 




difficult for new or inexperienced researchers as it involves simultaneous management of two 
data strands, and problems can occur when data sets do not agree or where there are 
inconsistencies (Teddlie and Tashakkori 2006). A sequential design remained more 
advantageous than a convergent design especially as the former provided the opportunity to 
explore unexpected findings.  
 Quantitative questionnaire survey 
The first stage of the sequential study used a quantitative questionnaire. Questionnaires are 
frequently used in mixed methods research and are often used to collect quantitative data, 
but they can make use of a variety of styles and delivery (Johnson and Turner 2003). 
Questionnaires were selected to gather quantitative data from a large sample because of their 
advantages and suitability to gather insight into the range of views and variables.  
Questionnaires have traditionally been conducted via post, in person, or via telephone, but 
there is an increasing number conducted via the internet (Granello and Wheaton 2004). Web-
based questionnaires have advantages including reduced completion and analysis time, less 
cost and increased format flexibility, especially when compared with non-internet methods. 
Disadvantages include difficulties obtaining representative samples, low response rates and 
technological problems (Granello and Wheaton 2004). Some of these disadvantages could be 
overcome considering the good standard of technology that is used to conduct questionnaires 
online and that accessibility to online questionnaires is increasingly high (Granello and 
Wheaton 2004). More general advantages of questionnaires include the ease of participant 
anonymity, the ease of data management and that questionnaires are recognised to be good 
for measuring attitudes (Johnson and Turner 2003).  
Studies have repeatedly investigated the use of VPs to change various elements of knowledge 
and ability (Battaglia et al. 2012, Douglass et al. 2013, Al-Dahir et al. 2014, Bindoff et al. 2014, 




repeatedly investigated with similar findings that this study did not use a knowledge test as a 
method of measuring knowledge changes. Additionally, the studies also reported some 
difficulties in measuring these outcomes due to subjectivity as discussed in the systematic 
review (section 3.5). Instead, the study adopted an approach focused on the perspectives of 
users on VP use. This included perceived usability, satisfaction, and self-reported ability 
changes, in line with the research aim of the study (section 4.2) and of the VP design (section 
1.5). This approach to the research also meant that it was not necessary to use a control 
group. The premise of the study was not to prove the efficacy of the VP versus other methods 
but to inform the learner reported value and acceptance of the VP and to explore perspectives 
with a focus on real-life considerations for practice. 
 Sequentially moving between methods 
Moving between two methods and their associated methodologies can be difficult and an area 
of conflict concerns how to select samples for mixed methods research (Teddlie and 
Tashakkori 2009). Particularly as it can be difficult to merge different types of samples and 
problems arise when there is disagreement (Creswell and Clark 2010).  
Mixed methods sampling focuses on generating a sample to address a particular research 
question, this is in keeping with the pragmatic approach of centralising the research question 
throughout the research (Teddlie and Tashakkori 2009). A guideline for mixed-method 
sampling by Teddlie and Tashakkori (2009) describes eight sampling stages, something broadly 
adopted in this study (Figure 4.1). Through using this guideline, the sampling strategy for the 
study was able to make use of sampling methods for each phase which were already 





Guidelines for Mixed Methods Sampling 
1. Your sampling strategy should stem logically from the research questions and 
hypotheses being addressed by the study.  
2. You should be sure to follow the assumptions of the probability and purposive 
sampling techniques that you are using.  
3. Your sampling strategy should generate thorough QUAL and QUAN databases on 
the research questions under study.  
4. Your sampling strategy should allow you to draw clear inferences from both the 
QUAL and the QUAN data.  
5. Your sampling strategy must be ethical.  
6. Your sampling strategy should be feasible and efficient.  
7. Your sampling strategy should allow the research team to transfer or generalise the 
conclusions of their study to other individuals, groups, contexts, and so forth.  
8. You should describe your sampling strategy in enough detail so that other 
investigations can understand it and perhaps use it in future studies.  
Figure 4.1 Principles of mixed methods sampling (Teddlie and Tashakkori 2009) 
Teddlie and Tashakkori further explored the rationale for different sampling methods: 
quantitative methods often focus on representativeness and qualitative on information-rich 
understanding or meaning of cases, in mixed methods a balance of the two may be required 
and this was incorporated into this research (Teddlie and Tashakkori 2009). Generalisability 
can also be an issue in mixed methods sampling as quantitative methods often focus on 
external validity whereas qualitative methods focus on transferability and again, a unique 
balance may be needed (Teddlie and Tashakkori 2009). It is for this reason that the two phases 
of the study, each with different designs and purposes, used their own recognised sampling 




 Qualitative interviews 
The second method of data collection used in this study and one commonly matched with 
questionnaires in mixed methods is that of interviews (Johnson and Turner 2003). Interviews, 
like questionnaires, can contrast in structure and design. In this study, the interviews used a 
semi-structured approach, which allowed for some topics to be pre-defined but equally, 
freedom to explore emerging topics (Johnson and Turner 2003). To some degree all interviews 
have a degree of structure, in the same way that a conversation does (DiCicco-Bloom and 
Crabtree 2006), therefore the term ‘semi-structured’ is a fluid definition that can mean 
different things. Throughout this research, semi-structured refers to an interview whereby 
open questions are asked to elicit narratives and stories, the interviewer asks questions but 
contributes little else to the interview, instead, it allows the interviewee to talk, as discussed 
by Whiting (2008) and DiCicco-Bloom and Crabtree (2006).  
Qualitative interviews have been chosen as they are recognised to be good for exploring 
participant attitudes, they have the ability to provide in-depth data and they are useful for 
getting insight into ideas and themes (Johnson and Turner 2003). This advantage means that 
interviews are well suited to be used as a follow-up after questionnaires to explore issues in 
the data further and confirm the intended interpretation of findings.  
Additionally, the use of interviews as one of the multiple methods of the study was anticipated 
to contribute to answering the research question. Through using mixed methods, specifically a 
mixture of interviews and questionnaires, the study’s objectives could be met, and the results 
could be strengthened and explored in more depth to better address the research aim. As 
discussed in section 3.5.2, one of the implications for the systematic review findings were to 
consider alternative methods of measuring the user-value of VPs without measuring set 




Telephone interviews (TIs) and video interviews (VIs), such as Skype, were offered as an 
alternative to face-to-face interviews (FFIs) where there were difficulties with organising the 
latter, for instance where geographical limitations applied. It was hoped that this would help 
recruitment for the interview phase as VIs and TIs may be an easier option for some 
participants and they are an alternative should an FFI not be possible. A major advantage to 
VIs and TIs is that of safety, as the interview takes place in a comfortable environment for the 
interviewee and they may be more likely to talk freely and honestly (Hanna 2012, Janghorban 
et al. 2014, Oates 2015). Furthermore, rapport can also be built as would be in an FFI (Novick 
2008, Oates 2015), however, VIs, TIs, and FFIs can differ in the way in which the participant is 
presented as body language and non-verbal observations are missed, particularly during TIs 
(Novick 2008, Janghorban et al. 2014). Despite this, TIs are still recognised to be useful and 
have even been shown to be as effective as FFIs in terms of the data retrieved (Colombotos 
1969, Novick 2008, Cachia and Millward 2011). A pragmatic approach to using Vis and TIs was 
adopted throughout the research. 
In qualitative research, researchers have an inherent effect on the interview and a process of 
reflexivity is required to acknolwedge the effects of the researcher on the interview and 
consider the signifance of this (Whiting 2008), as discussed in section 4.5.4. General 
disadvantages of interviews include that they can have low participant anonymity and in some 
studies this can be a disadvantage especially where sensitive or emotional topics are discussed 
(Whiting 2008, Janghorban et al. 2014). In this study, the topic was not sensitive and so it was 
anticipated that participant anonymity concerns would be low; nonetheless during the 
consent processes participants were assured of anonymity.  
 Integration of the methods 
Integration of mixed data is an important element when defining a mixed methods study 




states that data within a mixed methods study needs to be integrated for three reasons: 
illustration, convergent validity or triangulation, and for the development of ‘’richness’’. 
Within this study, the purpose of data integration was firstly triangulation or the convergence 
and corroboration of the results, but also secondly complementarity in an attempt to improve 
completeness or comprehensiveness of the data (Bryman 2006).  
Methods for integration can vary. Simple integration involves the transformation of one type 
of data so it can be used in conjunction with another such as using demographic data to 
provide context to qualitative data, whereas complex integration can use computer 
programmes to assist analysis (Bazeley 2003). In this study, the two phases were initially 
analysed separately each using their own recognised methods. This was followed by an 
integrated interpretation. The two sets of data were used in a confirmatory fashion to further 
explore and understand the ideas presented in each (Bryman 2006). As stated by Jick 
(1979), as well as the benefits of triangulation from a validity perspective, more broadly 
speaking it can also ‘’capture a more complete, holistic, and contextual portrayal of the unit(s) 
under study’’. This is one way in which triangulation was used in this study.  
Within the literature there is a recognition that the process of integrating data, particularly 
triangulation is somewhat clouded in mystery, with processes and methods unclear (Jick 1979, 
Bryman 2006, Fielding 2012). Jick (1979), explored that a triangulating researcher may 
somewhat rely on their feelings of the data during integration and that they are builder and 
creator piecing together the pieces of a puzzle. This highlights the significant role that 
reflexivity (sections 4.5.4 and 10.6) plays in the process of data analysis in a mixed methods 
study. This should be considered alongside the following description of how data integration 
was conducted in this study.  
Initially the data collected in phase one informed the questions and topic areas discussed in 




example, if a topic was mentioned in the questionnaire but was unclear or lacked detail then 
this was explored further in the interviews. The same occurred for significant or unexpected 
findings. This will be discussed, with examples, in section 10.2.1. This additionally contributed 
to triangulation via directly exploring specific topics in more detail and gathering data from a 
range of participants.  
Furthermore, during data interpretation, the two data sets were used to identify any 
similarities or differences between the two with the aim of using one dataset to support and 
explain the other, in line with a corroborative approach to integration. The two data sets 
allowed for a comparison of the reported usefulness and usability of the VP in a wide group 
(from the questionnaire phase) alongside individual perspectives on the place of the VP in 
practice (from the interview phase). As the interview results were socially contingent, these 
results could be triangulated with the satisfaction and self-reported ability results from the 
questionnaire to determine if the measured results from the questionnaire matched with 
participant’s reports from the interviews. This provided a deeper understanding of the study 
results and as discussed in section 4.3.3, this demonstrates the concept of being able to use 
mixed methods to ‘zoom in’ to specific results and ‘zoom out’ for perspective (Willems and 
Raush 1969).  
4.5 Research quality 
In using mixed methods assessing quality can be conducted in multiple ways with no single 
commonly adopted approach (Bryman et al. 2008). In this research, Morse's (2015) approach 
to rigor has been adopted to unify the quantitative and qualitative elements of the study into 
a single set of quality measures to try to produce research of overall good quality as 
summarised below.  
Quality in quantitative research can be assessed using ‘traditional’ quality measures such as 




assessed with some of these same broad concepts, but they need to be adapted to consider 
the distinctive goals of qualitative research (Mays and Pope 2000). Rigour in qualitative 
research is a widely debated area as some researchers argue that it is not possible to use 
conventional criteria to assess qualitative research due to differing ontological beliefs (Mays 
and Pope 2000). One concept that addresses quality in qualitative work is that research must 
be ‘trustworthy’ (Guba 1981, Morse 2015). This incorporates ideas of credibility, 
transferability, and confirmability which include aspects of the more ‘traditional’ quantitative 
concepts of validity, generalisability and reflexivity respectively (Guba 1981, Morse 2015). 
Conflicting with the concept of distinct characteristics of quality in qualitative and quantitative 
research, the work by Morse (2015) argues that qualitative research should revert to 
discussing rigour with the ‘traditional’ approaches on the basis that the newer concepts, 
conceptualised specifically for qualitative research, have only been critiqued in a limited 
number of works with questions concerning if they actually contribute to rigor remaining 
(Morse 2015).  
As this this study uses mixed methods, whereby approaches to rigour could conflict, Morse's 
(2015) approach to rigor has been adopted whereby the ‘more traditional’ quantitative 
concepts of reliability, validity, generalisability and along with reflexivity are used for both the 
quantitative and qualitative elements of this study. This is discussed below where the 
approaches taken to strengthen the quality of both the quantitative and qualitative phases 
and of the overall study will be discussed. This is an attempt to pragmatically produce research 
of overall good quality and rigour (Kitto et al. 2008, Braun and Clarke 2013, Morse 2015).  
 Reliability 
Reliability concerns the replicability of study results and it is particularly associated with 




is not entirely applicable to this study as the nature of qualitative elements, where context is 
paramount means that replicability is not possible.  
Efforts have been taken to increase the replicability of the quantitative methods within the 
study including the transparent presentation of the recruitment process, sampling strategies 
and the questionnaire development process. The reliability and validity of the questionnaire 
instrument were further assessed in the questionnaire development and piloting (section 
5.4.2.). A Cronbach alpha test was used to give a statistical indication of the reliability of the 
Likert scales used in the questionnaire, this is further discussed in section 5.4.2. 
Moving to consider the reliability of the qualitative phase, replicability of this phase of the 
research is not possible as individuality is valued. Despite this, efforts have been made to 
ensure that the research is ‘trustworthy’; the work by Morse (2015), has guided the approach 
to qualitative reliability as follows. Morse (2015) explains the concept of a ‘thick description’ 
as a way to contribute to internal reliability on the basis that plentiful data overlap and this 
allows the researcher to see replication, this therefore verifies the data set internally (Morse 
2015), although thick description is an area of debate and at times confusion. The work by 
Ponterotto (2006) explores this in detail and positions thick description as the roots of a tree 
that nourishes the trunk and leaves, or the interpretation and meaning respectively 
(Ponterotto 2006). 
Additionally, the reliability of the interview guide was addressed in an interview pilot to 
explore if questions were understood in a similar way and so answers could be coded without 
uncertainty. This is a recognised method to test interview instruments and was used in 
addition to the thorough training of researchers (Silverman 2014). A further approach to 
optimise the reliability of the whole of the research was to address that the researcher and 
the research instruments may be a source of bias (Braun and Clarke 2013). This was 





Approaches to improve validity consider if the measurements of a study are accurate or well-
founded, and if they measure the intended (Golafshani 2003). Validity can be broken down 
into multiple sub-types some of which will be discussed in this section. Morse (2015), 
highlights that validity enables theories from research to be generalisable and this is useful 
when these theories are recontextualised and applied in other settings.   
Concerning the quantitative phase of the research, three types of validity were considered as 
follows. Construct validity assesses whether an instrument measures what it aims to and if the 
measurements are representative of what the study is trying to investigate in a wider context 
(Braun and Clarke 2013). This was considered in the instrument development to ensure that 
the questionnaire measured what it was intended to and that the data collected was usable 
considering the research question. Similar considerations were made for the interview guide. 
Face validity was also considered in the piloting of the questionnaire. This assessed if the 
content of the questionnaire reflected the subject matter and was accurate and complete 
(Scott and Mazhindu 2014). Finally, content validity or the representativeness of questions, 
was assessed, to a certain degree, by the literature review which included assessing the 
content of questionnaires used in other studies (Scott and Mazhindu 2014). 
Moving to consider the qualitative approaches to validity, Morse (2015) presented a critique 
of common validity approaches and tools to summarise which are useful and relevant to 
qualitative research. As was discussed in section 4.5.1 but in the context of reliability, thick 
description of data can contribute to the quality of research. This is also true for validity. 
Morse (2015), details this in the context of a study sample and how this can contribute to the 
validity of a research study. This is further discussed in section 5.3. Similarly, Morse (2015), 
also discusses researcher bias or reflexivity as being important for the validity of a study. This 




The next approach discussed by Morse (2015), is that of triangulation. This has already been 
discussed in the context of mixed methods (section 4.4.5) but considering this from a validity 
point of view specifically, Morse (2015), states that triangulation can be useful to increase the 
scope or depth of a study. Although, this is only really useful in studies using multiple 
methods, whereby two methods each contribute their own data which could not be collected 
from the other method alone. Triangulation, therefore, in this study, does contribute to 
validity as it is used as part of a mixed methods study to enhance understanding.  
Similarly, negative case analysis is a closely related concept which can be useful to reveal 
important differences in data and help critical analysis and understanding of a concept. This in 
turn, helps to develop validity in a research study. This is something that was incorporated into 
this study as is discussed in section 6.11.2 and 10.2.1 whereby any data that was contradictory 
from majority views were identified and discussed, as this helps to refine an ongoing analysis 
(Mays and Pope 2000). 
Finally, respondent validation or member checking uses participants to validate the study 
findings and establishes if findings conform to an individual’s experiences (Silverman 2014, 
Morse 2015). Qualitative research is highly contextual and each participant is recognised to 
have their own individualised view and thus there can be difficulties with determining the 
credibility of findings as this can often result in further confusion rather than confirmation 
(Johnson and Waterfield 2004). This method of validation relies on a degree of belief in a fixed 
‘truth’ and as context is paramount, respondent validation was not used, this is as 
recommended by Johnson and Waterfield (2004) and Morse (2015).  
 Generalisability 
Generalisability is a form of external validity and relates to the extent to which the results of a 
study can be applied to a wider or different population (Braun and Clarke 2013). Morse (2015), 




validity enables qualitative theories to be generalisable when the theories are 
recontextualised and applied in different settings (Morse 2015). Moving to consider the 
questionnaire phase, it used a sample from a range of different sites across England and had a 
wider transferability than if the interview phase had been used alone. The generalisability of 
these results is discussed in section 10.5. 
A further approach to contribute to generalisability that was adopted, was to detail the study 
methods and conduct in such depth that the reader can judge if the findings apply to other 
settings and contexts for themselves (Guba 1981, Mays and Pope 2000). Furthermore, the 
study used a sample that best represented those with knowledge of the research topic, in this 
case, practising pharmacists and pre-registration trainees this is further discussed in section 
5.3. Overall these elements contributed to the aim to produce trustworthy, or as Morse, 
argued generalisable research (Morse 2015). 
 Reflexivity 
Reflexivity concerns the degree to which the research methods, including the researchers 
themselves, impact the research (Finlay 2010). Reflexivity is traditionally associated with 
qualitative research whereby researchers cannot be completely objective and remove 
themselves from the research processes. Personal biases and opinions need to be transparent 
in order to enhance the credibility of findings (Mays and Pope 2000). Braun and Clarke (2013) 
summarise this as:  
“…the process of critically reflecting on the knowledge we produce, and our role in 
producing that knowledge.” (Braun and Clarke 2013). 
To consider this, researchers engage in self-reflection and awareness of their circumstances 
and opinions to consider how this impacts the research (Finlay 2010). An additional level of 




relationship between research and professional identify. Richards and Emslie (2000), 
demonstrated this when they compared data from interviews conducted by a medical doctor 
and a sociologist. The results of the study demonstrate that interviewee’s perceptions of who 
the interviewer was did influence the interactions of the interview (Richards and Emslie 2000). 
An example of how this was considered in the study was that the researchers were 
pharmacists investigating other pharmacists. This needed to be transparent so that the 
participants could talk to the interviewer as a peer as opposed to a researcher or superior.  
A further example is that the chief researcher did not design the VP but was impartially 
evaluating the VP. This was made transparent to participants at the start of the interviews as it 
was hoped that this would allow participants give a more honest view of VP use and reduce 
any bias resulting from the participants not wanting to ‘offend’ the VP design. This is further 
discussed in section 10.6 alongside a more detailed application of reflexivity in this study. 
4.6 Summary 
This chapter summarised the methodological considerations within this research including 
considerations as to why the adopted methodology was appropriate. There was a discussion 
of the appropriateness of the chosen methods to answer the research question and how the 
methods impacted the quality and significance of the results. The study methodology utilised 
is that of a pragmatic mixed methods approach. This allowed researchers the freedom to tailor 







5.1 Introduction  
This chapter follows on from a discussion of the study methodology and the underpinning 
philosophy associated with this research. This chapter will discuss the study instruments and 
will outline the decisions and processes that were undertaken concerning data collection, data 
analysis, sampling, and recruitment. 
5.2 Overview of study design 
The study design is summarised in Figure 5.1. The two, sequential phases are linked via an 
integrated analysis and also through the analysis from phase one impacting phase two. The 
methods included in this design will be discussed across this chapter.  
 Ethical and governance approvals 
The study received ethical approval in February 2018 from Keele University (appendix I.), this 
included a peer review by the project supervisors and two academic pharmacists from the 
School of Pharmacy. Health Research Authority approval was granted in July 2018 (Appendix 
II.). Considering participant confidentiality, respondents recorded their name and email 
address during the consent process (consent forms and participant information sheets (PIS) 
available in Appendices III. And IV.), this identifiable data was essential to contact participants 
for interviews and to connect data between the phases. these data were stored in a separate 
encrypted Microsoft Excel spreadsheet. For interviews consent was taken prior to the 
interview because where video or telephone interviews were used participants could not 
provide written consent at the time of the interview. Participants made a second verbal 
consent at the start of the interview following further explanation of the interview process, a 
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5.3 Sampling and participant recruitment 
The following inclusion criteria applied to the study: 
• Participants needed to be practising U.K. community or hospital pharmacists or pre-
registration pharmacists who wished to undertake an educational training programme on 
NOAC use in AF because it was relevant to their current, or future, practice or professional 
development. This inclusion criterion was clear in the recruitment emails and PIS.  
The following exclusion criteria applied to the study: 
• Pharmacists who were involved in the development of the VP or in the instrument pilots 
(sections 1.5.3, 5.4.1 and 5.5.1) were not able to participate. 
• Pharmacists who work solely in other sectors of pharmacy than community or hospital 
were excluded from the study. 
The study required participants to be practising in U.K. community or hospital sectors as these 
sectors were considered to be where participants were likely to be conducting NOAC 
counselling. The VP was intended to be used by pharmacists or pre-registration trainees who 
felt that it may have relevance to their practise and consequently this was clear in the 
inclusion criteria, PIS and recruitment emails.  
Recruitment for the questionnaire made use of the research team’s professional networks. 
These networks facilitated access to fourteen sites, which included nine hospital sites and five 
geographical areas of community pharmacies covered by Clinical Research Networks (CRNs). 
The pharmacy manager or another appropriate senior staff member were asked to distribute 
the study recruitment email to appropriate staff. It was made clear to participants that their 
employer was not involved in the research and that their responses were confidential.  
Interview participants were directly recruited from the sample of questionnaire respondents 




the study and the consent process was separate from the first phase. A two-phase sampling 
method was used to recruit participants for questionnaires and then for interviews.  
Recruitment for the questionnaire phase occurred using a largely convenience sampling 
technique but with some levels of targeting such as getting a mixture of lengths of time since 
qualification and of sector of practice. Use of a convenience sample is quick, relatively 
straightforward and non-resource intensive compared to alternative random sampling 
methods (Flick 2002).  
Interview sampling was conducted using a mixture of sampling methods. Morse (2015), 
explored this approach and discussed that in qualitative research a mixture of sampling 
methods may be required. Morse stated ‘’data collection must begin somewhere’’ and that 
initially the data collection may be ‘’hit and miss’’, this is in part due to the fact that all 
sampling has a level of convenience especially when relevant characteristics or the 
information which needs to be sought is not known (Morse 2015). In this study, there was a 
level of convenience sampling as the interview participants were recruited from the earlier 
questionnaire participants which themselves were recruited to a degree by convenience as 
discussed previously. However, there was a level of purposive sampling on the basis of the 
participant’s questionnaire results and demographics. Purposive sampling selects the cases 
which are likely to best contribute to the research question and so this was a suitable where 
the questionnaire data was used as a basis for interview sampling (Flick 2002). This technique 
also has an association with pragmatism (Emmel 2013).  
Within the study, the stages to conduct this element of sampling were as follows. The 
questionnaire data underwent a preliminary analysis prior to interview sampling, this explored 
the questionnaire responses and identified those with particularly interesting and varied 
opinions, and those with a range of ability changes from using the VP. Following the 




different genders, ages, length of time since qualification and sectors of practice. The variation 
of participants was monitored as participants took part in interviews. Despite this, as the 
participants were taken from the pool of questionnaire participants and thus were finite the 
sampling strategy involved a level of convenience.  
 Sample sizes 
In mixed methods research sample sizes can be a dilemma as each method uses their own 
approach and thus the sample need to be guided by the research question (Teddlie and 
Tashakkori 2009). In this case, the sample sizes were established in reverse because the 
interview sample drove the sampling and recruitment for the questionnaire phase.  
In qualitative research, a term associated with sample sizes is that of data saturation. This can 
be a problematic concept to define with subjectivity between researchers. Guest et al. (2006), 
defines data saturation as “the point in data collection and analysis when new information 
produces little or no change to the codebook” and the authors took a numerical approach to 
exploring data saturation (Guest et al. 2006). Conversely, Morse (2015), had a different 
approach to sampling when they detailed that due to a host of different variables such as the 
subjectivity of the phenomenon, interview quality and the homogeneity of a sample that 
attempting to predetermine a sample size is ‘’a futile task’’ (Morse 2015). Fusch and Ness 
(2015), also discussed this and stated that the process of saturation is not about numbers but 
rather the depth of the data, is it both rich (concerning quality) and thick (concerning 
quantity)? This different idea of richness and thickness encompasses many of the ideals of 
thick descriptions previously discussed (Section 4.5) (Ponterotto 2006). 
Using Guest et al.'s (2006) definition of data saturation but Morse's (2015) and Fusch and 
Ness's (2015) approaches the following methods of data saturation were adopted. As the 
interview participants in this study were taken from the sample having completed the 




attempting to reach saturation whereby only key ideas were aimed to be saturated rather 
than every discussion. There was a focus on determining if the data was both rich and thick, 
this, in the context of the data, is discussed in section 5.5.4. 
Returning to consider sample sizes, it was estimated that the number of interviews would be 
15-25 based on the small number of characteristics which seemed to be relevant to the 
research question, that the topic was highly specific and the relative homogeneity of the 
sample. Following this, the questionnaire sample was considered. It needed to be large 
enough that an appropriate interview sample could be drawn, an approximation for this was 
80-100 respondents based on using around a 25% selection process for selecting participants 
for interview. This sequential approach to sampling is supported by a study discussing the 
typology of mixed methods sampling (Onwuegbuzie 2007).  
5.4 Quantitative data collection and analysis 
 Questionnaire design 
The study questionnaire was designed by the research team and in order to contribute to the 
quality of the instrument the lead investigator (CR) underwent questionnaire design training 
and the questionnaire was included in the peer review; following feedback the questionnaire 
was amended. This helped to contribute to the quality of the instrument and create an 
instrument using widely recognised ‘best practices’ (Artino et al. 2014). 
Google Forms was used for questionnaire distribution, it was chosen because it could support 
all of the question and could be easily delivered. Data could also be easily managed. The 
questionnaire contained six demographic questions plus 24 pre-VP questions and 34 post-VP 
questions (Figure x and Appendix V.). Demographic questions included basic information 






Figure 5.2. The participant's journey when completing the questionnaire. The process took 
place remotely via a single Google Form 
 
After completing demographics questions and some preliminary questions on self-reported 
ability on various aspects of NOACs and AF (this area of the questionnaire was based on the 
NICE guidelines for anticoagulant counselling (National Institute for Health and Care Excellence 
2014)) the respondents were presented with an embedded URL link to the VP application, and 
they were free to use the VP for as long as they wished, around 20 minutes was suggested. 
Respondents then returned to their questionnaire and completed a series of post-VP 
questions, this included identical self-reported ability questions as pre-VP. 
Other questions were mainly Likert scales using four different scales, there was one ranking 
question that asked respondents to rank five options from the most to least relevant. There 
were also seven short-answer free-text qualitative questions, these questions were based on 
common satisfaction questions from the literature to support further explanation of the Likert 
responses (Douglass et al. 2013, Taglieri et al. 2017).  
Pre-VP
• Demographic questions
• Preliminary questions on VP use and practice
• Pre-VP self-reported NOAC counselling ability
Using the VP
• Participant access VP via a URL web link
• Participant instructed to return to the questionnaire once they have 
finsihed using the VP 
Post-VP
• Post-VP self-reported NOAC counselling ability
• Satisfaction questions relating to the technology of the application




Responder literacy, or the demand on the respondent to understand the questions, was 
considered in the questionnaire design (Bowling 2005). As a consequence of the respondents 
all being HCPs, a high level of literacy was anticipated. Nevertheless, the questionnaire format, 
aesthetics, and wording were designed so that it could be understood by any of the 
respondents. No specialised wording was used and the terms NOAC and AF were defined 
within the questionnaire. Motivation for participation was incorporated in the recruitment 
emails and PIS as it was made clear to potential respondents that they may personally benefit 
from taking part in the study as they would have access to a novel education tool that may 
have consequences for their NOAC counselling abilities.  
The questionnaire used 5-point Likert scales. This use of scales with a central point has been 
the subject of much debate since respondents may naturally gravitate to the central point 
when they do not know an answer or do not want to select one from those provided (Rattray 
and Jones 2007, Scott and Mazhindu 2014). If a scale has no central point this forces an 
answer, which can be beneficial when the subject is sensitive or controversial. Conversely, 
people who are genuinely neutral are not able to select an appropriate option if a central 
point is absent (Scott and Mazhindu 2014). In this study as there was no reason to remove the 
central point 5-point scales were used. The questionnaire also used a minimum variety of 
Likert scales and asked simple questions as this can reduce cognitive load (Lietz 2010).   
To reduce acquiescence bias (‘yes-saying’/an excess of positive results) (Bowling 2005), the 
questionnaire included questions with a mixture of positive and negative anchors so it was 
clear if respondents had repeatedly selected responses of the same axis, as described by 
Bowling (2005), and Rattray and Jones (2007). This included asking if respondents found the 
VP useful, comfortable and enjoyable but in reverse, asking if the application was difficult to 
use. This helped to identify any acquiescence bias as these sets of questions should, in most 




 Questionnaire quality 
It has been highlighted that there is a lack of considerations for the quality of evaluation 
instruments (Jabbur-Lopes et al. 2012) and quality considerations appear to be absent from 
many of the studies discussed in chapters 2 and 3. A number of quality considerations have 
been considered in this study and are discussed below. 
Initial reliability testing of the instrument consisted of establishing content and face validity. A 
review of the questionnaire by people who are experts in the field contributed to addressing 
content validity (Artino et al. 2014). The research team as pharmacists had first-hand 
knowledge of the construct of interest and they could advise on the questionnaire content and 
language from the point of view of a respondent; the peer-review also contributed to this. 
Subsequently, improvements to the questionnaire delivery were made so that it was easy to 
use, accessible and not overly time-consuming as this has been shown to negatively impact 
response rates (Rolstad et al. 2011).  
The draft instrument was piloted, which aimed to test the design and processes of the study, 
and prepare for data analysis via exploration of which tests would be suitable for use (van 
Teijlingen and Hundley 2001, Artino et al. 2014). A convenient sample of pharmacists from the 
School of Pharmacy was drawn on, in keeping with the pragmatic approach to this research. 
To avoid contamination between the pilot and the main study data was managed separately 
and participants could only take part in either the pilot or main study (Leon et al. 2011).  
Within the pilot, all parts of the questionnaire data were examined to explore different 
statistical options for analysis of the data. Broadly, the pilot used the same data collection and 
analyses as the wider study. Ten participants took part in the pilot phase and data were 
examined for acquiescence bias. A significant Cronbach alpha result (P=0.917 and 0.865 for 
pre and post-VP Likert’s respectively) demonstrated a high level of internal consistency which 




2017). The pilot data behaved as expected, suggesting that the questionnaire functioned as 
intended, and there was also a trend in the data which implied that the respondents 
understood the questionnaire in a similar way. This increased its reliability for further use. 
Face validity was also assessed (Tsang et al. 2017). This involved using direct participant 
feedback gathered from the pilot to identify improvements to the delivery, design and overall 
experience of using and completing the questionnaire.  
Following the pilot, minor amendments to the questionnaire content were identified and 
made. These included grammatical and typographical errors which did not change the purpose 
or nature of the questions. One ranking question was amended to reverse the ranking scale 
and to include the correct number of outcomes. This was amended for data analysis purposes 
and to make the question easier to understand for the respondents..  
 Data analysis 
Questionnaire responses were accessed in Google Forms and converted to a Microsoft Excel 
spreadsheet for analysis. The data underwent descriptive analysis incorporating a mixture of 
SDs and means, and medians and IQR. These were used to establish the nature of the data and 
its common features and make data interpretable (Scott and Mazhindu 2014).  
Further statistical analysis was then undertaken to analyse specific parts of the data. The study 
collected a mixture of ordinal and nominal data and included both parametric and non-
parametric tests (Scott and Mazhindu 2014). In this study, Likert data were analysed using a 
mixture of parametric tests and means and medians. This depended on whether data were 
normally distributed and the intended purpose of the question(s) as described below.  
During analysis, the questionnaire was split into five sections. Demographic questions were 
first considered using descriptive statistics to establish and explore the nature of the sample. 
This was also particularly important for interview sampling. Self-measured ability Likert scales 




post-VP groups, the cumulative and average score for each was calculated, as well as the 
percentage change. The convergence of multiple scores into one overall score is a recognised 
method of managing Likert data (Boone and Boone 2012). The grouped data then underwent 
statistical analysis using paired t-tests to establish whether there was a significant difference 
between the two sets of scores (Healey 2014). T-tests are a common test and have been 
widely used, including in VP evaluations (Battaglia et al. 2012, Al-Dahir et al. 2014). After 
statistical consultation and considering the nature of the data, t-tests were deemed 
appropriate as the data was normally distributed. A Kolmogorov-Smirnov test of normal 
distribution was used to aid this decision making.   
The satisfaction questions were analysed using descriptive statistics, specifically calculations of 
medians and IQRs. Medians were used over means for these questions as the data was ordinal 
and there was no reason to treat it as interval data. A ranking question with five outcomes was 
analysed using a Friedman Test that identified whether there was a statistical significance 
between the responses (Field 2013). 
The final questionnaire section consisted of the qualitative free-text questions, these 
responses were thematically grouped, and the frequencies calculated. This was used to 
support, explore, and confirm numerical data and also contributed to interview sampling.  
5.5 Qualitative data collection and analysis 
Interview participants were approached to take part based on their demographics, specifically 
sector of practice, qualification status, age, gender and likely involvement in NOAC 
counselling. There were some additional considerations based on participant’s questionnaire 






Initial 8 key interview areas 
Experiences of AF and NOACs and associated education and training  
Experiences of VPs 
Feelings towards using VPs  
VP as an educational tool 
- Implementation of the VP 
- Purpose of the VP  
VP technology  
- Improvements to the VP 
Table 5.1 Key topics initially planned for inclusion in the interviews 
The study’s interview guide was based on the aim and objectives of the study and the review 
of the literature; the guide (Appendix VI.) was piloted prior to use and contained eight topics 
to be discussed (Table 5.1),. Furthermore, using the questionnaire results, the initial interview 
guide was adapted and new discussion points were added and development of the discussion 
topics continued throughout the course of the interviews. Additions included: perspectives on 
the use of MCQs (question design within the application) and potential alternative designs; the 
user feedback design; the perceived purpose of the VP; who the best users of the VP are; and 
considerations for implementation and use in practice. 
 Interview guide design 
Prior to the start of the main study, some interview preparatory work was undertaken to test 
the proposed interview guide and also to develop a working framework for data anlaysis. This 
was also useful to contribute to training interviewers (Boyce and Neale 2006). The interview 
guide was included in the peer review and was then tested in a number of pilot interviews; 
data were analysed in the same manner as for the main study. The target sample was three 
participants in line with the methods of the wider study where participants were selected 




The testing of the interview guide resulted in minor typographical changes and re-ordering of 
some of the elements, overall the guide was appropriate for use. This included three pilot 
interviews (two in person and one via video technology). Following analysis of the pilot 
interviews, an initial framework was developed this was the basis of the framework for the 
wider study and allowed initial themes to be identified.  
The working framework based on the pilot results included four themes:  
• The technology needs to work. This is made up of sub-themes of ‘’user satisfaction’’ and 
‘‘technology, designs, and decisions’’.  
• Subject matter – Perspectives on AF and NOACs.  
• Perspectives on the VP’s purpose. This is related to the final theme and also has its own 
sub-themes of ‘’benefits to the user’’, ‘‘considerations for implementation and future 
designs’’, and ‘’educational perspectives’’.  
• Audiences - pharmacist roles and sectors of practice. 
 Interview technique 
As discussed in section 4.4.4, the study used semi-structured interviews. As part of this, the 
interview guide that was developed (section 5.5.1) was a guide rather than a schedule 
intended to be rigidly stuck to. According to DiCicco-Bloom and Crabtree (2006), semi-
structured interviews are organised around a number of pre-set open questions with other 
topics and questions emerging from the dialogue. On the basis of this flexibility the participant 
to expressed themselves in their own words and the interview guide was adapted as 
interviews progressed to include new topic areas and discussion points. This allowed for the 
conversation to flow naturally and topics were introduced once previous ones had been 
exhausted. The interview guide included prompts should the interviewer be required to 




Interviews were conducted either face to face, in a location of the participant’s choosing and 
thus of familiarity to them or by video technology or telephone. Telephone or video interviews 
were pre-arranged, and the interviewer called the interviewee at an allotted time. The 
interviewer introduced themselves and an initial small amount of general chat occurred. 
Following this, the interviewer discussed consent and the structure of the interview, before 
which the participant provided a second verbal consent (written consent was obtained prior to 
interview). The interviews were unlikely to bring up any uncomfortable or distressing topics, 
nonetheless, it was clear to participants that the interview could be stopped at any time. The 
interviewer then discussed their background briefly in terms of reflexivity (sections 4.5.4 and 
10.6). before starting the interview. 
All of the interviews were audio-recorded and transcribed verbatim. The interviewer 
documented any observations, interpretations or opinions that occurred during the 
interviews. These notes were included to guide analysis where they contributed to the coding 
process and helped to interpret participant data and document perspectives (Pope et al. 
2000). The notes were also useful to refine interviewer technique as conducting interviews is a 
skill which needs to be reflected upon and refined to maintain and improve on (Byrne 2011).   
 Data analysis 
Interview data were analysed using the framework approach to thematic analysis (Pope et al. 
2000). This is process was designed for applied health research where the method identifies 
commonalities and differences in data on priority topics and focuses on relationships to arrive 
at descriptive and explanatory conclusions (Gale et al. 2013). It is well suited to this study’s 
research aim and objectives that were exploratory in nature and focused on understanding 
perspectives. The framework method is not associated with any particular philosophical stance 
but it is flexible provided the aim of the research is to generate themes (Gale et al. 2013). As 




reflection on the part of the researchers who need to become skilled in this (Gillham 2005). A 
degree of self-detachment is required to do this and researchers need an awareness of the 
pre-conceptions of the topic and of the participants before starting the research (Gillham 
2005), this was built into reflexive practice. An advantage of the framework approach 
specifically, is that it was designed so that data are systematically analysed, consequently this 
allows readers to make their own judgements about the transferability of the findings to their 
own work when the study results are presented (Pope et al. 2000).  
The framework method follows five stages (Ritchie and Spencer 1994, Pope et al. 2000). 
Initially, the transcripts were checked for accuracy and any errors amended by the lead 
researcher (CR). CR also went through a process of familiarisation with the raw data and 
transcripts to start constructing key ideas as the foundation for the themes. The data were 
then systematically reduced to codes using a set of stages to organise, categorise and analyse 
data (Pope et al. 2000 and Gale et al. 2013). The next stage mapped the codes to a framework 
which had been developed based on early familiarisation and coding. Following this, groups of 
codes were considered to identify themes; this was the lengthiest part of the analysis and was 
a cyclical process to consider and reflect on themes. Finally, the themes were interpreted and 
related to the aim and objectives of the study.   
Qualitative data analysis started while data collection was ongoing so that continuing data 
collection could be moulded by interim analyses. This allowed for the constant refinement of 
questions, the pursuit of emerging unexpected themes and identification of deviant cases 
(Pope et al. 2000). In this study, a balance between inductive and deductive analysis was used 
to do this, this is a method that has been shown to be useful when the research question has 
some pre-defined areas to explore but allows the option to discover unexpected themes and it 
is well suited to the framework (Pope et al. 2000, Gale et al. 2013). This process started when 
pilot interviews were conducted, where the data were analysed alongside some pre-set ideas 




directly from the data. Moving forward into the wider study, themes identified from the pilot 
study were used as a starting point for the wider analysis, these were not definite and as the 
analysis progressed new themes were added and older themes were transformed and thus the 
process was a balance between inductive and deductive analysis.  
 Data saturation 
To increase the quality of the research, the research team considered what defined the point 
of data saturation (Fusch and Ness 2015). As already discussed (section 5.3.1), Guest et al. 
(2006) recognised the difficulty of defining data saturation stating that there were no practical 
guidelines to implementing the theory in practice (Guest et al. 2006, Hennink et al. 2017). In 
this study, a number of approaches were adopted to address this. Firstly, considering studies 
reporting VP use, data saturation does not appear to have been discussed, although this may 
be because the majority of methods were not qualitative. In one study on VP use in pharmacy 
20 telephone interviews were undertaken and it is not clear whether saturation was reached 
(Thompson et al. 2017). Similarly, in another study that qualitatively gathered perspectives on 
VP use, data saturation was not discussed (Bearman 2003). Following this, key areas were 
identified which were the predominant topics to be saturated in the qualitative phase. These 
were based on the aim and objectives of the study and were adapted as the research 
progressed. The initial key areas to be saturated were: 
• Technological usability of the application; 
• Perspectives on the education and training, and CPD of pharmacists and pre-
registration trainees particularly around audiences and users of the VP;  
• Improvements to the VP application and other possible applications in the future; 
• Perspectives on the design and overall purpose of the VP especially regarding 




In addition to the initial key areas, other emerging areas were also incorporated into the 
themes such as the broader ideas of implementation which emerged to be significant (chapter 
9). In order to establish if the areas were saturated particular attention was taken to the 
coding process to consider the thickness and richness of the data and to the construct of 
themes by a number of internal reviews. Finally, considerations were taken regarding the 
nature of the participants undergoing an interview, as those with different demographics and 
pharmacy roles may have impacted the rate at which data saturation was reached.  
An important element of this approach to data saturation is that it does not solely rely on 
‘coding saturation’ but also embraces the idea of ‘meaning saturation’ as discussed by Hennink 
et al. (2017). Data saturation should not rely on simply identifying the range of thematic issues 
but also the richly textured understanding of the thematic issues (Hennink et al. 2017). This is 
evidenced by a small number of additional interviews being undertaken in order to better 
cement understanding of the themes once data saturation was reached (section 5.5.4). On the 
basis of this, the research team determined that all of the themes were present after 12-15 
interviews however it was not until 19 interviews that the research team determined that data 
saturation of the key areas had occurred. In order to cement this status an additional three 
interviews were conducted. These acted as a way of considering if any further meanings were 
retrieved from additional interviews.  
5.6 Implementation analysis 
During the course of the interviews the large range of perspectives on implementation and use 
of the VP in pharmacy practice became apparent. This was not anticipated in the planning of 
the research but emerged to be significant. On the basis of the iterative nature of this and of 
pragmatism as a methodology, the methods of the study were adapted to include a 




addition to the framework approach to thematic analysis (section 5.5.3) with the intention of 
complementing the thematic analysis via specifically addressing implementation.  
For the implementation analysis to take place the consolidated framework for implementation 
research (CFIR) was used (Damschroder et al. 2009). This framework was selected as it was 
developed as part of health service research and as stated by the authors it provides:  
‘’a pragmatic structure for approaching complex, interacting, multi-level, and transient 
states of constructs in the real world by embracing, consolidating, and unifying key 
constructs from published implementation theories.’’ (Damschroder et al. 2009) 
This sits well with the pragmatic approach to the research study and that the chosen 
framework had to be adaptable to best consider the research aim and objectives. A number of 
options were considered to try to identify a framework that would sit well with the study 
design and purpose. This included the reviews by Meyers et al. (2012) and Moullin et al. (2015) 
and the framework by Greenhalgh et al. (2004).  These were decided against for varied 
reasons including that they were not suitable for health research or for technology-based 
implementation. Choice of a framework was complicated due to the implementation analysis 
being an additional analysis and that the study was not designed around implementation 
research and so no framework would fit completely. Studies that referred to the 
implementation of VPs were consulted. Zary et al. (2006) and Guise, Chambers, Conradi, et al. 
(2012), discussed implementation of a VP but the authors do not appear to have used an 
implementation framework to structure this. As such, consideration of implementation, 
appears to be an original feature of this VP study.  
The CIFR was chosen because the constructs relating to the intervention sat well with the VP 
application as did the applicability of the CFIR to both a health and technology-based 




organisational level. The practicalities of using the CFIR to consider implementation of the VP 
will be discussed alongside the results of this analysis in section 9.3. 
5.7 Summary 
This chapter has summarised the methods used to conduct this research, including the 
decisions made during the choosing of the methods and the associated instrument 
development. Additionally, there was discussion around why the methods were appropriate 
for use.  
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 Questionnaire results 
6.1 Introduction 
In the previous chapters the context was laid for the planning and conduct of this research. The 
results of the first phase of the study are now presented. The questionnaire results include both 
descriptive and inferential analyses and an exploration of the demographics of the respondents. The 
chapter concludes with a brief discussion of the relevance of the findings, which includes 
highlighting results that were significant for the second phase of the study.  
 Aim of the questionnaire phase 
Considering the aim and objectives of the wider study, the questionnaire phase specifically aimed to 
contribute to investigating the learner reported value and acceptance of the VP primarily through 
exploring the ability and usefulness of the VP to teach NOAC counselling and to explore satisfaction 
with the VP and how this effects usability. Also, to gather preliminary information on possible 
improvements to the VP. 
6.2 Participant demographics 
The questionnaire went live in November 2018 and participation continued until August 2019. The 
study involved 14 sites, nine secondary care sites and five geographical regions for recruiting 
community pharmacists. Across the sites, 94 respondents took part in the questionnaire phase of 
the study. A number of potential respondents (n=32) initially consented to take part in the 
questionnaire phase of the study but then did not return a completed questionnaire despite being 
sent a number of reminders via email. The reasons for this are unclear. 













24 (25.5%) 1 (4.3%) 23 (32.4%) 8 (30.8%) 13 (21.3%) 
Female 
70 (74.5%) 22 (95.7%) 48 (67.6%) 18 (69.2%) 48 (78.7%) 
Age group 
20-29 years 
48 (51.1%) 22 26 11 33 
30-39 years 
29 (30.9%) 0 29 8 18 
40-49 years 
13 (13.8%) 1 12 4 9 
50-59 years 
4 (4.3%) 0 4 3 1 
Older than 60 
years 0 (0%) 0 0 0 0 
Qualification status 
Pre-     
registration 
trainee 
23 (24.5%)   3 18 
Qualified 
pharmacist 71 (75.5%)   23 43 
Length of time qualified 
Less than 5 
years 23 (24.5%)  23 8 13 
5-10 years 
29 (30.9%)  29 6 20 
11-20 years 
12 (12.8%)  12 4 8 
More than   
20 years 7 (7.4%)  7 5 2 
Sector of practice 
Community 
26 (27.7%) 3 23   
Hospital 
61 (64.8%) 18 43   
Other  
7 (7.4%) 2 5   
Table 6.1 Respondent demographics 
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Of the 94 respondents, 61 were from the hospital sector, 26 were from the community sector, with 
seven reporting other sectors of practice due to split roles (Table 6.1). The respondents were from 
14 sites which were well spread across England and a mix of secondary care NHS sites and regional 
CRNs for recruiting community pharmacists; the largest site had 14 respondents (n=14.9%).  
Concerning gender, there was a split of 25.5% (n=24) male and 74.5% (n=70) female across the 
respondents. Concerning age groups, 20-29 years was the most common age group (51.1%, n=48) 
and older than 60 years was the smallest group (0.0%, n=0) (Figure 6.1). Similarly concerning the 
length of time since qualification, 5-10 years was the most common length of time since qualification 
(30.9%, n=29) and more than 20 years the least (7.4%, 7) (Figure 6.2). There was a spread of 71 
respondents (75.5%) vs 23 respondents (24.5%) between qualified pharmacists and pre-registration 
trainees. 
 








20-29 years 30-39 years 40-49 years 50-59 years Older than 60 years




Figure 6.2 Respondent qualification status 
 
6.3 Initial thoughts and perspectives 
One of the first questions posed concerned previous experiences of using VPs, where the vast 
majority of respondents reported no previous experience (n=71, 75.6%). A number of respondents 
mentioned VP experience either through other courses such as independent prescribing or MUR 
training, or through other simulation technologies including both high and low fidelity applications, a 
named example being SimMan (Figure 6.3).  
Respondents were further asked about previous training concerning NOAC counselling. The 
responses to this question have been grouped into topics and the frequency that each topic was 





Participant qualification status distribution
Pre-registration Pharmacist less than 5 years 5-10 years 11-20 years More than 20





Figure 6.4). The most common response to this question was no previous training or education 
(n=23, 20.7%); this was more common in those from the community sector. A number of 
respondents did report forms of ‘in-house’ training, which appeared to be more common in those 
from the hospital sector. Within the ‘in-house’ group the form of the education and training varied 
and included both formal learning (n=11) and informal or observational learning (n=18). Formal 
learning included other qualifications including part of a clinical diploma (n=1) and the independent 
prescribing qualification (n=1), and informal or observational learning including peer discussions and 
peer-to-peer feedback as is illustrated by the quote below. A small number of respondents reported 
undertaking self-directed learning (n=7, 6.3%). 
 ‘’I carried out a role play counselling with my supervisor and peer using a trust 
guideline/checklist. I then counselled a patient with supervision three more times with 


































Figure 6.4 Content analysis of previous NOAC education and training 
Prior to trialling the VP, respondents were asked a series of Likert questions regarding their current 
practice and the likely interest in further NOAC education and training.  They were asked how often 
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(Figure 6.5); 67.0% of responses were for ‘’once in a while’’ or ‘’occasionally’’. The median score was 
‘’occasionally’’ (interquartile range IQR=1). Respondents were then asked how confident they were 
about conducting NOAC counselling using a scale of ‘’not at all’’ to ‘’extremely’’ and 72.4% of 
responses were for ‘’moderately’’ and ‘‘quite’’ (median ‘’quite’’, IQR=1) (Figure 6.6). 
The respondents were also asked about their interest in learning more about NOACs and AF (from 
‘’not at all’’ to ‘’extremely’’). Responses were more consistent for this question with the majority of 
answers (90.5%) corresponding to ‘’quite’’ and ‘’extremely’’ (median ‘’quite’’, IQR=1). The same was 
true for the question about the potential usefulness of such training, where the median was 
‘’extremely’’ and 94.7% of responses were for ‘’quite’’ and ‘’extremely’’ (IQR=1) (Figure 6.7).  
 
Figure 6.5 Responses to the Likert question concerning the frequency of NOAC counselling 
 
Figure 6.6 Responses to the Likert question concerning confidence in NOAC counselling 
 
10.6% 31.9% 35.1% 17.0% 5.3%
How often do you counsel patients on non
vitamin K oral anticoagulants (NOACs) e.g.
rivaroxaban for atrial fibrillation?
Never Once in a while Occasionally Frequently Very frequently
2.1% 16.0% 30.9% 41.5% 9.6%
How confident are you counselling patients on
NOACs for atrial fibrillation?
Not at all Slightly Moderately Quite Extremely




Figure 6.7 Responses to two Likert questions concerning the usefulness of further learning on 
NOACs and the interest in further learning on NOACs 
6.4 Pre- and post-VP ability 
Respondents were asked to rate their perceived ability to counsel a patient on given sub-areas of 
NOAC counselling using a Likert scale of ‘’poor’’ to ‘’excellent’’. There were 11 items, and these were 
asked before and after respondent use of the VP. The questions did not test knowledge but reported 
a participant’s perception of ability. As discussed in section 5.4.3, this Likert data was treated as 
interval data and underwent a t-test calculation, therefore averages were calculated using means; 
medians were also calculated to support use of the mean as discussed in section 5.4.3.  
This analysis showed that on average, respondents’ scores increased after VP use, with an average 
increase of 10.2% (-30.3%-39.6%). Similarly, the median percentage change pre- to post-VP use was 
8.2% (IQR=14.3%). Table 6.2 shows the similarity of the means and medians. Of the 94 respondents, 
71 (75.5%) demonstrated an increase in self-reported ability, 17 (18.1%) had no change and 6 (6.4%) 
had a decrease. Reasons for decreases were not entirely clear but are discussed in section 6.10. The 
significance of the average change in scores pre- to post-VP was measured using a paired t-test 











How interested do you think pharmacists and
pre-registration pharmacists would be in
learning more about counselling on NOACs in
atrial fibrillation?
How useful do you think learning about NOAC
counselling in atrial fibrillation would be for
pharmacists and pre-registration
pharmacists?
Not at all Slightly Moderately Quite Extremely
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VP use was significant (P<0.001). Further to this, the data were examined prior to the test to 
establish if the distribution was normal and thus that a t-test was suitable for use. As discussed in 
section 5.4.3, a Kolmogorov-Smirnov test was used to show that the change in participant scores 
pre- to post-VP were normally distributed (P<0.001). 






Pre-test 42.27 40.8-43.7 7.13 - 43 37-47 
Post-test 47.16 46.0-48.3 5.59 - 47 47-52 
Difference pre- 
to post-VP 
4.89 3.75-6.03 5.66 0.000 4 6 
Table 6.2 Analysis of the significance of the average change in pre- to post-VP self-reported ability 
using a t-test 
6.5 Satisfaction with the VP 
 Technology 
After using the VP, respondents were asked a series of Likert questions concerning their satisfaction 
when using the VP and their view of the VP’s technical usability. Respondents also scored the VP‘s 
usefulness, their enjoyment using it, the difficulty in using it, their comfort using the technology, 
likeliness to use it again and if they would recommend it to others. Each question used a Likert scale 
of ‘’not at all’’ to ‘’extremely’’ (Figure 6.8) 
For the questions regarding enjoyment, comfort, usefulness, likeliness to use the VP again and 
likeliness to recommend it to a colleague the median scores were ‘’quite’’ (IQR=1, except for 
questions on using the VP again or recommending it where IQR=2). Despite this, there were some 
differences in the spread of results across the Likert. Enjoyment using the VP had 73.4% of responses 
for ‘’moderately’’ or ‘’quite’’, likeliness to use the VP again had 53.1% of responses for ‘’moderately’’ 
or ‘’quite’’, and recommend to a colleague had 59.6% of responses for ‘’moderately’’ or ‘’quite’’. The 
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question regarding the usefulness of the VP was more positive as 80.9% of responses were for Likert 
scores of ‘’quite’’ and ‘’extremely’’.  
For the question regarding difficulty using the VP the median score was ‘’not at all’’ (IQR=1), 
suggesting that the majority (86.2% for ‘’not at all’’ and ‘’slightly’’) did not find the technology 
difficult to use. The usability questions indicate that respondents, on average, found the VP usable 
and would it again and/or recommend it to others. A small group of individuals appeared to not 
enjoy using the VP and were more negative regarding its usability.  



































How enjoyable did you find using the virtual patient
programme?
How comfortable were you using the virtual patient
technology?
How difficult did you find the virtual patient
programme to use?
How useful did you find the virtual patient
programme?
How likely are you to use the programme again?
How likely are you to recommend the programme to
a colleague?
VP Usability
Not at all Slightly Moderately Quite Extremely
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 Scenario content 
There was a further group of questions that concerned the VP scenario and design. This included 
questions concerning feedback, VP questioning style and realism and were measured on a scale of 
‘’strongly disagree’’ to ‘’strongly agree’’ (Figure 6.9). All of the questions in the series had a median 
score of ‘’agree’’ indicating that respondents on average were positive towards the VP. However, 
despite having the same median, the spread of data across the Likert did vary.  
The MCQ options question was the question with the biggest range in responses, percentage score 
for responses of ‘’agree’’ or ‘’strongly agree’’ was 57.4% (IQR=1). Similar results were observed for 
the scenario playing out much like it might in practice (68.1%, IQR=1) and the likability of the 
feedback (73.4%, IQR=2). Conversely, the question asking if the VP had fulfilled its aim had 82.9% 
‘’agree’’ or ‘’strongly agree’’ responses (IQR=0). The areas which had a greater spread across the 
Likert and a lower percentage of scores relating to ‘’agree’’ and ‘’strongly agree’’, namely the MCQs 
options, the scenario playing out like it might in practice and the likability of feedback, were 
identified as areas to explore in the qualitative interviews (section 6.11.2). 
Further questions asked whether respondents thought that the VP had changed their knowledge 
about NOAC counselling and their confidence, and whether this would result in a change in their 
practice. These questions also used Likert scales of ‘’strongly disagree’’ to ‘’strongly agree’’ (Figure 
6.10). The spread of the responses for the three questions were similar and the median scores were 
identical (median ‘’quite’’, IQR=0 for knowledge, IQR=1 for confidence and change of practice). The 
question regarding confidence had the lowest proportion of ‘’agree’’ and ‘’strongly agree’’ responses 
(70.2%) although this was close to the scores of the other two questions (72.3% knowledge, 75.5% 
change of practice). This suggests that users thought that the VP can change knowledge and 
confidence and could lead to changes in their practice. However, it is difficult to establish from this 
data whether there was a greater perceived effect of one of these outcomes over the other. Where 
there were responses that disagreed with this, they tended to be across all three questions when













































The scenario was realistic to practice
The scenario played out much like it might in practice
The multiple choice responses met the needs of what I wanted to say to
the patient
The patient’s responses were realistic.
The scenario helped me practice how to host a consultation on this topic
The feedback provided at the end of the case was sufficient to guide my
learning
I liked the method of feedback at the end of the case when the patient
verbally discusses my performance
The virtual patient programme fulfilled its aim of teaching how to counsel
a new patient on rivaroxaban for atrial fibrillation
VP Application satisfaction
Strongly disagree Disagree Neither agree nor disagree Agree Strongly agree
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individuals did not like the VP. Some of the reasons for this are addressed by the free text 
questions within the questionnaire (section 0) and the issue was also explored in phase two of 
the study.   
 
Figure 6.10 Implications of VP use across three Likert questions 
 
6.6 The purpose of the VP 
After using the VP, the respondents ranked five outcomes to indicate the way in which they 
perceived that it had impacted on their learning and development (1 biggest impact to 5 
smallest impact) (Figure 6.11). ’Change of knowledge’ and ‘change of confidence’ received 
scores corresponding to the largest impact (average ranking 3.3 and 3.6 respectively) followed 
by a ‘development in generic consultation skills’ and ‘contribution of CPD’ (3.1 and 3.0 
respectively). Finally, the outcome with the least impact concerned a change of knowledge 
around NOACs more generally in other indications (2.0).  
As the data for this question was ordinal, the significance of this result was assessed via a 
















The virtual patient programme increased my
knowledge regarding counselling on NOACs for
atrial fibrillation.
The virtual patient programme increased my
confidence regarding counselling on NOACs for
atrial fibrillation
As a result of using the virtual patient
programme, in the future I will change my
practice when counselling patients on NOACs
for atrial fibrillation
Implications of VP use
Strongly disagree Disagree Niether agree nor disagree Agree Strongly agree
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in section 5.4.3. The Friedman test indicated that the VP outcomes posed to the respondents 
were ranked statistically differently, χ2(4) = 52.175, (p<0.000). It is unclear exactly where this 
significance lies due to the nature of the statistical test. It is not possible to differentiate 
entirely between the options but, this question, along with the Likert questions contributed to 
an interpretation of what respondents reported to be the VP’s overall purpose. On an 
individual level, the majority of respondents ranked the outcomes in roughly the same order 
as the average rankings, but some individuals appeared to perceive the purpose of the VP as 
completely different. For example, some individual respondents reported a ‘contribution to 
CPD’ or ‘contribution to generic consultation skills’ as having the greatest impact with 
‘knowledge and confidence changes’ ranked lower down. ‘Contribution to CPD’ and 
‘development of generic consultation skills’ both received a similar number of rankings for 
both the largest and smallest impacts, this further highlighted that different users appeared to 
perceive the purpose of the VP differently to each other.  
From the free text questions later in the questionnaire (section 0), some further insight into 
the responses of this question were found. It appeared that some of the design elements such 
as the section at the start of the application which focuses on checking the identity of the 
patient, could be affecting respondents’ perceptions on the purpose of the VP: 
‘’Is the intended purpose to spend time making sure colleagues are checking the 
address on the script, or that they are offering to take the patient to the counselling 
room? If the session is on counselling for rivaroxaban, make it about counselling 
rivaroxaban.’’ [P25] 
Subsequently, respondent’s perspectives on the purpose of the VP were explored further in 
phase two of the study. 




Figure 6.11 The frequency of times that possible learning outcomes of the VP were ranked as 





Asymp. Sig. 0.000 
Table 6.3 Results of a Freidman test for analysing the results of a ranking  


















































Please rank the following outcomes in terms of the 
way the virtual patient programme impacted your 
learning and development
1 - smallest impact 5 - largest impact
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6.7 Additional thoughts and perspectives from free text questions 
At the end of the questionnaire, respondents were asked short answer questions to gather 
free text information on their perspectives and feelings towards the VP. This included what 
the respondents thought were the best and worst things about the VP, these responses were 
analysed for their content and frequency. A summary is shown in Figure 6.12 and Figure 6.13.  
The respondents gave positive feedback on the interactivity (14.5%) and realism (18.8%) of the 
application and also on the case feedback (15.4%). Other points included the opportunity to 
practice the NOAC consultation, the sophisticated animations and technology, and the 
importance of patient interaction. 
In relation to the three most common topics, respondents appeared to have appreciated the 
feedback and found it useful, for example:  
‘’The feedback received at the end; it was not in a generic form instead it was based on 
my responses’’ [P30] 
Respondents also enjoyed the realism of the case, particularly the patient responses, as the 
following comment shows:  
‘’Overall quite realistic patient responses’’ [P11] 
Additionally, respondents were positive towards the realism in that the VP responded to the 
choices of the individual user: 
 ‘’It was realistic, and the scenario changed based on the questions you asked’’ [P6] 




































































What was the worst thing about the virtual patient 
programme?
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The interactive nature was also appreciated and commented on multiple times:  
 ‘’Interactive nature. You can have a play around, and not be scared to cause any harm 
to a 'real' patient’’ [P35] 
Conversely, the most commonly cited negative comments were the MCQ options (which were 
the questions posed to the user through the case) (21.0%), the technology (11.3%), that the 
extent to which the case is reflective of practice is limited, (9.7%) and the perception of a 
limited case design (9.7%). However, a proportion of respondents said there was ‘’nothing’’ 
bad to comment on the application (n=12). These areas will be discussed in more detail below.  
The majority of comments concerning the MCQ options were around the perception that the 
question options did not include everything that an individual might say in a consultation or 
incorporate what an individual’s consultation structure might be.  
‘’The multiple-choice answers were generic and not always the options I would choose 
when counselling a patient’’ [P4] 
A number of respondents also commented on the restrictive nature of the MCQs and that this 
consequently limits the ability of the VP to be reflective of practice. Participant 11 discussed 
‘‘pigeonholed’’ responses which links to the idea of an underlying algorithm. 
 ‘’Every answer or action is pigeonholed to three or more answers and depending on 
your selection the consultation can come to an abrupt ending. This is not a true 
reflection of real-life practice’’ [P11] 
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Realism to practice was also reflected in a group of comments on the case length. Only a 
minority of users discussed this; where this was discussed the consensus was that the 
application was too long. It is unclear as to what the whole sample thought about the case 
length. 
‘’A bit longer that I would have liked’’ [P64] 
Technology was another key topic and some respondents reported that the system was ‘slow’ 
or that they had technical issues:  
‘’Very slow at responding. Quite frustrating waiting for a response. Instructions on how 
to use it would have been helpful (i.e. what each button does etc.)’’ [P56] 
Respondents also made recommendations for how they thought the VP could be developed 
(Figure 6.14). The most common responses, some of which are discussed below, were largely 
linked to the areas previously identified as the ‘worst’ areas of the VP design.  
This included comments around changes to the case pathway and design, particularly the 
MCQ options and the underlying questioning methods used in the VP application. This was 
one area which was identified as a ‘worst’ element of the VP but suggestions for improving 
this were made. Respondent 25 discussed that the MCQs were difficult to distinguish between 
as there was overlap between them. One example of this is evident in Figure 1.4, where the 
application gives the options of ‘’yes please’’, ‘’hello’’, and ‘’hi Henry how are you today’’. 




Figure 6.14 Content analysis of the question ‘‘Do you have any recommendations on how 
the virtual patient programme could be improved or developed?’’ 
 
 
‘’Adjust the options so that they are clearly different, some overlap or are so similar as 




















Other versions/applications (other than
sector specific version of current VP)
Clinical content needs altering or improving
Feedback needs improving
Inclusion of resources/references
Summary at the end of the application
Technology
Duration of the application
More realistic to practcie
Increased flexibility
VP should be sector specific
Other
Do you have any recommendations on how the virtual 
patient programme could be improved or developed?
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Some respondents did suggest further applications for the technology:  
‘’I'd like to see it used for more conditions/diseases requiring long term medications 
and encompass monitoring advice’’ [P17]  
Suggestions for a further summary at the end of the application were made by five 
respondents and there were a number of suggestions around further resources and references 
(n=8). For example: 
‘‘It would be good to have a transcript of an ideal patient counselling at the end of the 
programme’’ [P10]  
‘’Useful reference at the end would be beneficial for further reading’’ [P21] 
A few suggestions were made around clinical content and improving this element of the case, 
an example being: 
‘’more clinical depth, I get asked things like 'what is atrial fibrillation' 'is it dangerous' 
'why do I have to take this medication when my stroke risk is only 6% that seems low'’’ 
[P2] 
Equally, one participant suggested that the content of the application was currently not 
accurate considering what they were expecting of a patient with Henry’s past medical history. 
They did not elaborate on what exactly they meant by the following quote: 
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‘’Update the medical history to correctly reflect a real patient with these clinical 
conditions’’ [P37] 
Finally, respondents were asked about the potential impact of the use of the VP for patient 
care. Responses included benefits for pharmacist’s counselling skills, both, through knowledge 
acquisition and the opportunity to practice. 
‘’the virtual patient programme could help improve pharmacist patient counselling 
skills thus improving patient experience. It will also enable pharmacists to practice 
counselling patients enabling them to feel more confident in counselling patients and 
be more familiar with the process’’ [P4] 
The consequences of this learning for patient care was also related to patient safety and 
compliance: 
 ‘’If all new medicines especially high-risk medicines like DOACs [direct oral 
anticoagulants] and VKAs [vitamin K antagonists] were explained in this manner it 
would have a hugely positive effect on patient adherence and safety’’ [P11] 
A number of respondents also commented on the usefulness of practical experience for 
conducting this type of counselling.  
‘’Could play a significant role in improving counselling skills and improve skills for a 
particular subject without practicing on real patients. Improve confidence to talk to 
patients on a subject’’ [P40] 
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6.8 Analysis of results by sector of practice 
The study used respondents from the two main pharmacy sectors: hospital and community. A 
further analysis was undertaken which compared the results between the respondents who 
reported as working in one of the two sectors (Appendix VII.). Only those respondents who 
solely identified hospital or community as their sector of practice were included in this to 
avoid contamination by those working across multiple sectors. There were 26 respondents 
from the community sector and 61 from the hospital sector. 
For the majority of questions using Likert scales, the median scores were identical for 
community and hospital respondents and the spread of the data were similar (appendix VII.). 
A small difference was found between the two sector groups regarding previous experiences 
of NOAC training. More hospital pharmacists appeared to have received NOAC education and 
training and this was in line with the confidence scores where on average hospital were 
‘’quite’’ confident as opposed to community pharmacists who were ‘’moderately’’ confident. 
Due to the difference in the size of the groups, no analysis was undertaken to consider any 
differences in the changes in self-reported ability between the two groups of respondents; the 
significance of the different group sizes is discussed in section 6.10. The analysis did not 
attempt to make any inferences between the groups but aimed to determine whether there 
were any apparent differences between the groups that could affect perceptions on the VP.  
6.9 Analysis of results by qualification status 
The final part of the questionnaire analysis was similar to that discussed in section 6.8, but 
involved comparing the data of those identified as qualified pharmacists and those identified 
as pre-registration trainees (Appendix VIII.). There were 23 pre-registration trainee 
respondents to 71 qualified pharmacists and as for the previous section the significance of the 
differences in the group sizes is discussed in section 6.10.  
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For the majority of questions using Likert scales, the median scores for both groups were 
identical. This is the case for all of the questions except the question concerning the comfort 
using the VP where qualified pharmacists scored it ‘’quite’’ but pre-registration trainees were 
more positive and their median score was ‘’extremely’’ (Appendix VIII.). The spread of data 
across the Likerts were also similar between the two qualification groups. One question where 
there was a difference, although small, between the groups regarded confidence in NOAC 
counselling where the median score was ‘’quite’’ for qualified pharmacists and ‘’moderately’’ 
for pre-registration trainees.  
As in section 6.8 there was no analysis undertaken on any difference in the average change in 
self-reported ability. The differences that have been highlighted in this section are discussed in 
section 6.10. 
6.10 Discussion 
This section of the chapter discusses the results of the questionnaire in the context of the 
study’s aim and objectives and the relevant literature. It also highlights the issues that were 
identified to be explored in the second phase of the study. 
The majority of respondents appeared to find the VP usable, with few technical limitations. 
This was supported by the results for questions about the difficulty of using the application 
and comfort using the technology where a significant amount of the responses were positive. 
In line with a previous research recommendation to evaluate VPs with more sophisticated 
graphics and animations the VP makes use of modern animated technology (Jabbur-Lopes et 
al. 2012). This was something that respondents commented on as a positive feature and 
appeared to favour, which is particularly relevant as limitations in technology can detract from 
user experience and even affect outcomes (Douglass et al. 2013), as was a finding of the 
systematic review (section 3.5).  
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From the questions using Likert scales that had mixed results, some individual design elements 
of the VP were identified as not being well liked, this included the MCQ design and feedback 
design. The reasons for this were not entirely clear and so the topic was identified as needing 
further explanation in phase two of the study. There were mixed results concerning enjoyment 
using the VP and it was not clear why some respondents did not find using the VP enjoyable. 
This was another issue that was identified for further explanation in phase two. The realism of 
the patient’s responses was well-liked, and this appeared to contribute to the likability of the 
VP. This finding is in line with other quantitative VP evaluations and reviews where VPs have 
been recognised to have high levels of user satisfaction (Battaglia et al. 2012, Jabbur-Lopes et 
al. 2012, Douglass et al. 2013, Bindoff et al. 2014, Smith et al. 2014, Zlotos et al. 2016).  
A reasonable number of respondents would use the VP again or would recommend it to a 
colleague. No respondents had negative perspectives on the overall concept of the VP, but 
some suggested more clarity and instruction on using the application. Previous VP studies 
have found that familiarity with the technology can increase a user’s acceptance of it (Taglieri 
et al. 2017) and technical glitches can negatively impact user performance (Douglass et al. 
2013). In this study, although most respondents reported that the VP was not difficult to use, 
some did report that they did not like the restrictive or ‘’pigeonholed’’ design of the 
application. This could have contributed to some of the mixed results concerning usability and 
acceptance. 
The average increase in self-reported counselling ability pre- to post-VP suggests that there 
was a benefit to using the VP. For some individual respondents, there was no average change 
or a decrease in self-reported ability. For these users, the majority were still positive about 
using the VP and appeared to suggest that they still found some value in it although this could 
be in a different way to those users who reported an improvement in their ability. This could 
include learning around more general consultation skills, this type of learning became more 
apparent in the interviews (section 8.2.2). This is similar to the work by Taglieri et al. where 
6. Questionnaire Results 
134 
 
the measured improvement in student performance was not in line with that which was 
perceived by the respondents (section 3.4.3). The respondents did not find the particular VP 
useful for improving performance but, a change in performance was measured (Taglieri et al. 
2017).  
Negative changes in self-reported ability are more difficult to explain. One possible 
explanation is that the VP helped users to identify areas where they needed improvement 
hence their ability post-VP was scored lower than pre-VP as their ability was not as good as 
they had initially perceived (pre-VP). This concept was commented on in the work of Botezatu 
et al. (2010) who identified that VPs in medical students had a regulatory effect and helped to 
plan learning. Similarly in the study by Forsberg et al. (2016), nursing students reported feeling 
uncertain as the use of the VP had exposed knowledge gaps.  
When respondents were asked if the VP positively changed knowledge, confidence and would 
result in a change of practice, there were mixed responses. The most commonly rated Likert 
scores suggested that the VP did have these effects. However, it is not clear is whether the VP 
has a greater effect on either knowledge or confidence. There is some evidence that VPs can 
help to develop knowledge such as the study by Zlotos et al. (2016), but less is known about 
the impact on users’ practice and confidence. Equally, as already discussed in section 3.5, 
knowledge and ability outcomes can be difficult to measure which contributes to uncertainty 
about the value of the VP. Despite this, the findings of this phase of the study further 
demonstrate some of the already recognised advantages to VP use such as design potential, 
mobility, and accessibility, all with low levels of risk (Stevens et al. 2006, Douglass et al. 2013). 
The questionnaire data provided information on previous NOAC education and training and 
although there was a range of previous NOAC training experiences, the extent to which it 
appears to be underprovided was striking. Numerous respondents reported having had no 
education or training, or that they had only had brief informal ‘inhouse’ training on NOACs. 
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This appeared to vary, particularly by sector of practice and role but, pre-registration trainees 
and those working in the hospital sector seemed more likely to have received training. This 
difference in training provision is recognised in the work by Power et al. (2008), who found 
that community pharmacists have less time available for CPD compared to their hospital 
pharmacist counterparts.  
Across both sectors there appeared to be very few respondents that had reported having 
completed formalised training. Some respondents reported that sites had a protocol for NOAC 
training, but this appeared to be both sporadic in that there was variation between individuals 
from the same site and also localised with different protocols and methods across those from 
different sites. There was no evidence of consistent delivery of NOAC education and training.  
Considering the perceived confidence of the respondents to conduct NOAC counselling by 
qualification status, pre-registration trainees appeared to be slightly less confident than 
qualified pharmacists, although any difference is small. This is reasonable considering the 
stage of career that those in each of these groups are at, particularly as pre-registration 
trainees are still in a learning role and are largely, only just, applying their knowledge from 
university to day to day practise as a pharmacist. Overall, the median for confidence for the 
whole sample was ‘’quite’’, which is somewhat better than expected especially considering 
that the median for how frequently the respondents conduct NOAC counselling was 
‘’occasionally’’. This is surprising, firstly because NOACs accounted for over 4.5million items 
dispended in community pharmacies in 2018 (NHS Digital 2018) and so are a common 
medicine, yet the respondents reported only ‘’occasionally’’ counselling on their use; secondly, 
it is also somewhat surprising that on the basis of an ’occasional’ activity that the respondents 
were still ‘’quite’’ confident.  
If considered in isolation the results for the question on confidence in NOAC counselling could 
suggest there is no need for the VP as more than 75% respondents rated their confidence as 
6. Questionnaire Results 
136 
 
moderate or greater. Despite this, there was over 90% agreement that learning more on NOAC 
counselling would be ‘’quite’’ or ‘’extremely’’ useful (Figure 6.6). These results suggest that 
irrespective of how confident the respondent was or how often they do NOAC counselling, 
respondents still tended to think that it would be useful to learn more. This could also be 
linked to previous NOAC training, in that there was such interest in learning more because a 
large proportion of the respondents had not reported received any particular training in this 
area previously.  
Many of the free-text responses regarding the potential impact of the VP related to an 
increase in counselling standards and thus improved patient care. This suggests that 
respondents do see a purpose and consequence of using the VP that may benefit their 
practice and patients. A number of respondents directly related the use of the VP to either 
pre-registration training or as part of CPD, these ideas of incorporation of the VP into 
education and training were further explored in phase two of the study.  
Some respondents mentioned how the VP might fit into current practice and they seemed to 
accept it as a learning resource for implementation. This was sometimes to the detriment of 
other resources, such as respondents suggesting that the VP may be more engaging than 
alternative learning methods for example, presentations and roleplay. The value of VPs 
compared to alternatives is a topic that a number of previous studies have attempted to 
quantify (Battaglia et al. 2012, Douglass et al. 2013, Bindoff et al. 2014, Smith et al. 2014, 
Zlotos et al. 2016). Across these studies the findings are conflicting regarding the educational 
value of VPs. VPs were not found to be any less useful to alternatives and they were often 
more well-liked. Bindoff et al. (2014) appeared to be the only study to statistically 
demonstrate an advantage of VP use compared to a paper-based alternative and even so this 
study had limitations to this finding as discussed in section 3.4.3. The findings of this study 
support that VPs are well liked but no judgement of its value compared to alternative 
resources can be made.  
6. Questionnaire Results 
137 
 
From the results of the questionnaire phase one question that remained concerned the 
perceived purpose of the VP. The ranking question (Figure 6.11) had a range of results with 
some respondents identifying VP use for NOAC-specific knowledge and confidence outcomes 
and others for more generic counselling outcomes or CPD. Whilst this question contributed to 
establishing the overall interpretation of the purpose and educational value of the VP, it was 
also clear that in some cases the purpose or outcome of using the VP was individualised. This 
issue was explored further in the interview phase.  
There were several VP improvements and recommendations made by the respondents. These 
included changes to reflect the potentially restrictive nature of the VP, particularly through the 
MCQs and the underlying algorithmic design. Some changes to support learning were also 
discussed, this included adding more references and supporting documents. Respondents 
appeared to like the idea of a summary at the end of the application regarding the ‘desired’ 
consultation, although this does somewhat conflict with the educational ‘purpose’ of the VP 
and the exploratory focus. This will be discussed as part of part two of the study (section 8.3). 
As highlighted across this discussion, a number of areas were identified as having mixed views, 
such as the feedback style (visualised in Figure 1.8), these areas were addressed in phase two 
of the study. 
6.11 Questionnaire performance 
The study questionnaire appeared to perform well. There was a small problem associated with 
technological access to the questionnaire from inside NHS Trusts which was easily resolved 
and managed via communication with the individual sites affected. The data received from the 
questionnaire appeared to answer the questions that they were designed to answer.  
A Cronbach alpha test was conducted to indicate the internal consistency or correlation of the 
Likert scales in the questionnaire (DeVellis 2003, Field 2013, Scott and Mazhindu 2014), this 
was undertaken for both the pre- and post-VP questions. When interpreting the results a score 
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of 0.7 was taken to be the threshold for good internal consistency (Campbell et al. 2007, Field 
2013, Scott and Mazhindu 2014). When this threshold is reached it means that the items of 
the Likert can be grouped together and used as a single overall score (Scott and Mazhindu 
2014).  
The results of the Cronbach alpha test suggested that the part of the instrument where the 
Likert scores were grouped had a high level of inter-reliability (α=0.915 pre-VP; α=0.914 post-
VP) as the Cronbach alpha score was greater than 0.7 (Table 6.4) this indicates that merging 
scores into a pre- and post-VP scores was appropriate. These scores were similar to the pilot 
scores (α=0.916 pre-VP; α=0.906 post-VP) and this further helps to establish that the use of 
the Likert scales was appropriate.  
 Cronbach's Alpha 
Cronbach's Alpha Based on 
Standardised Items 
N of Items 
Pre-VP Likert 0.916 0.915 11 
Post-VP Likert 0.906 0.914 11 
Table 6.4 Cronbach Alpha analysis of the grouping of Likert scales measuring  
self-reported ability 
Furthermore, there did not appear to be any presence of acquiescence bias in the responses 
as no respondents were repeatedly giving the same response in a way that suggested ‘yes 
saying’. This was particularly evident from the difficulty question where the users had to read 
and understand the question to provide an answer in keeping with their other responses. A 
few individuals appear to have selected almost identical answers to each usability question 
but, using the difficulty question as an indicator, no single participant gave an answer to this 
question which suggested that they did not read the question or select a response without 
engaging. Where respondents did indicate they found the VP difficult to use this was alongside 
other responses or free-text comments that suggested that this was a genuine response.  
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These observations and results of questionnaire performance have demonstrated the 
robustness of the instrument, so that it is suitable for use in the study. The instrument has 
been transparently discussed (section 5.4.2) and the approach to developing and using a 
quality instrument further strengthens the quality of the research, this was an something 
undertaken on the basis of the results of the systematic review (section 3.5.2). 
 Strengths and limitations of the questionnaire findings  
The questionnaire phase of the study had a number of strengths and limitations. Firstly, the 
study aimed to discuss the approaches to quality which were used to develop the 
questionnaire instrument as this is one area which has been lacking in previous studies 
(Richardson et al. 2019). As discussed in the previous section, the questionnaire instrument is 
a strength of the study as multiple approaches to quality have been adopted, examples being 
the use of a peer review and piloting (section 6.11).  
Considering the measured average improvements in self-reported ability, the inclusion of the 
median value supported the use of the mean calculation as the two were very similar. This 
suggested there was little difference between treating the data as interval by using a mean 
calculation versus treating the data as ordinal and using a median calculation. This strengthens 
the analysis of this part of the data as there was clarity as to whether to treat the data as 
ordinal or interval.  
The process of completing the questionnaire, rather than using the VP, may have also made 
respondents more aware of what is to be included in NOAC counselling and could have 
adversely affected their perceptions and subsequently the questionnaire results. This is one 
example of construct validity and a potential limitation of the questionnaire phase. Despite 
this, there were no other apparent alternative options to evaluate the VP in a manner that 
would not have had this effect. The majority of the questions pertained directly to the VP and 
so any effect due to potential construct bias was likely to have been small. 
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Participant recruitment was slightly lower in the community sector (n=26) than the hospital 
sector (n=61); a number of respondents (n=7) worked in multiple sectors or it was difficult to 
establish which sector they identified themselves as working in. Due to this the split of 
participants across the study by sector not being equal this may be seen as a limitation. 
Despite this, the results have demonstrated that there is very little difference between the 
groups split by sector or by qualification status (section 6.8 and 6.9). Similarly, there was a 
lower number of male respondents and of older ages and this could have resulted in 
underrepresentation of these groups and affected results. The extent of this is unknown, 
however, the GPhC’s annual report on pharmacy registrants for 2019 shows a split of 62% 
female to 38% male pharmacists and that aged 25-34 years is the largest age group with sizes 
reducing gradually to only 15% of pharmacists being over age 55 years (General 
Pharmaceutical Council 2019a). This data is in line with the sample used in the questionnaire 
phase and suggests that rather than a limitation this sample is representative of the pharmacy 
work force and therefore could be considered a strength. A similar pattern exists for pre-
registration trainees (General Pharmaceutical Council 2019b).  
 Implications and next steps 
The results from this chapter and the first phase of the study highlighted a number of areas 
that were investigated further in the interview phase. These were the areas that had a wide 
range of responses across the Likert or received a high volume of free-text comments. This 
allowed for an exploration of the range of perspectives on these topics and helped to identify 
the underlying perspectives on certain elements of the VP as explained in the subsequent 
chapters. 
To summarise, the areas identified for further exploration in the interview phase were as 
follows.  
• Performance feedback  
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• MCQ options and style  
• The range of VP users and who is best suited to use the application  
• Use of resources and references  
• The frequency of VP use 
6.12 Summary  
From the questionnaire results, it appeared that most respondents liked the concept of the VP 
and found it usable. Some individual respondents were positive towards the VP and found 
very little wrong with it. Others were more negative, and a group of respondents had 
particular problems with the previously mentioned design areas. Some improvements have 
been suggested which will be further explored in chapter 10. The majority of respondents 
thought the VP had educational value and impacted either, or both of, knowledge and 
confidence. The questionnaire results also suggest that the VP could have more impact for 
pre-registration trainees than some qualified pharmacists; this is not entirely clear and will be 
further investigated. The next chapter moves to discuss the second, qualitative phase of the 
research and demonstrates how key findings from the questionnaire have directly informed 
the interviews. 




 Interview results I. does the VP work? 
7.1 Introduction 
This chapter moves on from phase one of the study to present the first results of the second, 
interview, phase. The interview phase uses the questionnaire findings as a foundation to further 
explore perspectives on VP use and to expand on and consider in more depth, the initial results. This 
chapter will first present the interview process and participant information. The interview themes 
are split into three categories as follows ‘Does the VP work?’, ‘How does the user experience the 
VP?’, and ‘Where can the VP fit into practice?’. This chapter presents and discusses the first category 
of themes, chapters 8 and 9 will complete the presentation and discussion of the interview results. 
 Aim of the interview phase 
Considering the aim and objectives of the wider study, the interview phase specifically aimed to 
further contribute to investigating the learner reported value and acceptance of the VP, more 
detailed exploration of perspectives on the satisfaction and the usability of the VP, and of the 
usefulness and ability of the VP to teach NOAC counselling and improvements to the VP. 
Additionally, this phase aimed to identify ways in which the VP can be incorporated into the 
education, training and CPD of pharmacists and pre-registration trainees particularly considering the 
VP audience and purpose.  
7.2 Results 
The interview phase of the study took place from March to August 2019, during which time 17 
audio-recorded interviews were conducted over the telephone, one over video-technology and four 
in person. The average length of interview was 31 minutes. The interviews used a semi-structured 
approach making use of the interview guide discussed in section 5.5.1. The lead investigator, CR, 




conducted all of the interviews; audio recordings were transcribed verbatim by The Transcription 
Company and checked for accuracy by CR. 
Following thematic analysis, 11 themes emerged across 3 groups (Table 7.1), A number of sub-
themes were also included as part of the themes. The themes are presented and discussed across 
the next three chapters; a brief discussion of each group of themes is presented at the end of each 
interview results chapter.  
• ‘Does the VP work?’ 
• ‘How does the user experience the VP?’  
• ‘Where can the VP fit into practice?’  
 Participant demographics 
A total of 22 participants were interviewed, 17 (77.3%) participants were from the hospital sector 
and 5 (22.7%) from the community sector (Table 7.2). One participant had considerable additional 
primary care experience and a number of hospital participants has also previously worked in the 
community sector. Two participants had recent rotational, or specialist roles in anticoagulation. 
There was a minor difficulty in recruiting community-based pharmacists compared to hospital-based 
ones but, those that were recruited were proportionate to those from the first phase (phase one, 
hospital 64.8% vs 27.7% community; phase two, hospital 77.3% vs 22.7% community). There was a 
split between qualified pharmacists and pre-registration trainees of 14 (63.6%), to 8 (36.4%) 
respectively. This is reflected in the age groups of the participants as the largest group was 20-29 
years of age (13, 59.1%). One pre-registration trainee was a qualified overseas pharmacist 
completing pre-registration training to meet the requirements for U.K. practice.  




Category Theme Key discussion points/descriptor 
A. Does the VP 
work? 
A.1 Running of the VP Does the technology work and did it function? Accessibility as a mobile resource 
 A.1.1 Technological improvements Improvements identified relating to the technology and running of the VP 
A.2 Technological realism and immersion 
Realism and immersion of the technology, animations of the patient character and of the 
environment 





B.1 Realism compared to pharmacy practice Clinical content, accuracy and realism to practice, realism of Henry as a patient 
 B.1.1 Restriction  How the restrictive nature of the VP affects its acceptability and realism 
 B.1.2 Case difficulty The difficulty and complexity of the application 
B.2 Facilitating learning 
How do participants perceive use of the VP? Considers alignment with ILO and if the 
users had the same perception on the ILO 
 B.2.1 The VP as an adjunct How the VP compares to other resources and how it is accepted by the users 
 B.2.2 Ways of using the VP 
How do users use the VP? Including is it a test, ‘right’ and ‘wrong’ answers and frequency 
of use 
 B.2.3 Performance feedback Perspectives on the feedback design and its usefulness 
 B.2.4 Improvements to enhance learning 
Improvements concerning the learning experience and value (includes the addition of 
references/resources and signposting for further learning) 
B.3 Wider benefits Benefits wider than individual users around workforce consequences 
 B.3.1 Other possible VP applications Participant suggestions of future VP use 
C. Where can 
the VP fit into 
practice? 
 
C.1 Implementation into pharmacy practice Considerations for how to implement the VP into pharmacy practice 
 
C.1.1 Continuing professional 
development 
How VP use links to CPD 
 C.1.2 Pharmacy sector Implementation considerations for pharmacy sectors 
C.2 The ‘Ideal’ user User perspectives on VP use for different types of user 
Table 7.1 Themes resulting from Framework analysis of interview data 
 








Gender Age group Qualification status Sector of practice Further comments 
1 14 Female 20-29 years Pharmacist Hospital Recent anticoagulation rotation 
2 21 Male 30-39 years Pharmacist Community Offers a warfarin service  
3 5 Female 20-29 years Pre-registration trainee Hospital  
4 30 Female 20-29 years Pre-registration trainee Hospital  
5 54 Female 20-29 years Pre-registration trainee Community Overseas pharmacist 
6 17 Female 20-29 years Pharmacist Mixed (primary care, hospital) Primary care experience 
7 7 Female 40-49 years Pre-registration trainee Hospital  
8 6 Female 20-29 years Pre-registration trainee Hospital  
9 57 Female 20-29 years Pharmacist Hospital  
10 11 Male 30-39 years Pharmacist Hospital 
Education and training role, 
interest in anticoagulation  
11 58 Female 30-39 years Pharmacist Hospital  
12 35 Female 20-29 years Pharmacist Hospital  
13 39 Male 50-59 years Pharmacist Community  
14 67 Female 30-39 years Pharmacist Hospital 
Specialist anticoagulation 
pharmacist 
15 43 Female 20-29 years Pre-registration trainee Hospital Previous community experience 
16 50 Female 20-29 years Pre-registration trainee Hospital Previous community experience 
17 73 Female 20-29 years Pre-registration trainee Hospital Previous community experience 
18 74 Female 20-29 years Pharmacist Community Academic experience 
19 77 Female 30-39 years Pharmacist Hospital  
20 80 Male 20-29 years Pharmacist Hospital  
21 75 Female 30-39 years Pharmacist Hospital Education and training role 
22 83 Male 50-59 years Pharmacist Community  
Table 7.2 The demographics of interview participants




7.3 Does the VP work? 
The technology used to create and deliver the VP was a significant discussion point within the 
interviews. This covers two themes: running of the VP (section 7.3.1); and technological 
realism (section 7.3.2). The first theme addresses views around whether the technology was 
functional, and the second theme addresses wider issues around the users’ views of the 
realism of the technology. There was one sub-theme associated with these themes: 
technological improvements.  
 Running of the VP 
The VP technology appears to be functional and most users reported good access and that 
they could use it without problems. A small number of individuals reported technological 
issues which potentially limited use. Overall, there is evidence that the VP is user-friendly but 
there could be scope for clarity regarding how to use the VP. 
The first significant discussion area concerned the technology of the VP, whether it functioned 
and if it was usable from the participant’s perspective. A majority of the participants reported 
that they had encountered no technological issues and had found that the VP was functional, 
as the following quote illustrates.  
‘’Yeah, well I used it on an NHS desktop, so it wasn’t particularly modern, so it worked 
fine, yeah, I didn’t have any difficulties.’’ [P11] 
A minority of participants did encounter technological issues of varying types. These included 
problems accessing and running the VP although it was not clear in some cases why this had 
occurred and could have been due to anyone of a number of reasons including the VP 
application, and/or the device being used.  




‘’So, the first time I did it, it was absolutely fine. Er, it worked like a treat. Erm, 
however, when I... went back on that same computer to use it, it did freeze, and it kept 
freezing which was frustrating...’’ [P35] 
Some participants also reported parts of the VP being slow, this appeared to not be due to the 
technology but rather the design and the speed at which the application had been 
programmed to deliver aspects of the case. 
‘’I think it was more that the patient was talking slow and…everything else was fine 
and the whole programme went fast and everything.’’ [P50] 
The next most common discussion area concerned access to the VP. This was not raised by a 
large group of participants, but those that did, all said that access to the VP was at least 
adequate; no one reported a negative experience of this.  
A minority of participants reported that they had accessed the VP via mobile devices including 
mobile phones. These participants spoke in overwhelmingly positive terms about this mobility. 
However, the majority of participants did not comment on this as they did not appear to have 
tested this feature.  
‘’Yeah, I mean because it’s digital, you can use it anywhere really, bottom line…I think 
it’s fantastic. I think I love how you can get it up on different devices’’ [P17] 
Focusing on the reported perspectives on VP use, a number of participants explicitly expressed 
that they thought the VP was user-friendly.  
 ‘’No, I think that was more or less it, it was user friendly, it was quite straightforward 
to actually use the programme.’’ [P14] 
Technological improvements 




Across the interviews, all participants suggested forms of technological improvement to 
improve the VP user experience. These ranged from minor adjustments where the user 
experience was thought to not be optimum to more significant changes which could affect 
technological delivery of the VP. In the majority of instances, the participants still found the VP 
to be useable without the suggested changes being made. This was shown in what participant 
35 said on this issue: 
‘’I think it's [the VP] a very good idea. I think it's something new and it's something 
different and I do think, you know… I'm highlighting issues that it can improve. Erm, 
otherwise if I say everything positive, there's no improvement. It's constructive 
criticism’’ [P35] 
Another example concerned improvements to the speed of the patient talking: 
‘’maybe have the patient speaking a bit faster and have the subtitles coming as he's 
speaking.’’ [P50] 
The single largest technological change that was most frequently talked about was the 
possibility of introducing a ‘back’ button so that the user could return to previous decision 
points within the application. The majority of participants who raised this idea, particularly of 
pre-registration trainees, favoured it as shown in the following quote:  
‘’I don’t know if there was an option to go back and change your option. I feel like 
there wasn’t so if you had made that decision you wasn’t able to go back so maybe 
that would be something to consider.’’ [P5] 
For those who thought a back button was a good idea, the reason appeared to be because 
they could rectify their consultation if they thought it was going less than optimally. One 




participant stated that they thought this was a good idea because at one point they clicked an 
option they weren’t intending to.  
On the other hand, some participants said that use of a back button was not a good idea. The 
commonest reason for this was that there is no such thing as a ‘back button’ in real-life 
practice.  
‘’In a way, from a technological perspective, probably it would be useful if you could go 
back. But in real life, if you start a consultation and you said something or you make a 
decision, how do you backtrack? Like you can’t really, or you just have to rectify it as 
you progress. So, I think – well I suppose from the user-friendly point of view it would 
be nice to have as an additional option, but in reality, it doesn’t happen.’’ [P74] 
In a small number of instances there were a number of issues that seemed to have caused 
frustration about the algorithmic nature of the VP design, as shown in Participant 35’s 
comment below. The limitations of this and improvements will be further discussed in section 
7.3.2.  
‘’Erm, for me, it was, like I said, something different, something new. It was - and it 
was exciting. However, it was almost pre-set and, like you said, algorithmic where it's 
just almost like - 'Okay, this gives this, and this gives this.'.’’ [P35] 
 Technological realism 
Technological realism includes a number of elements namely, realism of the technology as an 
environment simulating real life and the realism of the VP character as a person. All of the 
participants appeared to like the overall idea and concept of the VP and part of the reason for 
this appeared to be due to the technology, within the conversation around likability, most 
interviewees reported liking the VP because it was ‘’quite lifelike’’, for example:  




‘’It was quite lifelike. I did enjoy that, but it doesn't - it's not like it's - erm, it's not too 
fake, if I can put it that way?’’ [P34] 
Other points made concerning technological realism included the novel nature of the VP 
technology, and the high-quality technology and animations. This appeared to be well liked by 
participants, as shown in the following quote: 
‘’I liked the way it worked, actually. I, I thought, you know, having the patient - I mean 
I, I played it through one time erm, somewhere where I could actually hear the person 
talking… but I actually quite liked that sort of interaction side of things with the 
patient, where you feel like you are - you know, the guy - er, making expressions as 
well. So, you know how happy or unhappy he is and what you're saying and you're 
getting that feedback’’ [P58] 
Another participant said that the VP was ‘’uncanny’’, and it appears that the virtual nature and 
realism of the patient interaction had made them feel uncomfortable. However, despite this, 
they said that they thought that it was ‘’good’’ and ‘’authentic’’: 
‘’Erm it was a bit erm, it looks a little bit uncanny really when the gentleman, the 
virtual patient is… it’s very good, like the reactions are very good but it’s just a bit 
uncanny erm but it’s a good way of representing it and so it looks good, it looks like a… 
in a virtual environment, the consultation room needs to look good when you take a 
patient in there, it’s very authentic.’’ [P11] 
Technological realism could also be seen in the way that many participants appeared to 
identify with the VP character of Henry as a person. Some participants appeared to have 
identified with the realism of Henry to the point where they recognised different types of 
response: 




‘’Yeah definitely, cos if you accidentally click the wrong thing you don’t get a great 
response from Henry.’’ [P73] 
Conversely, a number of participants appeared to suggest that the VP had limited immersion 
due to it being a computer, and not a real patient, although some participants did recognise 
that the VP was always going to have this limitation. Participant 34, focused on this from a 
rapport building and non-verbal communication perspective: 
 ‘’because it's a virtual patient, you, you can't really erm... there's a lot of room for sort 
of er, a, a casual conversation, you know. Erm, yeah, so I mean there was a few things 
but there's - unfortunately, that's something that's going to get lost in technology, you 
know; the friendliness or the erm... er, the jokes, you know...’’ [P34] 
One participant appeared to think the VP was not realistic saying that it was ‘’impersonal’’, 
although, this participant did seem to appreciate that this was because the VP is a computer 
simulation: 
‘’I feel like it's more personal when it's a patient. I felt this was impersonal, but it would 
be because it's a virtual reality programme erm, and... there is scope for this, if this 
was developed properly. I think its early days… it lacks personality. It lacks emotion.’’ 
[P35] 
7.4 Discussion  
The VP was reported to have good functionality and usability in that the majority of 
participants could access and use the VP, although a few technical problems were reported. 
These need rectifying as technical limitations can detract from user experience (Ellaway et al. 
2009). Considering the technology in detail, a number of users highlighted that they thought 
that the VP was user friendly. This differs from the study by Bindoff et al. who found that due 




to their VP design the users had an adjustment period which somewhat distracted from 
usability (Bindoff et al. 2014). Although as Bindoff et al.’s VP used computer game navigation 
and thus it is not directly comparable to the technology used in this study, the navigation 
choice may account for the adjustment period. In this study the participants did not appear to 
have to adjust to using the VP and the VP was reported to be, in the most, user-friendly. This is 
encouraging as Taglieri et al., pointed out that familiarity with the technology can improve 
learning (Taglieri et al. 2017) and thus usability could potentially impact user learning 
outcomes.  
The VP was also cited to have lifelike animations, which contrasts with the work by Jabbur-
Lopes et al. (2012) who suggested that VP animations can be limited. This review was 
previously discussed in section 2.4.4 where it was highlighted that of the studies included in 
the review, most of them used now out of date technology and so the recommendation for 
more sophisticated graphics is unsurprising. The results of this study contrast with this finding 
and suggest that the animations were sufficient; it could be that this VP uses animations of a 
higher quality. However, building on this, the animations although lifelike, may benefit from 
running at a faster speed as for a minority of participants the current speed appeared to affect 
usability.  
The VP was identified by a minority of participants to have limitations in simulating non-verbal 
body language such as eye contact. This is especially relevant as body language is recognised 
to be an important factor in consultation skills (McDonough and Bennett 2006) and previous 
VPs have also been limited in this area (Stevens et al. 2006). Similarly, one user discussed that 
elements of building rapport such as jokes was lost when using the VP. Building rapport is a 
key part of effective consultations and this would be difficult to incorporate into a simulation 
particularly those using multiple choice rather than free text questioning designs. One study 
recognised that building rapport was the most significant skill to master for effective 
communication (Hargie et al. 2000). As rapport building is so significant in developing 




communication skills it is surprising that this has not been investigated in the context of VPs; 
the opportunity for rapport building within a VP interaction is relatively unknown. This may be 
due to the ability of the VP technology currently being the limiting factor for using VPs to 
develop rapport building skills within a consultation.  
A majority of participants recognised that some of the limitations around realism were a part 
of simulation technology more broadly and could not necessarily currently be technically 
overcome. One participant did highlight that Henry has different expressions as part of the 
application and identified these non-verbal responses in a positive manner. The VP was also 
positively described as ‘’authentic’’ and ‘’genuine’’. Authenticity of VPs was considered in the 
concept map by Hege et al. (2016), where it was recognised as being ‘’critical’’, this was linked 
to wider concepts of realism which will be further discussed in sections 8.2.1 and 8.3.  
The suggestion to include a back button within the VP interface was made by a number of 
participants. As already highlighted, in the study by Bindoff et al. (2014), a similar usability 
issue was reported as navigation around their VP used computer game navigation and this 
limited user’s acceptability of the application. This study demonstrated that a design feature 
of an application can detract from use to the point that it affects usability. Therefore, changing 
the VP’s interface to improve navigation may better optimise user experience. 
Despite this, from an educational point of view, use of a back button may not be in keeping 
with the purpose of the VP, as was evident when participant 74 stated there was no such thing 
as a ‘back button’ in real life. The current lack of a back button does not appear to be 
prohibitive of VP use but perhaps an alternative way of improving the navigation of the system 
could be made as to minimise any negative effects of changing the navigation. This should be 
done in a way which considers both the user experience and the purpose and educational 
principles of the VP.  




An advantage of VP use which was demonstrated is that of mobility and accessibility. The 
mobility of VPs has not been a widely documented advantage of VPs, especially as a number of 
previous VPs were not designed to be mobile, partially due to previous technological 
constraints (Stevens et al. 2006, Shoemaker et al. 2015). This study demonstrates that users 
favoured that the VP was available on mobile devices and could be used anywhere without 
any specific requirements. This demonstrates a practical opportunity for incorporation of the 
VP into education and training and also an opportunity for future VPs to be also developed to 
be mobile. The VPs in the work by Bindoff et al. (2014) and Shoemaker et al. (2015) used 
common web browsers to host their VP with no specialised equipment; although this was not 
evaluated directly the authors stated that this was intended to increase usability. Similarly, 
Douglass et al. (2013) and Kononowicz et al. (2014) cited that VP technology has advantages 
around mobility but did not expand any further; this did not appear to have been incorporated 
as a measurable outcome in to any of the VP studies. Despite this, the results of this part of 
the thematic analysis appears to be one of the first studies to consider the mobility and 
accessibility of a VP and reports direct findings around this issue. On this basis, mobility maybe 
an increasingly important issue to consider when designing future VPs. 
7.5 Summary 
This chapter has presented and discussed the interview participants and the results of the first 
category of the thematic analysis. This builds on the previous chapter where the questionnaire 
results provided areas for further investigation. The themes were discussed relevant to the 
study’s overall aim and objectives, and key results have been highlighted. The next chapter 
moves to present the next group of themes.  




 Interview results II. how does the user 
experience the VP? 
8.1 Introduction 
The next stage of this thematic analysis moves past discussing the technology of the 
application to focus on the next category of themes. This category concentrates on the 
educational uses and benefits of using the VP.  
8.2 How does the user experience the VP? 
The three themes of this group are: realism compared to pharmacy practice (section 8.2.1); 
facilitating learning (section 8.2.2) and wider benefits (section 8.2.3). There are also a number 
of sub-themes which will be discussed. 
 Realism compared to pharmacy practice 
Realism compared to pharmacy practice incorporated a number of points around the realism 
and accuracy of the clinical content of the application and of Henry as a patient. There were 
mixed views on whether the VP application was realistic. Some participants recognised that 
the VP was an educational resource and thus it was not trying to portray a pharmacy 
environment with complete accuracy.  
‘’As an education tool I think it’s very useful. Erm and I think that’s what it aims to be. 
It’s not trying to make out that you know, this is what really happens.’’ [P83] 
Despite this, some participants were concerned that the VP was not realistic to all pharmacy 
practice. 




‘’It should be more like - okay, if you're in this situation, … if you've got a consultation 
room, it would be nice to have them in there. However, you know, some pharmacies 
may not have them…you can't really penalise or flag it up to say, 'Actually, it's 
incorrect, and red, and harsh,' because actually, each environment is different.’’ [P35] 
Furthermore, building on one of the ‘worst’ elements of the VP identified in the questionnaire 
(section 0), the length of time to counsel the patient was discussed multiple times and that 
this maybe unrealistic of practice. This is highlighted in the following quote from the 
perspective of a community pharmacist:  
‘’perhaps it needs to be highlighted that this is an ideal situation and you’re fully aware 
that this isn’t gonna happen practically, but in an ideal world this is what we would like 
to happen, which is fine…the reality is very different.’’ [P36] 
A significant part of the discussion of realism concerned clinical accuracy. There were a group 
of participants who raised issues with the clinical aspects of the application, and they 
suggested improvements to make the VP content better representative of clinical practice. It 
tended to be longer qualified or specialist pharmacists with this perspective.  
A number of participants expressed concerns that the information provided about the 
medications were not reflective of real patients and current practices:  
‘’When you have a, a diabetic patient, who's got AF, there should be other medications 
that should be prescribed. You know, you have - you haven't got your rhythm or rate 
control. You haven't got your Bisoprolol. So, for me, there was - it, it - clinically, it 
wasn't accurate. You can tell that they're focusing very much on the counselling which 
is fine erm, but in a real patient, you won't just have, you know, a diabetic who's Type 
2 with AF. They'll have, you know, other co-morbidities or er, more of a pharmaceutical 
challenge.’’ [P35] 




The next discussion within the theme of realism to pharmacy practice concerned the patient, 
Henry. A number of users suggested that Henry asked questions similar to real patients. 
Although it was also suggested that Henry was a ‘perfect patient’ in that he only asked fairly 
straightforward and reasonable questions. 
‘‘[Henry] asked me questioned that I’d sort of expected him to ask…I think that is a 
good starting point.’’ [P57] 
Although, in contrast, the view was expressed that Henry was one individual patient and it was 
suggested that sometimes patients do not want the level of information incorporated in the 
application.  
Restriction 
A sub-theme within realism concerned restriction as many of the users perceived the VP to be 
restrictive and thus this affected the realism and acceptability of the application.  
Of the group that thought that the VP was restrictive there was a split concerning if this 
affected learning. Some participants specifically identified that despite some restrictive 
characteristics this would not affect the outcome of the application.  
‘’Yeah, overall it probably didn’t impact in the learning. Yeah, so it was probably 
alright, but some of [the MCQs] I just find that they were a little bit restrictive.’’ [P74] 
Equally, some participants expressed frustration that they could not control the flow or 
content of the consultation. Longer qualified participants tended to have this view.  
‘’Yeah they [MCQ options] can be quite restrictive, you go down some ways and you 
are like, well I want to say something but all the options here are like err, they don’t 
have the range of what I need, whereas like if you are doing a consultation, if you 
know you’ve missed something, you bring the consultation back’’ [P11] 




Conflicting with this, restriction was not always seen as a negative. As discussed in section 0, 
some participants identified that the VP was never going to be completely realistic.  
One participant took a different view of this by saying that the restrictive nature of the VP may 
be useful as it directs the user to take the consultation in a direction they may not otherwise 
have done.  
‘’it was interesting that some of the options…It sort of directed you maybe to choose 
one maybe that you wouldn’t have chosen if it was sort of a free thing…[It] might’ve 
sort of led to a different outcome in the consultation.’’ [P74] 
Case difficulty 
Most participants discussed the difficulty level of the application. This appeared to be multi-
factorial and linked closely with the other themes and the wider concept of realism. Some 
participants agreed that the VP was of a suitable complexity and others thought that it was not 
difficult enough; no participants thought that the VP was too difficult.  
‘’Yeah, I think it was challenging enough, without being overly challenging.’’ [P83] 
There did appear to be a slight difference between the participants across the sectors where 
community-based participants thought it was a suitable level and hospital-based participants 
wanted something more complex.  
‘’it’s good for general learning about counselling and for the initial stuff like asking the 
patient questions … but for, if it was something for like, something like this, for like a 
diagnostic thing, you’d need it to be a bit more clinical’’ [P14, hospital pharmacist] 
Moreover, one participant expressed that relative to community practice you would be 
unlikely to see more complex patients. This suggests that the difficulty level was appropriate 
for this individual.  




‘’I don’t think in the community setting you would get a much more complex case than 
what was in the technology.’’ [P73] 
Some participants discussed that they thought the VP case was too simple and should be 
altered to become more complex. Despite this, one participant recognised that even if the VP 
case is ‘‘basic’’ it was useful for reminding them of the basics which sometimes get forgotten. 
This participant was one of the longer qualified participants and this demonstrates a different 
perspective within this user group as the majority of the longer qualified pharmacists 
appeared to want a more complex case. 
‘’Yes, the consultation stuff was a bit basic. And you know, it may need to be if people 
haven’t done many consultations. Having said that, you can get very blasé and you 
know, it’s no bad thing to sort of be pulled up’’ [P36] 
Views on case difficulty appeared to be linked to perspectives on the purpose of the VP, since 
a minority of participants seemed to assume that the VP was not difficult enough due to its 
clinical content rather than general aspects of consultation skills. 
 Facilitating learning 
The intended learning outcome (ILO) of VP use was to ‘’learn how to counsel a new patient on 
rivaroxaban’’. This theme firstly considers users interpretation of the ILO and if users reported 
meeting it. The VP appeared to be recognised to facilitate learning in a number of ways. These 
will be discussed alongside perceived improvements to better facilitate learning. 
A significant number of participants reported feeling more prepared to counsel patients on 
NOACs as a result of using the VP.  
‘’Erm, I think so [more prepared] because I feel like, erm, I know more about what 
information should be included.’’ [P30] 




Learning how to counsel on NOACs could incorporate a number of elements but most 
participants first picked up on increasing knowledge as shown in the following quote:  
‘‘For me, the, the main thing it focused on was erm, the, the rivaroxaban and, you 
know, how - erm, how it works; how the counselling for that specific erm, medication is 
more than just general erm, counselling skills.’’ [P35] 
However, one participant added that having a baseline knowledge was needed prior to using 
the VP.  
‘’I think it could be quite difficult to - if you didn't have any basic knowledge to go 
straight into using the tool... because you do need to know about the side effects erm, 
like why patients might need to go to like a Walk-In Centre or might need to seek 
urgent help.’’ [P53] 
In addition, multiple participants (n=5), used the term ‘‘refresh’’ to summarise their learning.  
‘’Erm, I wouldn’t necessarily say that I learned it. I think it was more a refreshment…’’ 
[P57] 
Considering this more, this included contextualised learning.  
‘’You can sit and just learn facts from a book, but you never in your head actually think 
about how you’re gonna get that information across to the patient. Whereas with this 
you’re forced to do that. So, when you do it for the first time it won’t feel like you’re 
actually doing it for the first-time cos you’ve already had a practice.’’ [P73] 
Most participants acknowledged that the VP may not be useful for only one type of learning 
but that it contributed to different elements of NOAC counselling. Participant 75 summarised 
this:  




‘’I think it’s hard to narrow it down to one area. I think it’s probably a good 
combination of consultation and, and knowledge-based skills. It’s down to the 
individual really and how they then apply that to real-life situations’’ [P75] 
A few participants seem to consider that the VP had particularly improved their consultation 
skills as the following quotes shows:  
‘’I can see it being useful for… people who probably have got a lot of presumptions 
around their consultation skills … it has made me go back and actually look at um, the 
whole patient centred approach as opposed to um, as opposed to just, you know, 
spilling that knowledge and, and, talking to patients err, you know, as if it was if you’re 
just trying to offload a lot of information on them’’ [P83] 
Notions of confidence were also mentioned throughout, which appeared to be intertwined 
with the other types of learning. One participant discussed how for them the learning was 
more about confidence than knowledge. Encouragingly, participant 57 reported confidence-
based benefits to their practice. 
‘’after using the tool I actually came across options where I could counsel a patient on 
a NOAC, and I felt much more confident.’’ [P57] 
The VP as an adjunct 
This sub-theme concerns how the VP is largely seen as an adjunct to other education and 
training resources. It incorporates comparing and contrasting the VP with other educational 
resources used to learn about NOAC counselling. One participant discussed that the VP should 
be used alongside real-life experiences and not in isolation. 




‘’I think you need to continue like the real-life thing, so actually having experience 
talking to patients in person. If you don’t really get a chance to do that then, then 
there is an education tool but, erm, I don’t think it should be solely relied on.’’ [P5] 
A number of specific education and training resources were mentioned. One participant 
thought that the VP complimented CPPE resources: 
‘’there’s a portal on CPPE and I think it complements everything else that I’m doing at 
the moment, to improve my consultation skills in this area.’’ [P83] 
This individual went on to note that the VP provides an ‘’extra dimension’’ to learning and 
discussed the elements of the VP which make it more acceptable. They also appeared to 
suggest that the VP was more acceptable than roleplay.  
A further participant similarly suggested that due to the nature of the application users would 
engage more and use the learning in practice: 
‘’I think people would find it more interesting to use than just doing the basic kind of 
click through and answer some questions at the end type learning. I think it’s probably 
going to engage people more and then they’re more likely to remember what they’ve 
learnt from that kind of exercise and use it more in practice’’ [P67] 
The VP was also cited to have distinct advantages over inhouse training as it allows mistakes in 
a safe environment. 
‘’we’ve got an in-house thing where they sort of talk to a colleague about [NOACs] 
before we let them talk to the patients but equally, you already know the information… 
you know what they mean and you won’t necessarily – it won’t always be picked up 
on. Whereas, I think that virtual patient allows them to make some mistakes and, and 
realise how would be a better way of saying things’’ [P58] 




Ways of using the VP 
Within the conversation on VP learning it became apparent that there was a range of ways 
that participants used the application, including a range in the frequency of VP use. The 
majority of participants stated that they had or would use the VP more than once, although 
this was in a variety of ways. For some users repeated use was via an initial in-depth use 
followed by less formal follow up learning potentially from practice or patients: 
‘’Yeah, I would definitely use it repeatedly…I always learn better when I’ve had an 
incident with a patient; you know, when they have asked me something and I’ve had to 
look it up, then it feels like I – I’ll always remember it erm.’’ [P34]  
Two participants discussed that they used the VP more than once to achieve all ‘green’ 
feedback (feedback design shown in Figure 1.8). It appeared that the main reason for using the 
VP a second time was not necessarily for the learning but to get ‘perfect’ feedback.  
‘’I did my second attempt also because … with the first one, there were still two things 
which were, had been highlighted in red or something like that and that’s why I was 
thinking okay, why it’s like that, so then obviously I’d gone back and then I learned that 
okay, patient can say this also…’’ [P7] 
From the other point of view one participant only visualised VP use as a single interaction.  
‘’Erm, I think I would use it once just to have where my knowledge, like where, like 
whether I know all the information.’’ [P30] 
A number of uses commented that the VP had ‘right’ and ‘wrong’ answers. This appeared to 
affect the individual’s perception and use of the VP and was closely related to getting ‘perfect’ 
feedback. Some participants appeared to think that there was a spectrum of answers within 
the case and that it may depend on personal counselling styles.  




‘’Erm, maybe not right and wrong but, erm, but there was one option that was more of 
a cert whereas, so my option wasn’t wrong, but it wasn’t the preferred option.’’ [P5] 
Performance feedback 
Feedback was one area that was identified from the questionnaire results as requiring further 
exploration in the interviews. As briefly highlighted in the previous sub theme, one element 
which was a particularly unexpected discussion point was the use of red and green colour 
coding to deliver ‘good’ and ‘bad’ feedback (as seen in Figure 1.8). A significant proportion of 
the users appeared to not like this method of feedback as they perceived the colour coding to 
categorise answers unduly: 
‘’Like I just feel like the red shouldn't really be red. I think they should have killer points 
where, you know, 'Okay, you didn't - you forgot to say to have it with, with food.’ Okay, 
yeah, that, that is a point. You know, that should be highlighted in red, if you've missed 
that… .like, 'You didn't offer me a seat' you know, and that would be red…Well, 
actually, you know, you gauge…they're not important points to put, to put a red, a red 
mark against erm.’’ [P35] 
In contrast, one participant stated that they were ‘indifferent’ to the use of the colour coding. 
‘’I don’t know, I think I’m a bit indifferent to that [the colour coding], I think just any 
feedback was good’’ [P17] 
Similarly, one interviewee positively highlighted that getting feedback on ‘soft skills’ in 
addition to the drug specific content was useful. 
‘’So, I think the feedback was, was spot on really. Um, I liked how it gave you the 
feedback on your soft skills for consultations as well as medication related.’’ [P17] 




A number of participants discussed the usefulness of the feedback to improve their practice.  
‘’I have already had a couple of consultations with patients since the first time, and I 
felt, you know, that it’s, I’ve kind of built in some of the um, some of the advice and 
some of the feedback already.’’ [P83] 
Improvements to enhance learning 
As part of the interviews, a number of participants made suggestions to improve and develop 
the VP educationally. As for technical improvements (section 7.3.1), one participant 
summarised their perspective towards improvements pragmatically discussing that 
improvements may be good but that nothing ‘’major’’ should be changed. 
‘’I don’t think it’s anything major that needs amending. I think there may be a few 
points to maybe kind of have as a summary, um, about maybe a bit more feedback as 
to why certain options might be the case with certain patients, um, and maybe like 
highlighting the key.’’ [P75] 
A small number of participants discussed the use of alternative questioning styles (n=5). Of 
these participants, there was most interest in the use of free text answers as an alternative 
method of questioning although often this was suggested in combination with MCQs.  
 ‘’I think it should be a mix of multiple choice and free text erm there’s no reason why 
you can’t have both, obviously if everything was free text it would be quite long as 
well…but if certain points were free text that would be quite good’’ [P14] 
The possibility of incorporating further references and providing signposting for more learning 
was identified in the questionnaire results (section 0) and was further explored in the 
interviews. This was the most frequently mentioned change suggested for the application 
content, most participants expressed that they were in favour of this.  




‘’Yeah, some references as well so…you’ve got this question wrong, you need to 
understand this, if you want to find the information this is the website you need.’’ [P73] 
There were a number of examples of the types of signposting and references to be included. 
This included key links for an individual depending on their performance like participant 73 
stated above to local protocols and summaries of ‘ideal’ NOAC consultations; Summaries of 
Product Characteristics (SPCs) and NICE guidelines were not favoured. It appeared that in 
order for references to be useful they need to be contextualised and relevant for practice. 
They should also be accessible as some participants were unsure as to if users would actually 
make use of the references, despite this, no participants were opposed to this. 
‘’Yeah, say if a certain area you’ve done bad in, if you could just get the link there and 
then ‘maybe this could help’. Erm, I think it would be good if the link was there, if it’s 
easy and accessible, if you could just click the link and go straight there, that’s fine. But 
if you have to search it yourself, I don’t think it will be any benefit.’’ [P73] 
 Wider benefits 
A number of ‘wider benefits’ to using the VP were identified. This included any type of benefit 
wider than individual users. The most frequently cited wider benefit related to consequences 
for the pharmacy workforce, particularly for the NHS. The user below commented on this and 
appeared to think that the VP offered an advantage as the VP is not labour intensive. 
‘’you afford us a good training tool in a hospital because at the moment we have to 
organise quite labour intensive training sessions for our technicians to go on and a lot 
of people out of a ward, where pharmacists rotate technicians to train them on how to 
do counselling and a digital tool like this would be a great opportunity.’’ [P11] 




Consequences of the VP for the NHS from a patient safety and admissions perspective were 
also highlighted.  
‘’it’s a higher understanding of the medicine so it will hopefully lead to a lot less 
unnecessary hospital admissions for the NHS…patients do not take their medicine 
correctly and with high risk medicine like this you cannot afford that’’ [P21] 
General comments were also made regarding the VP aligning with the NHS’ current drive to 
increase digital utilisation. 
‘’as things progress within the NHS and stuff, we are trying to be more digitally 
advanced as possible so something like this is actually quite a useful tool.’’ [P14] 
Other possible VP applications 
All participants suggested ideas for future and alterative VP applications. These included 
extended anticoagulation topics, and also topics completely unrelated to NOACs. A number of 
participants suggested extending the current VP to include other conditions where NOACs are 
used, namely deep vein thrombosis, and pulmonary embolism. An alternative suggestion was 
to involve patient characters with different needs in order to increase the range of information 
about NOACs that are covered in the scenario.  
‘’It would be useful maybe to have maybe a young female who had a, a DVT [deep vein 
thrombosis] or something but is still having menstrual periods and… discussing that 
side of things and the pregnancy side of things as well because…obviously, you're 
never going to discuss with a man, it would be useful to have a variety of different 
patients, so you can discuss different scenarios with them because obviously, he was a 
walker who liked to hike but you might have, you know, like I say, the female or 
somebody who does - I don't know - snowboarding’’ [P58] 




There were also numerous suggestions regarding wider applications for the VP. The main 
topics that were cited were other high-risk medicines, complex counselling areas, and 
medications new to the market. Named medication classes which were suggested on this basis 
included insulin, inhalers and lithium. It was also suggested that a library of different VPs may 
be useful. Participant 75 summarised that there is a host of possibilities for the VP’s future: 
‘’Yeah. I mean I think it’s, um, the kind of options are endless really. I think there’s a lot 
of options where we could use it, you know, more, in more scenarios where in-depth 
counselling is required… there’s lot, there’s lots of ways we could advance this, you 
know, this option and, and apply it elsewhere.’’ [P75] 
8.3 Discussion 
The interview results provided novel insight into how participants use the VP. The majority of 
participants appeared to see value in repeated VP use and this links to educational theory of 
experiential learning as part of a continuous cycle whereby users amend and then test mental 
models using learning from the VP and also from practice (Zigmont et al. 2011, Poore et al. 
2014). This was especially evident when one participant discussed using the VP as a starting 
point and then reusing it after an incident with a patient. Similarly, a large group of users 
considered the VP as useful to refresh their ability, although this juxtaposes some of the 
evidence of exactly how the VP was used as it was reported that some individuals focused on 
‘getting a perfect answer’. There appeared to be a desire from a minority of the participants to 
‘perfectly perform’ when using the VP. This could be evidence of ‘surface’ learning although 
others appeared more engaged and did demonstrate the ideas of ‘deep learning’ as described 
by Biggs and Tang (Biggs and Tang 2013). Deep learning can be described as a type of learning 
which ultimately contributes to a higher quality and understanding of the learning (Biggs and 
Tang 2013). Through the design of the VP as part of an experiential learning cycle this can 
encourage a deep approach to learning and the VP has demonstrated some of the elements to 




deep learning including positive perspectives and a sense of importance of the learning (Biggs 
and Tang 2013).  
Users tended to favour the opportunity to practice the patient interaction and, in the majority, 
they appeared to find the patient realistic and educationally useful. Some users seemed to 
perceive the patient to be a ‘perfect patient’, which may not be realistic of practice, but most 
of these users could see the necessity of this from an educational perspective. Some 
participants discussed elements of the VP which may not be realistic to all environments, this 
included differences between the perceived difficulty of the application between the sectors. 
Due to the constraints of the technology and because the VP is a learning tool some aspects 
will be slightly different from practice and so ‘complete realism’ maybe unattainable, this is 
further discussed in section 10.3.2. 
Moving to explore the results around ‘right’ and ‘wrong’ answers to the VP, a number of 
participants expressed that the VP should have ‘preferred’ answers rather than ‘right’ or 
‘wrong’ answers. This concept is in line with single best answer (SBA) questions. SBAs have a 
number of options, one of which is the preferred answer although the alternative options may 
not be technically incorrect (Sam et al. 2016, Dell and Wantuch 2017). This is an accurate 
representation of the types of questioning used in sections of the VP. For example, a question 
concerning missed doses of Rivaroxaban had a defined ‘right’ answer whereas other 
questions, for example regarding side effects may have had a preferred answer which 
balanced accurate information with delivering this information in line with needs of the 
patient. This also links to feedback as depending on the choices made the feedback changed. It 
is important that the VP demonstrates a range in delivery of, sometimes the same 
information, to allow for some flexibility in choice and also for the user to help develop their 
consultation skills. Some participants directly commented on this when they recognised that 
the VP helps to learn how to deliver information about NOACs to patients in a suitable way. 
Although in contrast some users did not appear to favour this approach and stated that the VP 




was not clinical enough; it appears that these users did not appreciate the concept of SBAs in 
the context of delivering patient-centred, yet accurate information regarding NOACs. This was 
evidenced by participant 35 who sounded quite uncomfortable with the VPs approach to 
teaching when they stated that ‘’They're trying to learn about the clinical aspect of this 
medication’’. This individual appeared to think that the VP was currently lacking in ‘clinical 
aspects’, when in fact, through use of SBAs, not only was the user faced with learning the 
correct information but also that different deliveries of the information may have different 
outcomes for the consultation. Despite this, the way that the feedback was delivered to 
consider the concept of SBAs could perhaps have be improved.  
All of the participants valued getting feedback although the design and delivery of this could 
be improved. The use of feedback colour codes should be reviewed as the majority of users 
reported disliking this; a number of changes to the feedback options were suggested including 
reviewing the ‘red’ feedback points as not all of these were clinically incorrect things but also 
concerned consultation style which is much more fluid. Feedback is an important element of 
VP interactions and this needs to be developed in as much detail as the remainder of the VP 
(Botezatu et al. 2010, Bindoff et al. 2014, Hege et al. 2016). This is pertinent as feedback is a 
key part of the experiential learning cycle and it is during the debriefing stage that learning 
actually occurs via amendment of mental models (Zigmont et al. 2011). It is therefore 
important, that feedback is delivered in the best way possible to meet this stage of learning. 
Further considering the learning cycle, a minority of participants commented on the ways in 
which they have applied learning to practice. This demonstrates the value of the VP and 
suggests that the application did facilitate learning including learning which is relevant to 
practice.  
Some participants were initially sceptical of the VP, but ultimately all the participants 
appeared to find a benefit in using the application, although the learning was not always 
knowledge based as some users expected. The VP was designed to be intentionally 




exploratory and the ILO non-specific, but this was not clear to some participants as they 
perceived the learning to only be about knowledge, this may need to be more transparent in 
the future. The majority of learning appeared to incorporate knowledge, confidence and an 
opportunity to practice. Contrasting with other VP studies, this research has not attempted to 
overtly measure any of these outcomes as VPs have already been shown to be beneficial for 
these purposes as discussed in section 3.4.3. This study has gathered direct perspectives on 
what users think of this learning and how relevant it will be for their practice. Most users 
reported seeing a personal benefit to VP use; some users reported consultation-based learning 
benefits, for others it was about knowledge acquisition and application. No single type of 
learning or benefit to all users was clear, yet the VP has shown its value and acceptance by the 
majority of users.  
Some users reported that the VP had advantages over other methods of teaching NOAC 
counselling such as role play (section 8.2.2) Despite this, a large proportion of users said that 
the VP would be best not used in isolation, but rather used alongside various other education 
and training options and the VP was largely seen as an adjunctive resource. This appears to be 
an original finding as the majority of studies in the literature on VP use focused on either the 
satisfaction of using the technology or use of the technology versus other methods such as 
paper-based alternatives (section 2.4.4). What appears to be absent is any other studies which 
found that VPs may be useful not in isolation but as part of a range of educational resources. A 
small number of studies have recognised that VP use is impacted by factors from practice but 
no study appears to have considered this in its methods (Fleming et al. 2009, Zlotos et al. 
2016) and very little has been considered between a possible synergistic relationship of VPs 
and other learning methods. In the concept map by Hege et al. (2016) there is no mention of a 
relationship between VP use and practice; this is one area which requires further investigation.  
A further advantage of VPs that was demonstrated is that of safety. This is a well-recognised 
design feature and advantage of VPs (Stevens et al. 2006, Zary et al. 2006, Thompson et al. 




2016a) as is learning from mistakes (Cook and Triola 2009, Bindoff et al. 2014, Georg and Zary 
2014), this was also a finding of the systematic review (section 3.5). The results suggests that 
the users felt in a safe environment to practice counselling, potentially more so than some 
alternative educational methods. Users appeared to value this opportunity.  
A level of restriction within the VP, partly due to the design and questioning style of the 
application, was identified by a majority of users. For some this was negative, for others this 
did not appear to detract from their VP use. Within the literature there is little is documented 
on VP questioning styles but from a technical perspective, the results have provided insight 
into user likability of MCQs which appeared mixed. It is not clear how the different types of 
questioning may impact learning outcomes and there is little available within the literature on 
the perspectives of users on the alternative questioning types. The underlying algorithmic 
design of the VP should be reviewed to consider increased flexibility and reduced restriction. 
This should consider the educational principles of the VP, user experience and technical 
abilities. This multifactorial approach to the design of VPs is supported by Huwendiek et al. 
who stated that VP designs involve a range of factors including educational, design and 
technical elements (Huwendiek et al. 2009). This is further discussed in section 10.5.1. 
A number of improvements were suggested to educational elements of the application, 
including increased transparency regarding the potential learning from using the VP and that 
this will not always be knowledge-based. Furthermore, the content of the VP should be 
reviewed as some participants, particularly the longer qualified or specialist pharmacists, 
raised concerns regarding the clinical accuracy of the application content. Any content of the 
VP should align with NICE recommendations for the treatments used in AF (National Institute 
for Health and Care Excellence 2014). Using the NICE guideline for AF management, and 
Henry’s past medical history it would be expected that he would also be taking a rate or 
rhythm controlling medication such as a beta blocker for the treatment of AF, but this is 
currently absent (National Institute for Health and Care Excellence 2014). Furthermore, 




someone with type 2 diabetes, as Henry has, would not normally be only on insulin, but rather 
a number of additional oral therapies and there may also be concurrent use of a statin 
(National Institute for Health and Care Excellence 2015b). The past medical history and 
medications of Henry should be reviewed to ensure, where best possible, that they are 
reflective of current U.K. practice and realistic, yet educationally useful.  
Considering the possibility of further references to support learning as a change to be made to 
the VP design, there is limited discussion of this within VP studies and no other VP studies 
appeared to include references or further learning in their designs. Although the use of further 
references is commonly used in other pharmacy CPD resources such as CPPE modules, and so 
inclusion of this may better contribute to identifying the VP as a CPD resource.  
Lastly, there are numerous possible applications which could be developed in the future and 
multiple topic ideas have been suggested; there was interest in a library of VPs. The literature 
for each of these should be considered prior to development of applications. It was also 
highlighted that the VP has almost unlimited potential as already recognised by Stevens et al. 
(2006).  
8.4 Summary 
This chapter has presented and discussed the results of the second group of the themes, these 
particularly related to the educational aspects of the VP and how participants used the VP. The 
next chapter presents the last group of themes and considers the implementation of the VP.




 Interview results III. how can the VP fit into 
pharmacy practice? 
9.1 Introduction 
Moving on from the discussion of the first two groups of the thematic analysis, this chapter presents 
the final group. This category considers the wider implications for the VP and incorporates 
considerations for implementation. Due to this, the final group of themes is followed by a specific 
analysis of the interview results relative to an implementation framework. A discussion of the results 
of the last group of themes and of the implementation analysis completes the chapter.  
9.2 How can the VP fit into pharmacy practice? 
This group of themes relates largely to use of the VP in pharmacy practice which was discussed in 
varying forms by all participants. It is split in to two themes: implementation into pharmacy practice 
(section 9.2.1) and the ‘ideal’ user (section 9.2.2).  
 Implementation into pharmacy practice 
A number of discussion points were raised that relate to VP use and the everyday practice of 
pharmacy this included ideas of implementation of the VP into specific pharmacy environments.  As 
has already been discussed across chapter 8 there was a majority of positive comments regarding 
the potential of the VP but, what became clear is there was some unfamiliarity of how to start using 
the VP in practice. 
’’my feelings towards it are I’d feel like I’d want to use it, but I don’t know how I’d start to use 
it.’’ [P11] 




A number of participants commented on the time commitments required to use the VP and the 
consequences of this on implementation. This appeared to be a prohibitive factor for these 
participants. This was also a result of the questionnaire phase of the study (section 0). 
 ‘’Erm, I would possibly say it was a little too long. Especially if people are doing it in their 
own time... just from my experience, I worked in a really busy erm pharmacy…to have the 
time to even do things that you have to was a struggle.’’ [P73] 
Similarly, one participant recognised that different user groups may have different levels of 
engagement due to different consequences for the learning. This closely links with ideas of an ‘ideal’ 
user (section 9.2.2) and wider implementation strategy (section 9.3).  
‘ ‘cause you don’t, as a student, you don’t really care. You just want to get your grade and 
move on whereas as a pre-reg it’s, ‘oh well, I want to learn this for the exam’. And then as a 
pharmacist like ‘oh, I’d better remember this again’ ‘cause I’m actually doing it’’ [P57] 
Continuing professional development 
Building on ideas of integration of the VP into pharmacy practice, CPD was a significant discussion 
area. CPD was discussed by all of the participants and all of the participants could see some sort of 
purpose of the VP for CPD. No participants stated that the VP was unsuitable for CPD purposes.  
 ‘’it would be quite a good sort of tick box for CPD and if… if this was available for different 
sorts of topics as well, you could do one topic as your CPD learning…’’ [P14] 
One participant detailed how they visualised the VP being used for CPD purposes. The comments of 
this participant link closely with the discussion in section 8.2.2 and this also maps directly on to the 
experiential learning cycle.  




‘’for the CPD… I think it would be useful to say, you know, I've gone and - it's almost saying, 
I've gone away and learnt about X and then I've had a go on a simulator before I then went 
and used whatever information on - in the context of your work environment and sort of 
show how you've gone through that development process.’’ [P58] 
There were some participants who thought that for the VP to be used for CPD it needed changes or 
improvements to better align with the structure of CPD. It is not clear if all participants thought that 
these changes would be beneficial and conflictingly some participants stated that changes were 
unnecessary just to better align with CPD design. The changes discussed below link to the suggestion 
for further references within the application (section 8.2.2). 
A wider issue that became apparent when discussing CPD was that there was confusion across the 
participants regarding what constitutes CPD and what an educational resource for CPD purposes 
should consist of. These perspectives occurred across the participants. Similarly, some participants, 
particularly those which were longer qualified, had comments to make on wider aspects of CPD. 
There seemed to be some frustration from participants regarding the process and value of CPD. 
‘’I say, with a lot of CPD, I find it a joke. Erm, you know, doing modules… they tell you you’ve 
got to do CPD, so you’ve gotta do four modules, so frankly, you do four modules. And to a 
certain extent, that’s not the point, is it? You should have the professional responsibility to 
already be doing CPD without it being a sort of statutory requirement.’’ [P36] 
Despite this, one participant said that they had used the VP experience as part of their CPD already.  
‘’I am actually currently doing it as a reflection um, CPD anyway and I’ve tried to focus on AF 
in general, and sort of using it as part of um, of that.’’ [P83] 
Pharmacy sector 




Pharmacy sectors and the consequences of this on VP implementation was a significant discussion 
point. In the most, participants commented on their own sector of practice and again similar to 
other discussions it was a topic with varied perspectives. The consensus of the participants was that 
the VP was applicable to both hospital and community sectors.  
‘’I suppose the reality is that it looks like a community pharmacy, but I don’t think that really 
matters or detracts from the overall usefulness of the programme.’’ [P74] 
Despite this, a few participants appeared to focus on the minutiae of the application content for 
particular sectors. In most cases, participants concluded that there is still transferable learning 
across the sectors.  
‘’Erm, the way it is it’s very community pharmacy based erm as a hospital pharmacist it’s 
quite a bit different in terms of how we do counselling and consultations, a lot more in-depth, 
so maybe that’s why I initially thought there’s not so much clinical information in’’ [P14] 
An unexpected finding of the interviews was that there was confusion regarding who is responsible 
for providing NOAC counselling to patients. This was apparent when participants discussed use of 
the VP in different sectors; some participants seemed to think that it was primarily a hospital 
pharmacist’s role and that the VP should reflect this. Others as already discussed, found benefits to 
the application being set in a community pharmacy. 
 The ‘ideal’ user 
Ideas of who the ‘ideal’ user for the VP is came up in every interview with a range of perspectives. 
The participants had a range of ideas of who could use the VP, across the interviews, very few 
individuals discussed only one potential user group with most discussing that the VP was suitable for 
a number of types of user.  
 ‘’I think whoever looks and uses this, it’s always gonna be beneficial.’’ [P73] 




Pre-registration trainees were one group of participants specifically identified prior to this study as 
being potential users of the VP. All of the interview participants identified pre-registration trainees 
as good users for the VP. The most commonly discussed reason for pre-registration trainee use was 
because the VP acts as a refresher and/or prepares for practice.  
‘’I think it's at a level where like a pre-reg pharmacist could do it and that would be useful’’ 
[P67] 
As well as pre-registration trainees, qualified pharmacist’s use of the VP was one area that was a key 
part of the evaluation. All of the participants commented on this in some; many of the participants 
referred to qualified pharmacists in two broad groups: newly qualified pharmacists (normally classed 
as the first five years of qualification) and longer qualified or specialist pharmacists. Broadly, users 
thought that the use of the VP by newly qualified pharmacists was appropriate. There were mixed 
views regarding the use of the VP by longer qualified pharmacists.  
‘’I’m saying newly qualified because for myself I knew it, but I had forgotten about it. It was a 
good refresher whereas once you’ve become a pharmacist for a bit longer you’ve had more 
chance to do it.’’ [P57] 
There were a number of participants that appeared to think that use of the VP by pharmacists with 
more experience would not be useful. One reason cited for this was the complexity of the VP case. 
This has already been discussed in section 8.2.1.  
There were a few comments regarding the limitations of having newly qualified pharmacists as users 
of the VP as there is a potential for ‘bad’ learning; similar ideas were also presented for pre-
registration trainees.  
‘’Because I don't - I wouldn't really want people that are newly qualified to go by just 
this…It's almost like it's okay just to ask the bare minimum…’’ [P35] 




The next group most often discussed group was pharmacy technicians. Where pharmacy technicians 
were discussed it was suggested that pharmacy technicians are an appropriate user group. 
‘’Counselling can be done by a technician and in that case, if it's just counselling about the 
NOACs, that can be easily done by them.’’ [P35] 
9.3 Implementation analysis 
As discussed in section 5.6, on the basis of unexpected results that presented implementation as 
being significant to the use and uptake of the VP, a supplementary analysis specifically concerning 
implementation was undertaken. The analysis uses the CFIR and the results are discussed in the 
following section. 
 CFIR results 
The CFIR was used to undertake the implementation analysis (Table 9.1). The CFIR uses five domains 
to address constructs which are needed for successful implementation. Table 9.1, presents the 
results of the CFIR analysis, the constructs have been mapped to the results of the VP evaluation to 
identify areas of the framework which are currently: being met; partially being met but in need of 
development; and not yet being met, these may be useful for future VP research and 
implementation.  
Overall, of the 39 constructs or sub constructs, 19 (48.7%) were not covered by the study, 13 
(33.3%%) were partially covered by the study and 7 (17.9%) were being met. This demonstrates that 
the majority of constructs are not yet being entirely met and suggests that further considerations 
may be needed to be made to ensure a successful implementation. Despite this, this was one 
purpose of conducting the CFIR, to identify areas which need development prior to the wider roll out 
of the VP. The CFIR analysis also provided an opportunity to identify any barriers to implementation 
from the current VP design, this will help to optimise the application design, not only from a 




technical and educational perspective but also from an implementation perspective. Moreover, the 
analysis directly contributes to the study objective of ‘’identify how the VP can be incorporated into 
the education, training and continuing professional development of pharmacists and pre-registration 
pharmacists’’ (section 4.2). 
The first domain, ‘’intervention characteristics’’, considers implementation with a focus on the 
intervention, in this case the VP application. A number of the constructs of this domain were being 
met, or partially met (Table 9.1). This included that there was an awareness of the relative 
advantages of the VP and its adaptability and trialability (constructs 1d and 1e). Areas which need 
further addressing include the perspectives of the participants on the external development of the 
VP (construct 1a) and users’ awareness of the literature base for its use (construct 1b). Cost is 
another significant factor which was not addressed in the study as all of the participants accessed 
the VP free of charge (construct 1h). It does not appear that the content of the VP itself is currently 
limiting the possibility of implementation but some of the supporting elements need development, 
particularly cost.  
The second domain was ‘’outer setting’’ this covers some of the wider issues around 
implementation. No areas of this domain are currently being met and all need further development 
(Table 9.1). There is some evidence of the importance of NOAC counselling (section 6.8) but it is not 
clear if this is being prioritised by organisations and thus if there is sufficient interest for wider 
implementation of the VP (construct 2a). Participants identified NOAC counselling as important with 
potential benefits to both patients and organisations, but no information appears to be available 
considering organisational perspectives on the implementation of VPs. Furthermore, there does not 
appear to be any evidence of external policy and incentives to support VP implementation 
specifically (construct 2d), this may be a current barrier to implementation.  
The ‘’inner setting’’ domain considers more closely the preparation for implementation on an 
organisational level. Large areas of this were not covered in the evaluation as the focus of this study 




was not implementation within particular organisations (Table 9.1). Positive data were collected 
concerning the significance of the need for the VP by individuals, whereby the majority of users 
identified that there was interest in learning more about NOACs (section 6.3) (construct 3d). There 
were also a number of advantages identified for patients, this concerned an increased 
understanding of medicines which may have implications for their care (section 0). Where there 
needs to be further consideration prior to implementation this concerned cultural norms and how 
VP use will fit into organisations, including concepts such as rewards (construct 3d). This is significant 
especially as some participants expressed negative perspectives on CPD and mandatory training 
(section 9.2.1). Despite this, there were some promising discussions concerning where VP use may 
fit into CPD alongside other resources and this could be built in to the implementation strategy 
(section 9.2.1).  
The penultimate domain of ‘’characteristics of individuals’’ highlighted a number of areas which 
need further consideration (Table 9.1). One area which was not covered by the study but is 
significant for future use of the VP pertained to behaviour change and how use of the VP may lead to 
‘sustained use of the intervention’ (construct 4c). This needs further development and 
consideration. Despite this, there were some areas within this domain where the VP performed well. 
As discussed in chapter 7, data were collected on the acceptability of the VP, this largely meets the 
CFIR requirements for ‘’knowledge and beliefs about the intervention’’ (construct 4a). Equally data 
on engagement and learning styles of different audiences and groups contributed to meeting the 
‘‘personal attributes’’ construct (construct 4e). Although this could be better developed moving 
forward to ensure that all named elements of the ‘’personal attributes’’ construct are met.  
The final domain of ‘’process’’ was largely not covered by the evaluation as it also relates to 
organisational level implementation (Table 9.1). Some data were gathered on engagement and this 
was demonstrated through the course of the study where there was enough interest to recruit 94 




participants (construct 5b). Equally the design of the study included a small level of implementation 
and utilised individuals to act as leaders and champions at each site (constructs 5b and c).  
Reviewing the overall CFIR, large proportions of the framework were not covered by this evaluation, 
largely because implementation was not the focus of the study. Despite this, some foundations for a 
wider scale implementation have been presented and the results of the domain ‘’intervention 
characteristics’’ suggest that the VP application is largely ready for implementation. There does not 
appear to be any need to change the design of the VP on the basis of implementation, but what is 
currently absent, and needs developing prior to implementation of the VP, is a network of 
supporting infrastructure to facilitate a successful a wider-scale implementation. This will be further 
discussed in section 9.4. 













Perception of key stakeholders about whether the 
intervention is externally or internally developed. 
No participants discussed this. It is not clear if who 
developed the VP affected use. Participants aware that VP 
was developed outside of their organisations. 
b. Evidence 
strength and quality 
Stakeholders’ perceptions of the quality and validity of 
evidence supporting the belief that the intervention will have 
desired outcomes. 
Not covered by the study. 
c. Relative 
advantage 
Stakeholders’ perception of the advantage of implementing 
the intervention versus an alternative solution. 
Advantages of VP vs other options (section 8.2.2). 
d. Adaptability The degree to which an intervention can be adapted, tailored, 
refined, or reinvented to meet local needs.  
Discussion of how the VP is adaptable to be used in 
different sectors and setting etc. but not on changing the 
design of the VP for this purpose.  
e. Trialability The ability to test the intervention on a small scale in the 
organisation, and to be able to reverse course (undo 
implementation) if warranted. 
Study has proven ability to test the intervention on the 
small scale. Ability to reverse implementation not 
discussed. 
f. Complexity Perceived difficulty of implementation, reflected by duration, 
scope, radicalness, disruptiveness, centrality, and intricacy and 
number of steps required to implement. 
Some comments on where the VP sits in practice and how 
it could be incorporated (section 9.2.1). No discussion on 
the complexity of this or remainder of the construct. 
g. Design quality 
and packaging  
Perceived excellence in how the intervention is bundled, 
presented, and assembled. 
Usability, functionality, user friendliness discussed (section 
7.3). Technical quality and maintenance not discussed.  
h. Cost Costs of the intervention and costs of implementing that 
intervention including investment, supply, and opportunity.  





a. Patient needs 
and resources 
The extent to which patient needs, as well as barriers and 
facilitators to meet those needs are accurately known and 
prioritised by the organisation. 
Users aware that this is an area lacking in education and 
training and how this can affect patients. Limited 
information on priority. 
b. Cosmopolitanism The degree to which an organisation is networked with other 
external organisations. 
Not covered by the study. 
c. Peer pressure Mimetic or competitive pressure to implement an 
intervention; typically, because most or other key peer or 
competing organisations have already implemented or in a bid 
for a competitive edge. 
Not covered by the study. 
d. External policy 
and incentives 
A broad construct that includes external strategies to spread 
interventions including policy and regulations (governmental 
Not covered by the study. 




or other central entity), external mandates, recommendations 
and guidelines, pay-for-performance, collaboratives, and 







The social architecture, age, maturity, and size of an 
organisation. 
Not covered by the study. 
b. Network and 
communication 
The nature and quality of webs of social networks and the 
nature and quality of formal and informal communications 
within an organisation. 
Not covered by the study. 
c. Culture Norms, values, and basic assumptions of a given organisation. Not covered by the study. 
d. Implementation 
climate 
The absorptive capacity for change, shared receptivity of 
involved individuals to an intervention and the extent to which 
use of that intervention will be rewarded, supported, and 
expected within their organisation. 
Wider issues with practice, working pressures and CPD 
engagement highlighted (section 9.2.1). This may be 
prohibited and needs considering before implementation. 
- Tension for change  The degree to which stakeholders perceive the current 
situation as intolerable or needing change. 
Identification of some of the reasons why VP would be 
good – e.g. consequences for the NHS (section 8.2.3) but 
no information on if organisations think this needs to 
change 
- Compatibility The degree of tangible fit between meaning and values 
attached to the intervention by involved individuals, how 
those align with individuals’ own norms, values, and perceived 
risks and needs, and how the intervention fits with existing 
workflows and systems. 
Some discussion of how the VP fits with alternative 
resources and methods (section 8.2.2). This requires 
further consideration. 
- Priority Individuals’ shared perception of the importance of the 
implementation within the organisation. 
Qualitative results on the importance of NOAC counselling 
broadly and quantitative results identified some with no 
previous NOAC counselling (section 6.3). No information 
about organisation level importance.  
- Incentives and 
rewards 
Extrinsic incentives such as goal-sharing awards, performance 
reviews, promotions, and raises in salary and less tangible 
incentives such as increased stature or respect. 
Some confusion over who is responsible for NOAC 
counselling (section 9.2.1) this may be prohibitive in the 
perceived reward for using the intervention.  Further 
consideration required.  
- Goals and 
feedback 
The degree to which goals are clearly communicated, acted 
upon, and fed back to staff, alignment of feedback with goals. 
Not covered by the study. 




- Learning climate A climate in which: a) leaders express their own fallibility and 
need for team members’ assistance and input; b) team 
members feel that they are essential, valued, and 
knowledgeable partners in the change process; c) individuals 
feel psychologically safe to try new methods; and d) there is 
sufficient time and space for reflective thinking and evaluation. 
General perspectives on learning climate gathered 
(section 6.3) and the intervention may offer advantages in 
user safety. More information is needed on reflective 
space and time, and how the intervention links with 
leadership support and guidance.    
e. Readiness for 
implementation  
Tangible and immediate indicators of organisational 
commitment to its decision to implement an intervention. 
Not covered by the study. 
-  Leadership 
engagement 
Commitment, involvement, and accountability of leaders and 
managers with the implementation. 
Not covered by the study. 
- Available 
resources 
The level of resources dedicated for implementation and on-
going operations including money, training, education, 
physical space, and time. 
Some comments on accessibility (section 7.3.1). No 
mention of ongoing application management and delivery 
package for the VP still to be decided. 
- Access to 
knowledge and 
information 
Ease of access to digestible information and knowledge about 
the intervention and how to incorporate it into work tasks. 
Some comments on limited information on the ‘purpose’ 
of the VP (sections 6.6 and 8.2.2). This needs to be more 










a. Knowledge and 
beliefs about the 
intervention  
Individuals’ attitudes toward and value placed on the 
intervention as well as familiarity with facts, truths, and 
principles related to the intervention.  
Qualitative results on the acceptability of the VP. Some 
mixed information on who is responsible for NOAC 
counselling. Some users not aware of truths relating to 
some of the values of the VP. 
b. Self-efficacy Individual belief in their own capabilities to execute courses of 
action to achieve implementation goals. 
Not covered by the study. 
c. Individual stage 
of change 
Characterisation of the phase an individual is in, as he or she 
progresses toward skilled, enthusiastic, and sustained use of 
the intervention. 




A broad construct related to how individuals perceive the 
organisation and their relationship and degree of commitment 
with that organisation. 
Did not consider single organisations as part of the study. 
e. Other personal 
attributes 
A broad construct to include other personal traits such as 
tolerance of ambiguity, intellectual ability, motivation, values, 
competence, capacity, and learning style. 
Results from the study include considerations for personal 
engagement and learning styles. 







a. Planning The degree to which a scheme or method of behaviour and 
tasks for implementing an intervention are developed in 
advance and the quality of those schemes or methods. 
Not covered by the study. 
b. Engaging Attracting and involving appropriate individuals in the 
implementation and use of the intervention through a 
combined strategy of social marketing, education, role 
modelling, training, and other similar activities. 
Through the research each site implemented the 
intervention to gain participants, this used varied 
strategies. Participants also commented on 
implementation strategies broadly (section 9.2.1). Chosen 
engagement methods still needs to be finalised and 
implemented with considerations for single organisations.  
- Opinion leaders Individuals in an organisation who have formal or informal 
influence on the attitudes and beliefs of their colleagues with 
respect to implementing the intervention. 
Not covered by the study. 
- Implementation 
leaders 
Individuals from within the organisation who have been 
formally appointed with responsibility for implementing an 
intervention as coordinator, project manager, team leader, or 
another similar role. 
Within the study sites individuals to promote participation 
were identified and utilised. For a larger scale 
implementation this needs scaling up. 
- Champions “Individuals who dedicate themselves to supporting, 
marketing, and ‘driving through’ an [implementation]”, 
overcoming indifference or resistance that the intervention 
may provoke in an organisation. 
Within the study sites individuals to promote participation 
were identified and utilised. For a larger scale 
implementation this needs scaling up. 
- Change agents Individuals who are affiliated with an outside entity who 
formally influence or facilitate intervention decisions in a 
desirable direction. 
Not covered by the study. 
c. Executing Carrying out or accomplishing the implementation according 
to plan. 
The study demonstrated some ability to execute small 
level implementation, a widescale plan is required before 
full execution.  
d. Reflecting and 
evaluating 
Quantitative and qualitative feedback about the progress and 
quality of implementation accompanied with regular personal 
and team debriefing about progress and experience. 
Not covered by the study. 
Table 9.1 Consolidated framework for implementation analysis (CFIR) constructs and construct definitions taken from Damschroder et al. (2009)




Building on the discussions within chapters 7 and 8, the VP was largely considered acceptable 
by the participants although from these results it became apparent that wider elements of 
pharmacy practice may impact the potential usability of the VP in practice. The VP is not an 
isolated opportunity and so must be usable within the constraints of practice.  
There were concerns regarding the time users would get in practice to use the VP. This is an 
increasingly common concern in pharmacy practice with recognised incidences of working 
pressures being prohibitive of other duties, including education (Resnik et al. 2000). This 
appeared to be a problem far wider than the VP evaluation but nonetheless for some users 
this was a limiting factor in its usability. Another significant discussion area was the use of the 
VP across different sectors. For most users the community nature of the VP setting was 
acceptable, and they could appreciate the transferable nature of the application content, but 
for others this distracted from its usability. As highlighted in the systematic review (section 
3.5.2) and is further discussed in section 10.5, the majority of other VP applications have been 
highly specific to single organisations and universities and thus transferability is not something 
which has been evaluated in detail.  
Within the discussion of pharmacy sectors, there was some wider debate around whose role 
in practice NOAC counselling is. For some participants they did not see the counselling as part 
of a particular role, and this limited its acceptability although this did seem to be due to wider 
perspectives on NOAC counselling rather than due to the VP. This contrasts with the literature 
discussed in section 1.2.2 from the ESC who stated that anticoagulant counselling is the 
responsibility of all HCPs, including pharmacists (Heidbuchel et al. 2015). This disputes any 
suggestion that those working in a particular sector or role are ‘responsible’ for NOAC 
counselling.  
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Considering CPD, there were some negative comments and perceptions of CPD generally and 
this could limit the VP’s acceptability for CPD. This was not the case for the majority of 
participants who did find the VP acceptable for CPD purposes; no participants commented 
that the VP was completely unsuitable for this purpose, but this is not without disagreement. 
Some users commented that they were unsure how exactly the VP could be implemented and 
would be used practically for CPD. If the VP is to be used for this purposes then the VP 
developers should consider altering the VP to better align with CPD requirements as set by the 
GPhC (General Pharmaceutical Council 2018a). Any change in the targeting of the VP for CPD, 
should be carefully considered as not to limit the potential uses of the VP and to solely restrict 
VP use to CPD purposes as uses outside CPD were reported (section 8.2.2).  
As for CPD there was a lot of discussion around different users of the VP and possible changes 
based on the audience. Most participants could see uses for multiple user groups, although a 
particular group may have been favoured by the individual. As discussed in section 9.2.2, pre-
registration trainees and newly qualified pharmacists appeared to be the favoured groups to 
use the VP. Pharmacy technicians were also strongly favoured, and this contrasted with 
specialist and longer qualified pharmacists where perspectives were wider ranging. Similar to 
CPD, any changes to the VP based on the target audience should not limit use to single groups 
as the broad nature of the VP appears to currently be an advantage. One possibility is the way 
in which the VP is presented to different groups could be improved to meet these suggestions. 
This could possibly be done without changing the content of the VP application specifically; 
this links with an implementation strategy which is discussed later in this section. In the future, 
one group that it appears could particularly benefit from VP use is that of pharmacy 
technicians, particularly as they are underprovided for educationally (Schafheutle et al. 2017). 
This is a suggested area for future VP development (section 10.5.1).  
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Engagement also needs to be considered when implementing the VP for CPD purposes as 
mandatory training and CPD have been reported to have a lack of engagement from users 
particularly due to time commitments and their mandatory status (Laaksonen et al. 2009). 
Until employers and/or the regulator move to focus on allowing pharmacists the opportunity 
to undertake education and training this is likely to be a continuing when evaluating 
educational tools. In the meantime developers could look to optimise the time requirements 
of their tools without compromising on educational value. Additionally, across the user groups 
it was suggested that the consequences of conducting this learning may also have different 
consequences for different types of users and thus this may affect engagement. This concept 
is evidenced in the literature when Thompson et al. (2017) discussed that their participants, 
pre-registrations trainees, were significantly concerned with learning associated with the 
registration assessment. On this basis, the consequences of the learning for the different user 
groups should be considered in implementation. This also meets some of the requirements for 
the CFIR construct ‘’implementation climate’’ whereby the priority and incentives for use of 
the intervention are considered.    
Across the participants it was clear that many found the VP useful as an intermediate between 
knowledge-based aspects of NOAC counselling and using the learning in practice with real 
patients, this has already been discussed in section 8.2.2. Despite this, it was highlighted that 
for some users the VP had the potential to nurture bad practice and this reduced its 
acceptability. Within the literature there does not appear to be any examples of learnt ‘bad’ 
practice from using VPs, but somewhat surprisingly it has been recognised that experiential 
learning cycles within practice alone could reinforce and perpetuate bad practice picked up 
from peers (Stevens et al. 2006). This directly conflicts with the reported perspective of the 
participant previously discussed. It is not clear if there is a risk of nurturing of ‘bad practice’ 
from VP use. Furthermore VPs are recognised to be useful to standardise learning so this is 
unlikely (Hege et al. 2016). If the learning from using the VP would otherwise take place in 
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practice and could result in variable learning, it is possible that VPs could actually reduce the 
level of ‘bad learning’ where the learning would normally be conducted on a variable peer-to-
peer basis.  
Regarding the implementation analysis, no issues with the VP content were identified which 
would limit implementation, but the supporting infrastructure of the VP needs development 
to prepare for implementation in order to fully implement the VP and meet the domains of 
the CFIR. The CFIR analysis could be repeated prior to wider implementation to identify that 
the support needed for an efficient implementation is in place. Participant perspectives on the 
proposed implementation would also be useful to better develop this. VP infrastructure 
includes an implementation strategy, organisation-level support and identification of 
individuals to help implement the VP. This is supported by the work of Moullin et al., who said 
that implementation should include implementation indicators to help measure the progress 
and success of implementation (Moullin et al. 2016). The implementation strategy should help 
to target implementation and ensure that the VP is being used as part of quality education and 
training. There does not appear to have been any research conducted into the wide scale 
implementation of VPs, this would help contribute to the literature-base on VP use in practice. 
No other VPs appear to have been externally developed but rather, in the majority developed 
by universities. As this VP was commissioned externally, this is an additional factor that could 
potentially impact implementation and will need to be considered as perception of who has 
developed an intervention can effect implementation and uptake (Damschroder et al. 2009). 
Equally, this would need to incorporate considering the influence of cost on implementation. 
Moreover, areas such as the packaging and maintenance of the VP need to be considered. 
These concepts were discussed in the work by Hege et al. (2016) who’s framework for VP 
design was presented in section 2.3.1. Hege et al. (2016) recognised that VPs have a level of 
cost associated with not only the development of VPs but also their maintenance and ongoing 
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support. This is similar to the work of Tan et al. (2010), as discussed in section 2.3 who stated 
that as VPs are a rapidly evolving technology they require a level of constant maintenance.  
A number of roles and responsibilities are presented by the CFIR to help with a successful 
implementation. The VP was not at the stage of recruiting these individuals during the 
evaluation although the framework provides a useful list of roles to use as a starting point for 
future implementation. Despite this, the study took place across 14 sites and some sites only 
had a single participant therefore further work is required around engaging with wider groups 
of users at each site. This demonstrates that some of the elements for a wider scale 
implementation have been considered but this needs more comprehensive development prior 
to any wider scale implementation. An implementation strategy could incorporate 
organisational level aspects, identification and training of key stakeholders in the 
implementation process, and some of the broader areas covered by the CFIR to facilitate a 
successful, wider-scale implementation. 
The majority of participants were positive towards the incorporation of the VP into practice, 
but a significant proportion were more pragmatic and cautious regarding the practicalities of 
implementation. Despite this, it appears that the VP users recognised the CPD opportunity, 
with one participant stating that they had already used the VP for this purpose. Overall, the VP 
was largely acceptable and useful, but some areas of everyday pharmacy practice could limit 
use for some individuals.  
9.5 Summary 
This chapter has presented and discussed the final group of themes relating to the interview 
analysis. Following this, an implementation analysis was undertaken using the CFIR, this 
discussed the study results relative to an implementation framework. The next chapter will 
collectively consider the results and discussions of the two phases together to give an overall 






This chapter follows on from the presentation of the results of the study to discuss the 
relevance and implications of the findings in the context of wider literature on VPs. The 
findings will be related to wider pharmacy practice to highlight their significance. 
10.2 Key results 
The results of the evaluation have been discussed in sections 6.10, 7.4, 8.3 and 9.4. The key 
findings of this evaluation are as follows: 
• The majority of users appeared to like the concept and delivery of the VP, although there 
were a few technical issues which need investigation before any further implementation.  
• Benefits to the users appeared to range widely but included: combinations of changes in 
knowledge and confidence, including contextualisation of learning to a patient interaction; 
an opportunity to practice; and, reflective opportunities. These benefits map to Kolb’s 
theory of experiential learning, this will be further discussed in section 10.3.3. 
• A statistically significant average improvement in self-reported counselling ability was 
demonstrated pre- to post-VP use (average improvement of 10.2%, -30.3%-39.6%). This 
average improvement in ability could incorporate a number of types of learning as 
discussed previously, such as knowledge and confidence changes.  
• The VP has demonstrated its use by a range of pharmacists and pre-registration trainees 
although it may be of more use to pre-registration trainees or newly qualified pharmacists 
to help transition knowledge to practice by providing contextualised and experiential 
learning (section 8.2.2). Use of the VP by pharmacy technicians was suggested although 




• Elements that need consideration prior to implementation of the VP have been 
highlighted, such as the way in which feedback is delivered, particularly around the use 
of the colour coding and also the restrictive nature of the MCQs (sections 6.5 and 8.2.2). 
An implementation strategy is required to ensure that when the VP is implemented it is 
done so with the infrastructure in place to support its use.  
This evaluation is the first to provide insights into the use of a VP by qualified pharmacists and 
further contributes to the literature on the use of VPs by pre-registration trainees. This 
evaluation has further demonstrated a number of advantages to VP use that have been 
reported in literature previously. Two examples being that the VP provides a safe environment 
and also an opportunity to practice (section 8.2.2). This directly contributes to the literature 
base for VP use. This evaluation appears to be the first to consider implementation into 
practice and provides insight into the areas of VP infrastructure that need addressing for a 
successful implementation (section 9.4). Furthermore, the evaluation has, in some detail, 
shown insights into the relationship between the VP and how it can be used in practice. This 
has identified some barriers which may limit the use of the VP in day to day practice which is a 
more realistic view of the synergistic relationship between the VP application and practice 
rather than considering VP use in isolation (section 8.3). 
 Summary of data triangulation and integration of the results 
As stated in section 4.4.5, the results of the two sequential phases were integrated to give an 
overall interpretation of the findings. Throughout the discussions of this chapter, data from 
across the study have been considered together; some key areas and discussions are 
highlighted and discussed below. 
The first approach to integration was that the data from phase one of the study directly 




perspectives and of corroborating the initial data. The areas which this applied to are largely 
discussed in section 5.5.1. 
The questionnaire findings gave an overview of perspectives on the VP with a number of areas 
identified from the results as requiring further investigation (section 6.11.2). This included that 
the questionnaire results concerning feedback showed mixed results. When this issue was 
explored within the interview phase it emerged that the aspect of the feedback which the 
participants did not favour was the use of the colour coding to categories feedback as ‘good’ 
and ‘bad’ and this limited the acceptability of the application (section 8.2.2).  
Similarly, within the questionnaire, the VP technology was cited to be less favourable by some 
respondents. This was an unexpected finding as the VP technology uses current high-quality 
animations and designs, additionally the pilot study suggested that it was functionable. When 
this unexpected finding was explored in the interviews it emerged that the technology as a 
whole was not the problem, but rather it was the slow speed of the animations experienced 
by some users (section 7.3.1). The qualitative phase allowed for this greater depth of insight 
and the initial unexpected finding was explained by being able to pinpoint the exact issue.  
Furthermore, some of the areas identified from the questionnaire results as the ‘best’ things 
about the VP were also highly discussed as ‘worst’ areas as part of the questionnaire (section 
0). This initially appeared to be a somewhat contradictory finding but, after the interviews, 
which were designed to directly address some of these areas, this became clearer. One key 
area was the MCQs within the application not being well liked. It emerged from the interviews 
that it was not the question style which was disliked, but rather the restrictive nature of it and 
the underlying algorithmic design of the VP. Similarly, within the questionnaire results the 
realism of the VP was reported to be fairly well liked but the VP not being reflective of practice 
was one of the least favoured concepts. This juxtaposition became clearer following the 




based. Using this classification, technical refers to realism of the animations and of the 
application to simulate a real environment whereas practice-based refers to the realism of the 
application to day to day pharmacy practice and the realism of the clinical content of the 
application. Using this concept of different types of realism, it is possible that in the 
questionnaire the respondents thought that the VP technology was realistic in that it looked 
and acted realistically but some of the content was not reflective of what happens in practice 
clinically. This is also an example of using data integration to provide real life contextualised 
findings that consider pharmacy practice. 
The second element of integration involved comparing the two complete data sets to identify 
similarities and differences between to the two to corroborate the findings. The two phases of 
the study largely agreed with each other and the benefit of the adopted methods, as discussed 
in section 4.4.5, were that results could be explored in greater detail and corroborated to 
provide a holistic and contextualised overview of the results.  
The questionnaire results demonstrated that on average user’s self-reported an improvement 
in their ability to conduct NOAC counselling (section 6.4). This was further explored in the 
interviews where a number of different types of learning were identified and a greater depth 
of insight was possible. This resulted in the realisation that VP use can provide an opportunity 
to practice safely and can result in a number of outcomes such as refreshment of knowledge. 
This is also true of the question concerning repeated use of the VP where the questionnaire 
responses largely agreed with the interview discussions in that most users would use the VP 
more than once. Despite this, as part of the interviews a further level of insight was possible 
whereby it was established exactly what repeated use might look like in practice. This included 
the possibility of an initial ’in depth’ use of the VP followed by repeated use although in less 




There were some lesser reported uses of the VP, such as one participant who stated that they 
used the VP a second time only to get all ‘green’ feedback. This closely links to the other 
results regarding the feedback, particularly that the colour coded feedback was not well liked 
(Figure 1.8) (sections 6.5 and 8.2.2). The identification of a minority use of the VP in this way 
will be useful for VP developers to appreciate the unanticipated decisions of users and to 
better design VPs moving forward.  
As the interviews were socially contingent, the interview results have provided vital context 
and individual perspective on the questionnaire satisfaction and usability results. This allowed 
confirmation that the majority of experiences matched with those reported across chapter 6 
from the questionnaire results. 
10.3 Significance of the key results 
 Pharmacist’s and pre-registration trainee’s satisfaction in usability 
Overall the VP had largely positive reports of user satisfaction and this resulted in a level of 
acceptability by the participants, although some improvements have been identified to 
optimise this (section 7.4). From a technological point of view the VP was functional and this 
appeared to contribute to its usability. In previous VP studies, technology was found to have 
significant limitations to its uses (Stevens et al. 2006, Botezatu et al. 2010, Douglass et al. 
2013) but, this study has demonstrated an application which is largely accepted by the users.  
Some limitations of the technology were highlighted although in most cases the participants 
accepted these and they did not limit use; these are further discussed in section 10.4.2.  
As stated in section 1.4.3, the five questions posed by Sharples et al. (2005) considering mobile 
learning were considered and the results of the study have demonstrated that the VP meets 
these as follows. The VP is significantly different from other methods of teaching used in its 




The VP provides mobility for users as it can be used anywhere, at any time and on any number 
of devices with an internet connection; this was favoured by the respondents who used this 
feature. The VP also covers both informal and formal learning as it can be used for CPD 
meeting formal requirements and also informal learning outside of CPD. The learning resulting 
from VP use appears to be constructive, especially as a number of participants directly 
commented upon the constructive nature of the feedback (section 8.2.2). This could be 
improved by changes to the delivery of feedback such as rethinking the colour-based design.  
Finally, the VP learning is personal yet mediated by technology, as the learning is part of a 
cycle which incorporates taking the learning out into practice, supplementary to other 
methods and experiences in practice. A number of participants discussed the ways that the 
learning has impacted their practice. This is also in line with the work by Georg and Zary 
(2014), who stated that VPs are not merely objects but learning activities. This evaluation has 
demonstrated this but has taken this further to also incorporate daily pharmacy practice and 
cycles of learning, in line with Sharples et al. (2009) who said that mobile learning should 
extend ‘’into the conversations and interactions of everyday life’’.  
The VP questioning method was one area that was highlighted by almost every participant 
particularly as it has been described as ‘restrictive’ (sections 6.5 and 8.2.1). Despite this, 
participants appeared to not want the questioning method changing to an alternative method 
but rather the questioning method optimised possibly through some level of free text or 
extended option questions. Although this may increase the flexibility to the user and better 
improve usability and user experience, there may need to be a level of compromise with 
regards to the technical abilities of the application and the complexity of programming. Not 
changing the question style completely is also in line with the work by Bearman et al., who 
discussed that multiple-choice questioning is recognised to be suited to narrative VPs 




Within the results of this evaluation, realism was a reoccurring topic that spanned many of the 
themes and results. Realism refers to the ability of the application to recreate a life-like 
scenario and it is closely linked with ideas of authenticity (Hege et al. 2016). Considering the 
current literature base for VPs, this study approached the concept of realism from somewhat 
of a different perspective; this has already been briefly presented in section 10.2.1. Following 
mixed questionnaire results on realism (section 6.5.2) rather than broadly considering realism 
the authors tried to consider what realism consisted of and two main areas were identified: 
realism of the technology (section 7.3.2) and realism compared to pharmacy practice (section 
8.2.1). This breaking down of realism appears to be novel within the literature despite realism 
being recognised to incorporate distinct ideas as previously been discussed in the systematic 
review (section 3.4.3).  
This multi-faceted concept of realism was illustrated with Henry as the patient. He was 
recognised to look, react and function largely like a person, albeit within the constraints of the 
technology (section 7.3.2). But there were some concerns as to whether Henry was 
representative of patients with AF and taking NOACs due to his medication history (section 
8.2.1). These concerns largely related to clinical details which some participants did not think 
were likely to be representative of real patients. Rather than grouping this into broad realism a 
deeper level of insight was established and thus more targeted areas for optimisation were 
identified.  
Bateman et al. (2013), described a ‘trade off’ between learning quality and realism whereby a 
VP cannot be completely realistic as this would conflict with the learning experience and 
ultimately a compromise between realism and learning is required. Although different types of 
realism were not explicitly referred to, and no other literature appears to have done this, 
Bateman et al. (2013), recognised that complete realism may be unattainable for an 




opportunity as the focused would be on realism rather than the learning within the application 
design. Within the results of this study, it appears that the realism of the technology is largely 
good and well-liked, but clinical realism may still need developing prior to reaching the 
‘optimum’ realism. Any developments to the clinical realism should be done without losing 
educational value as discussed by Bateman et al. (2013). Although technically this may not be 
possible, and a level of compromise may be required between the realism to clinical practice 
and technical usability.   
 The ability and usefulness of the VP to teach NOAC counselling 
The findings of this study demonstrate that the VP can be a valuable tool in teaching how to 
conduct NOAC counselling with patients. This value manifests in different ways with various 
possible benefits to using the VP. This value is in line with findings of other pharmacy VP 
evaluations (Fleming et al. 2009, Thompson et al. 2016b, Zlotos et al. 2016) but goes further to 
detail the different types of learning that users may experience. As discussed in the narrative 
systematic review (chapter 3), VP use in pharmacy students already has a significant literature 
base with demonstrated benefits. Not only has this evaluation demonstrated benefit in in a 
new audience, qualified pharmacists, and further added to evidence around pre-registration 
trainee VP use, it has also provided insight into user perspectives, how the VP is used 
educationally, and how this can relate to practice and experiences as part of a learning cycle. 
As discussed in section 8.2.2, there was a range of ways that users used the VP, particularly 
around the frequency of use. One participant discussed using the VP to get perfect feedback. 
This individual only appeared to be bothered about getting the ‘right’ answer without 
necessarily learning or understanding why this was the case. This, as already discussed, could 
be an example of surface learning possibly due to gamification of the learning. Gamification 
refers to “the use of game design elements in nongame contexts” (Deterding et al. 2011). This 




technology (McCoy et al. 2016). When developing an application with some game principles a 
balance is needed particularly if reflection is an aim of the application (Nicholson 2015). 
Nicholson (2015), discussed that applications based on Kolb’s theory of experiential learning 
may lose some of their value if there is too greater emphasis of game principles. This occurs 
when the emphasise on game principles removes the opportunity and time to reflect and 
consider the learning in a deep way as the user is pushed to the next task or level. In this 
evaluation the majority of users did not appear to try to ‘play’ the VP for perfect feedback and 
get drawn into the VP’s gamified features, but more commonly a deeper learning including 
reflection and linking learning to practice was reported. This could suggest that the balance of 
gamification is appropriate, but as demonstrated by the single participant the balance 
between game and educational application needs to be carefully considered.  
The VP appeared to have some sort of benefit to all of the participants albeit varied, even 
those which reported a negative change in their ability pre- to post-VP were positive towards 
the VP and its uses (section 6.10). It is stated that branched or narrative VPs, such as this one, 
are suited to encourage reflection-based learning to teach communication skills because 
of the ‘stronger sense of the real patient’ (Bearman et al. 2001). A significant proportion of the 
participants appeared to use the VP in this way but also as a more overt practice opportunity 
to help to develop confidence in NOAC counselling (sections 6.6 and 8.2.2). This does not 
entirely align with the work by Bearman et al. and perhaps highlights the range in which VPs 
may be useful and also that the VP is an individualised learning tool. Despite the VP design not 
always aligning with the concepts described by Bearman et al., another of the demonstrated 
benefits of allowing for mistakes in a safe environment is in line with the work by Bracegirdle 
and Chapman (2010), who explained that VP use can make users appreciate the consequences 
of mistakes. This is a well discussed advantage of VPs (section 2.4.4) (Cook and Triola 2009, 




 Incorporation of the VP into education, training and CPD 
The VP appears to be largely suitable for incorporation into the education and training of a 
number of types of pharmacy professional, particularly pre-registration trainees and newly 
qualified pharmacists and in both hospital and community sectors (section 9.2.1), although 
how exactly this should be done needs consideration. The VP has demonstrated possible wider 
benefits, particularly to the NHS (section 8.2.3) over more labour-intensive educational 
alternatives. Its unique contextualisation of learning in a patient-facing way appears to be 
favoured by users compared to more subjective alternatives such as role play, and other more 
knowledge-based alternatives (section 8.2.2). Additionally, the specifics of CPD requirements 
such as the information required by the GPhC and how this information can be mapped to VP 
use need to be considered in order to make it easy for users to use the learning as evidence of 
CPD.  
Furthermore, from an educational perspective, use of the VP maps directly to the experiential 
learning cycle as presented by Poore et al. (2014) (section 1.4.2). But what seems clear from 
the results is that the participants were not always appreciative of how exactly the VP 
facilitates learning. Regardless of this, the users often discussed reflection and refreshment 
which both sit well within the experiential cycle particularly the phase where mental models of 
tasks are redefined and refined (Zigmont et al. 2011) (Figure 1.2) The VP could sit as part of 
the concrete experience or also as the active experimentation depending on how the user 
uses the VP and their opportunities for active experimentation in practice. As the majority of 
users would use the VP repeatedly this suggests some identification of a cyclical process.  
Bloom’s Taxonomy is an educational classification model of skill development which is of 
relevance to the VP. This taxonomy has been selected as it is one of the most well used 
frameworks and it has established use for pharmacy-based training and thus the taxonomy 




taxonomy uses six classifications for the different processes which are included in learning 
objectives (Anderson et al. 2001). In this case, the VP appears to encourage learning of the 
higher orders particularly analysing and evaluating. This links closely with the experiential 
cycle as depending on where someone is within the cycle they may be learning at a different 
level of Bloom’s taxonomy. The VP appears to encourage users to move through the 
experiential cycle and work at higher levels of Bloom’s taxonomy but, in order to do this the 
application should be implemented around other education and training, and CPD with 
considerations for pharmacy practice and curriculum integration.  
Duff et al. (2016) supported consideration for the incorporation of VPs into a curriculum as 
timing and placement may impact user experience. Some of the participants of this study 
expressed concerns about where exactly VP use could be incorporated into practice. This, 
therefore, provides an example of the users themselves being aware of the importance of 
curriculum integration as discussed by Duff et al. (2016). Throughout this study, the VP has not 
been considered as an isolated learning tool and in a similar way this should be the case in 
practice. The VP can be used alongside other educational tools and methods as part of the 
experiential cycle depending on an individual’s requirements, this is in line with Sharples et al. 
(2005) as discussed in section 1.4.3 who suggested mobile resources be used alongside other 
‘traditional’ resources and methods . For example, a user may choose to use the tool first, as 
part of concrete experience, followed by role play and then real consultations as active 
experimentation or alternatively knowledge-based learning such as CPPE first followed by the 
VP as part of active experimentation. Ultimately, the way in which the VP can be used can be 
tailored to an individual, the stage they are at in the experiential cycle, and the other forms of 
experiential learning available to them.  
Considering longer term use of the VP, a small number of VP studies have considered longer 
term outcomes of competence, although these are in the minority (Bindoff et al. 2014, Zlotos 




how the VP was used were gathered specifically around repeated use of the VP and how it 
could be used within pharmacy practice. The study by Zlotos et al. (2016) stated that findings 
six months after VP use were confounded due to the participants also working in practice 
during this time. If this was to be considered with regards to the VP under investigation in this 
study an evaluation of long-term outcomes would need to consider that the VP may be used 
repeatedly, alongside other resources and experiences in practice as part of an experiential 
learning cycle. Thus, any evaluation of behaviour change or longer-term outcomes would need 
to be multi-faceted and consider that VP use is not an isolated opportunity.  This evaluation 
appears to be the first VP study to place an emphasis of the results for use in practice, in line 
with the methodology of the study. Furthermore, the finding that participants often 
repeatedly used the VP (section 8.2.2) is useful for an implementation strategy as information 
regarding exactly how users are likely to use the VP will contribute to establishing its use in 
practice and getting the support of organisations to implement the VP.  
The discussion in section 9.2.2 on different VP audiences and that the VP may be particularly 
useful to pre-registration trainees and newly qualified pharmacist, is supported by Duff et al. 
(2016) who discussed that VP use is better in the earlier stages of training, although this was 
based on the medical profession and with limited evidence from robust studies. This study 
shows that the audiences which were most often favoured were those with less experience 
such as pre-registration trainees and newly qualified pharmacists. Through the use of multiple 
and varied participants groups within this study, this meets a suggestion by Jabbur-Lopes et al. 
(2012) for research using wider populations to better contribute to the validation of VP use. 
This could be taken further by incorporating other forms of pharmacy professional such as 




 Improvements and next steps for the VP 
On the basis of the findings of this evaluation as summarised in section 10.2, a number of 
improvements to the VP have been identified. It should first be highlighted that, despite a 
range of recommended changes or developments to the VP application, these should only be 
made when appropriate considering the technological capabilities of the VP. VP applications 
are a complex web of algorithms and pathways and even the smallest changes can have 
effects on usability and experience (Bracegirdle and Chapman 2010). Therefore, any changes 
should be made with careful consideration for a balance between technology, educational 
principles and user experience as the three are closely linked (Huwendiek et al. 2009). In 
reality this may not be completely possible, and a level of compromise may be required, this is 
articulated the in the following sections.  
Technology and design 
The majority of technological recommendations are minor as the VP has demonstrated 
usability but there are a number of recommendations to hopefully optimise VP use. Firstly, the 
programming of the VP should be tested and any issues rectified after a number of users 
reported the application freezing or not loading (section 7.3.1). Although it is more likely, that 
this was due to the computers and devices being used rather than the application. The 
significance of poorly functioning technology emerged as a key area within the systematic 
review (section 3.4.3) and thus this should be improved as far as possible although there may 
always be a level of technical limitation as was discussed in section 10.4.2. 
A more significant technological and design change that should be considered is the possibility 
of a ‘back’ button (section 7.3.1), but this may not be in keeping with the exploratory 
educational purposes of the VP and that experiencing mistakes is a useful learning opportunity 




how to improve navigation within the application without including a back button. This may 
overcome any associated potential negative consequences of a back button whereby users 
could use the button to go back when they realise they have selected a less than optimal 
response rather than to navigate around the application or to un do genuine errors (section 
7.4). Bateman et al. (2013) and Hege et al. (2016) explored the concept that navigation is a 
variable in VP design that should be considered in as much depth as other variables would be, 
with the latter study stating that navigation impacts the level of standardisation for the user; 
although there is little evidence of how this translates to the design and functionality of VPs.  
Another recommendation for consideration concerns the style of questions within the 
application. There were a range of perspectives on the use of the MCQs and the possibility of 
other types of questioning such as free-text questioning. This should be reviewed in line with 
the educational recommendations below and also potential future VP applications. It is 
possible that a range of applications increasing in complexity and with different questioning 
styles could be used, this links to the concept of a VP library as is discussed below under 
implementation. This needs to be carefully considered also thinking about who the audience 
of the VP is likely to be.  
A clearer recommended change is that the feedback design should be reviewed, the use of the 
colour coding for delivering feedback as visualised in Figure 1.8 was not favoured due to the 
perspective that ’red’ feedback should not be ‘red’, therefore this should be changed (section 
8.3). One option being that the red coding should only be used for obviously unsafe or 
incorrect feedback and possibly an amber coding for areas for improvement which are not as 
clear and obvious. Alternatively, a complete removal of colour coding is another possibility; 
any change would need to be evaluated. This is in line with Guise, Chambers, and Valimaki 
(2012) and Hege et al. (2016) who discussed the importance of feedback as a design element 
of VPs and also Zigmont et al. (2011) and Poore et al. (2014) where the importance of effective 





A number of educational elements have been highlighted for improvement and development. 
This starts with a recommendation that there should be clarity regarding why users are using 
the VP and what they can expect to get out of it, this should emphasise that is not a purely 
knowledge-based learning experience and should encourage reflective thinking and 
experiential learning. This should be carefully incorporated as not to stem individualism 
outside of this, one method could be to make this clearer in the case introduction (Figure 1.6) 
or to include this in the implementation strategy when the application is promoted and 
circulated to potential users.  
Additionally, it should be emphasised to users prior to VP use that the VP should encourage 
exploratory use of the application and not focus on ‘right’ and ‘wrong’ answers, this should 
encourage further experiential learning. As discussed in section 2.4.2, a VP nursing study 
reported that VP users moved through Kolb’s experiential cycle and became more aware of 
the process (Forsberg et al. 2016). This suggests that users can be made aware of the cycle and 
that this may aid their learning.  
Implementation 
As discussed in section 9.2.2 a range of types of user could benefit from use of this VP and also 
of wider VP use. It would not be beneficial to stifle this range of user but, within 
implementation it may be worth targeting the VP at particular audiences to maximise 
beneficial use. The range of user that the VP appeals to appears to be one of its advantages 
and this should remain, but the practicalities of implementation may require a somewhat of a 
more targeted approach such as by targeting individuals newer to counselling.  
The implementation analysis (section 9.3) demonstrated that the VP still needs large areas of 




constructs which largely relate to organisational level issues; the intervention itself is largely 
ready for implementation. Process constructs also need improvement and there should be 
named individuals within an organisation to support the implementation process. As discussed 
in section 5.6, few previous studies have considered implementation of VPs wider than 
individual organisations and none appear to have done this rigorously through using an 
implementation framework. If this is therefore further considered this would be a significant 
contribution to the field of VP research. 
Further VPs 
The developers of the VP could consider developing a library of VP applications. This could 
incorporate both other NOAC based applications with a range of patients and scenarios, and 
also applications outside of NOACs. This is not the first time a VP library has been considered, 
Zary et al. (2006) suggested the potential for a template library which designers could use as 
the basis for further VP development; this does not appear to have yet been developed.   
10.4 Strengths and limitations of the research 
The strengths and limitations of this study will be discussed in this section generally as will the 
strengths and limitations of the interview phase specifically. The strengths and limitations of 
the questionnaire phase have already been discussed (section 6.11.1). Reflexivity relative to 
the strengths and limitations of the study are discussed in section 10.6. 
This piece of research is the first to incorporate qualified pharmacists as VP users, something 
which as previously been identified as needed by numerous studies (Bracegirdle and Chapman 
2010, Kane-Gill and Smithburger 2011, Duff et al. 2016, Thompson et al. 2017). This novelty 
has proven to be useful as the perspectives of pharmacists have been explored for the first 
time and the findings add considerably to the literature. The use of mixed methods to explore 




research as few VP studies have used qualitative methods and gained individual user 
perspectives. This strength of the research is due to the adopted pragmatic approach to the 
evaluation which allowed for a focus on contextualised findings relevant for practice. A 
particular strength to note is that the adopted methods allowed for the exploration of 
questionnaire findings and unexpected perspectives in greater detail to give a better overview 
of VP use. Further to this, the participant group was from a mixture of secondary and primary 
care sites from across England and therefore has applicability to many types of reader and this 
adds to the usability of the findings. The demographics of the participants were also wide 
ranging with many different experiences and roles which further contributed to the likely 
transferability of the findings.  
There was a risk of self-selection bias from the participants as participation in the study was 
voluntary and so those that took part may have been more engaged with education and 
training (Collier and Mahoney 1996). Despite this, there should have still been a range of 
perspectives on the VP. Furthermore, via the process of data saturation, any perspectives 
obvious to the researchers which were absent could be addressed and the research would not 
have ceased until the process of saturation was complete as discussed in section 5.5.4.  
These limitations were somewhat countered by the strength that this research has attempted 
to adopt the strategy of detailing study methods enough so that a reader can judge if the 
results are applicable to their own contexts (Mays and Pope 2000). It is hoped that a reader is 
able to judge the applicability of the study and the findings to their own area of practice and 
the application of VPs. 
The study is unable to conclude any long-term effects of VP use on practice. Some information 
on the short-term consequences, between questionnaire completion and interview, have been 




be argued that this in itself is a strength of the research as no previous studies clearly 
identified uses of VPs in this way.  
 Interviews 
The interview phase of the study had a number of characteristics reflective of a rigorous 
qualitative study particularly the transparency of the design and of the conduct of the study so 
that readers can judge if the findings are applicable to their own areas of practice (Braun and 
Clarke 2013). 
The interview guide was developed based on literature and the pilot findings, but also due to 
the interviews being the second phase of the research, the guide was adapted based on the 
questionnaire responses. This allowed unexpected results from the questionnaire to be 
explored further thus contributing to the study quality.  
Additionally, the design of the study meant that the second, interview phase acted in part like 
a follow-up to the questionnaire. This allowed the participants to reflect on their initial 
perspectives towards the VP and potentially see the consequences for it in practice such as 
participant 83 who had actually used the VP for CPD purposes (section 9.2.1). This contributed 
to the depth of qualitative results and the realism of the perspectives reported.  
As discussed in section 6.2, there were less respondents from the community sector than the 
hospital in the interview phase of the study. The respondents were in the same proportions as 
the first phase of the study and as for the first phase there appeared to be little difference in 
the results split by sector. In order to maximise recruitment incentives such as the interview 
taking place at a convenient hour and location including out of hours and over the phone were 
offered. Considering the analysis of the data collected, it appears as if data saturation was 
sufficiently reached (section 5.5.4) and thus the recruitment was not a problem as far as to 




sectors or were able to comment on other areas of pharmacy practice and sector. This added 
to the range of perspectives reported.   
Finally, the interview analysis used the Framework approach (section 5.5.3) and the analysis 
and identification of themes was detailed and prolonged. The themes went through several 
iterations each time developing and progressing data analysis. Throughout this processes the 
themes moved from being descriptions of discussion or ‘features’ to true themes which tell 
the reader meaningful things about the data (Braun and Clarke 2006). This is considered a 
strength of the conduct of the interviews. 
 Limitations of the VP technology and application 
During the course of this study a number of limitations of the current VP application have 
been identified. These have been discussed across the thesis where relevant but the key, 
limitations relative to the findings and implications of the results are highlighted below.  
Technical 
A small number of participants reported elements of technical limitations as discussed in 
section 7.3.1. Although these results were in the minority, they did reveal a limitation of the 
technology. As the VP relies on an individual user’s internet connection, any weak or 
ineffectual connection may negatively impact user experience of the VP. The VP development 
team maintained the VP functionality throughout the study and thus the reports of failing 
connections or trouble loading the VP are more than likely to be due to the user’s internet 
connection or device. As discussed in the systematic narrative review (section 3.5), multiple 
studies have previously considered the accessibility of VPs in terms of functionality and 
navigation such as through using common web browsers but none appear to have considered 





A number of design limitations to the application have been identified and these largely have 
been discussed elsewhere; a number of these which are more inherent limitations to the VP 
are discussed here.  
As discussed in section 8.3, VPs which use an MCQ design will all have limitations around user 
restriction as they have inherently been designed this way. This has repercussions for the 
potential for the VP to achieve ‘maximum realism’, if such a thing is possible. VPs, when being 
designed, need to consider the three factors described by Huwendiek et al. (2009) of 
technology, educational principles and user experience.  
Similarly, there are limitations on a user level as the application cannot account for individual 
approaches to consultations. This appeared to be particularly problematic for those longer 
qualified with more established methods of conducting consultations. This closely links to the 
discussions of the ‘ideal’ VP user (section 9.2.2) and it could be posed that limitations of the 
technology which cannot be overcome with current technical abilities could impact the way in 
which a VP is designed and implemented. In this example, as the VP is somewhat restricted, 
particularly for users with more established consultation skills, this could be positioned not as 
a limitation but rather a strength which can be utilised by targeting the VP not at those with 
established consultation styles but at those new to consultation skills, this could be done via 
an implementation strategy. In this way the limitations of the technology can be managed in 
such a way in which that they become useful.  
A further limitation of the technology design is that a number of users reported that it ‘felt 
algorithmic’ (sections 0 and 7.3.2). This is somewhat of an inherent limitation of the 
technology as it runs based on a decision tree using an algorithmic design (section 1.5.5). As 




methods, this may provide an alternative which may alter the limitations of VPs, by moving 
away from algorithmic elements. 
Other 
One question which largely remains unanswered concerning this VP application is the costs of 
building, maintaining and proving access to it. Although elements of this have been considered 
in the context of implementation (sections 9.4 and 10.5) this was not an aim of this research. 
Despite this, this remains an unanswered question and a possible limitation of the technology 
if application costs are deemed too great. As discussed in the overview of VPs (section 2.3), 
costs are broadly seen as a potential limitation of all VPs although this appears to be yet to be 
determined in a research study. 
Similarly, VP applications remain largely individual applications which are highly specific to one 
case and or organisation, this is further discussed in section 10.5. This remains a limitation of 
VPs broadly and links closely with cost. It may be that until a ‘VP library’ is created or there is 
collaborative working with a national organisation to maintain and develop a collection of 
standardised VPs then this limitation will remain. 
10.5 Implications of this research 
The VP can be considered useful for learning in a safe environment. This is something that is 
well discussed in the literature in the context of VPs for pharmacy students (Zary et al. 2006, 
Zlotos et al. 2016) but this is the first time it has been demonstrated in qualified pharmacists. 
This is particularly relevant as it was pharmacists working in practice who considered the use 
of the VP as synergistic to their practise rather than in isolation or relative to a university 
course (section 8.2.2). Further implications for individual users which go past previous 
research include that the VP is perceived as largely realistic given the constraints of the 




such as knowledge rather than user perspectives and consequences for practice. The results of 
this study are therefore more useable to daily pharmacy practice as they remain 
contextualised.   
Practice level implications are that the VP should be considered as an alternative or 
complementary educational resource with potential for being used for CPD by pharmacists. 
The exact strategy for when and how to implement the VP is still speculative and should be 
based on further research into pharmacy implementation and CPD practices to best target the 
implementation process. The VP has demonstrated uses for practice and could start to be 
used in this environment, although implementation needs to be considered so that the CFIR 
domains are better met (section 9.3.1). This is particularly true for the domains around wider 
organisational aspects and monetary elements to VP use and implementation.  
Implications for policy include that the GPhC could consider the possibility that VPs maybe 
used as a way of teaching pre-registration trainees in a complementary manner to other 
resources. The current pre-registration training manual discusses that simulation can be 
incorporated into learning in order to meet the GPhC pre-registration training standards. This 
suggests that the GPhC do see a value in simulation, although as discussed in section 2.2, this 
is a wide concept and thus could be more specific or detailed (General Pharmaceutical Council 
2019c). The GPhC go as far as to cite some simulation methods such as role-play and OSCEs 
but they do not mention technological examples other than ‘’online training packages’’. 
Although this technically does include VPs this is a vague term and examples of what is 
included in this would be useful. Furthermore, employers and organisations should consider 
the implementation of VPs with the potential to ease training pressures, although this is 
largely undemonstrated but rather speculative on the part of the participants. A significant 
factor of this would be cost, which as discussed in section 9.4, has not yet been considered. 




For the areas of implementation around both qualified pharmacists, possibly for CPD, and for 
pre-registration trainees as discussed in the preceding paragraphs, current implementation is 
likely to be local, by individual organisations or people. This is based on the literature which 
has been discussed across this study where VPs have largely been developed and used by 
single organisations, this was also a finding of the systematic review (section 3.4.1). It would 
be difficult to have a consistent and widespread implementation of this VP unless a national 
organisation such as Health Education England (HEE) or the GPhC levied for and encouraged, 
or even took responsibility for, implementation, although this is unlikely for a single VP 
application but may be possible if a VP ‘library’, as discussed in section 10.3.4, is developed.   
As discussed in section 4.5.3, efforts were taken to demonstrate a level of generalisability of 
the results of this study. The study has clearly presented the methods and conduct of the 
research enough for readers to judge if the findings are applicable to their own areas and the 
questionnaire results in particular used a wider group of participants across England. Thus, the 
results may have a level of transferability to different population groups of pharmacists and 
pre-registration trainees across England. Despite this, the VP itself is a specific application to 
its own context and this study has not discussed its generalisability to other VPs. As was 
discussed in section 10.4.2, the majority of VPs that have been developed are highly specific to 
their own contexts and the cross use of VPs in different contexts is low. This links to research 
recommendations which are discussed in the next section. 
 Research recommendations 
A number of recommendations can be made to develop areas that this work was unable to 
address. Firstly, there could be further research into the use of VPs for pharmacy technicians. 
This research study has identified them as a potential VP user and there have been 
suggestions that they are underprovided for in terms of education and training (Schafheutle et 




responsibility in counselling patients (Langham 2000, Blyth 2008), this could be an area worth 
investigating. The VP of the study may be suitable for pharmacy technicians and this is a 
starting point for research although there may also be potential to widen pharmacy technician 
use of VPs to other applications. 
The use of VPs for CPD purposes should continue to be investigated and further research 
around CPD could have relevance for both pharmacists and pharmacy technicians. This could 
include a study specifically evaluating how users use a VP for CPD, specifically considering the 
GPhC’s requirements (General Pharmaceutical Council 2018a). Additionally, there appears to 
be a need for research round CPD generally, particularly around the perspectives of 
pharmacists on CPD, the need for it and the types of learning they see as being suitable.  
In line with the next steps for the VP (section 10.3.4) further research may be required on the 
basis of any changes and improvements to the VP, this could incorporate a VP ‘library’ and VPs 
using different questioning styles.  
The last recommendation concerns implementation. There should be research centred around 
implementation, specifically, concerning the largescale implementation of VPs into 
organisations such as NHS trusts or community pharmacies.  A recognised advantage of VPs is 
that they require low levels of staff to deliver learning (Bateman et al. 2013). In this study, the 
VP has been shown this to be relevant particularly for the NHS. HEE have a dedicated website 
for e-Learning on which they state ‘’The NHS needed a radically different approach that gave 
greater flexibility in meeting training needs whist at the same time ensuring that the training 
received was consistent’’ (Health Education England 2019). They then go on to discuss the 
advantages of e-Learning for the NHS. This demonstrates that e-Learning, of which VPs are 
one type, does fit with the current HEE and NHS agenda. Despite this, VPs have not yet been 
specifically identified by the NHS or HEE as a potential resource to contribute to the e-learning 




organisations; this should be undertaken using an implementation framework to guide and 
support the VP’s use. 
10.6 Application of reflexivity 
The background of the reflexive approach to this research was discussed in section 4.5.4. This 
section will practically present some of the reflexive thoughts and processes which were part 
of this research and of my personal journey (CR).  
The researcher is an integral part of what is studied and reflexivity seeks to value the role of 
the researcher in analysis by allowing critical self-reflection of the researchers role on the 
research process (Johnson and Waterfield 2004, Finlay 2010). Prior to the study I had 
experienced an older version of a VP which aimed to teach ‘responding to symptoms’ to 
undergraduate pharmacy students. This VP used considerably older graphics and a ‘free text’ 
questioning design. My limited previous experience of VPs meant that I entered into this 
research with an almost ‘blank slate’ on which to make judgement.  
Prior to embarking on this journey, I had an interest in pharmacy education, this is in part due 
to a mixed experience of pre-registration training, of training provisions and of varied attitudes 
of pharmacists in practice. I was a newly qualified pharmacist for the period of this research, 
and I drew on my personal experiences to include both pre-registration trainees and qualified 
pharmacists in the evaluation. As part of my pre-registration training, I conducted NOAC 
counselling and received informal observational training to do so; having experienced first-
hand the limitations of this, I have a belief that medication counselling generally, and NOAC 
counselling specifically, requires additional educational support. Additionally, the NHS hospital 
trust where I worked as a pre-registration trainee made use of pharmacy technicians to deliver 
the NOAC counselling which the VP aims to teach. Thus, I was unsurprised by the results 
concerning pharmacy technicians. Despite this, the results concerning potential use by 




As I am a newly qualified pharmacist this could have affected relationships with interviewees 
in both a positive and a negative way. The proximity to pre-registration training and the 
transition to newly qualified pharmacist meant that I could empathise and appreciate the 
experiences of these groups slightly more than longer qualified pharmacists. It is hoped that 
this enabled the participants to speak honestly about their experiences and thoughts of the 
VP. This is also true for community pharmacists as I worked as a locum pharmacist in this 
sector during the course of this research and so I had some appreciation of the working and 
training pressures within this sector. The fact that I was a practising pharmacist ultimately 
gave access to perspectives which would not be apparent to a non-pharmacist as there was a 
degree of interpretation and translation of shared knowledge and experience. Throughout the 
conduct of this research a reflexive diary was kept to note down any reflexive thoughts, the 
content of the diary is discussed as part of this reflexive discussion (Gale et al. 2013). 
A particular strength of the reflexive approach to the study was that the interview participants 
were told that I, as the chief researcher, was independently evaluating the VP and had no role 
in the VP’s development. It was hoped that this would enable participants to speak openly and 
honestly about the VP without making a judgment about what response the researcher 
‘wanted’ to hear. This was an effort to make sure that personal biases were clear to 
participants (Mays and Pope 2000, Richards and Emslie 2000). 
Reflexivity as a process can contribute to improving work and can aid analysis or interpretation 
of the results (Finlay 2010). One process within the study where time was taken to incorporate 
reflexivity was the thematic analysis of the interviews. At the point where this was taking 
place, I had moved to take up a full-time position as a lecturer of pharmacy practice and work-
based learning at the School of Pharmacy at Newcastle University. Due to this, the completion 
of this thesis occurred alongside this role. This was of benefit to the process of thematic 




for mental gaps from the analysis due to working pressures before which it was returned to. 
This contributed to the quality and depth of the thematic analysis.  
On the topic of thematic analysis, the research itself is a product of my own construct. I 
acknowledge that the research is distinctive to me, my experiences and perspectives and that 
a different researcher may have reached alterative conclusions. Despite this, I have attempted 
to be transparent concerning the construct of themes and the resulting conclusions of the 
research.  
Morse (2015) considered two types of researcher bias which can be limited by the process of 
reflexivity. The first being unconscious bias in the design of the research. To consider this, the 
interview guide was internally reviewed to consider its face validity (section 5.5.1) and 
considerations for any bias in the demographics of participants were discussed in section 
6.11.1 relative to the wider pharmacy population.  
The second concept of research bias is that there can be a tendency to see what you want to 
see within the data (Morse 2015). To minimise this, as part of data analysis, minority and 
contradictory data and negative cases were actively sought in order to deepen the 
understanding of the data and reveal unanticipated insights when these findings were 
compared with majority views. This also embraces Morse's (2015) approach to negative case 
analysis as a way of demonstrating validity. Despite these measures, it should be highlighted 
that this research is socially contingent and that the responses and the interview experience 
may have been impacted by any number of factors. This can include, but is not limited to, the 
time and place of the interview, the respondent’s previous experience of research and their 
previous experiences of the interview topic. Similarly, my interpretation of the data is socially 
contingent. I have, where possible tried to be aware of how my own previous experiences 




findings, is of my own interpretation but I hope that I have best represented my participants 
perspectives and viewpoints to give a realistic and useful view of the VP.    
10.7 Conclusion  
This research has demonstrated the value of the particular VP application under evaluation 
both from a technological and educational perspective. Individual users may benefit from 
using the VP in a number of ways such as through application of knowledge and practicing in a 
safe environment. A number of types of pharmacy audience who could benefit from using a 
VP have been debated but ultimately any number of pharmacy professional may find benefits 
to use of the VP. A number of improvements, developments and further considerations have 
been discussed including aspects to be addressed prior to any further implementation. If the 
VP is to be implemented, then a wider and well thought out implementation strategy should 
be developed which includes the CIFR domains. The VP application is a useful additional 
resource which should be considered when pharmacy professionals are undertaking 
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III. Consent form and participant information sheet - questionnaire 
The consent form and participant information sheet which was used for respondents is 













IV. Consent form and participant information sheet - interviews 
The consent form and participant information sheet which was used for participants taking 


















The online study questionnaire is available at https://goo.gl/forms/Tcrcr7KIVKa6jxCU2 and is 




























VI. Interview guide  
Interview guide 
An Evaluation of the use of Virtual Patient Technology in  
Pharmacist Education on Atrial Fibrillation 
Overview 
1. Greetings, welcome, explanation of the structure of the session and the interviewer’s role. 
2. Confirmation of informed consent and that the participant has used the VP intervention. 
3. A semi-structured interview see guide below. 
4. Summary and closing remarks. Opportunity for further questions from the participant. Contact 
details and dissemination of the study results highlighted. Thanks.  
 
Interview Plan 
a) Tell me about your current and past roles in pharmacy. 
 
b) Experiences of AF and NOACs  
     - What are your experiences to date of NOACs and AF?  
Probe: What about the patients with AF on NOACs? 
     - Tell me your thoughts and feelings on education and counselling for pharmacists on NOACs in AF  
 Prompt: What are your experiences of education and training for NOACs in AF? 
 Probe: Do you think more education and training is needed? 
 
c) Experiences of virtual patients  
     - What are your experiences to date of VPs? 
Prompt: Prior to today, had you heard of/experienced/used VPs? When and what for? Did you 
have a good or bad experience? 
     - What are your feelings towards using VPs? …… And why?  
  
d) VPs as an educational tool in Pharmacy 
     - What are your thoughts on using VPs as an educational tool in pharmacy? 
 Probe: What about specifically for AF and NOAC education and training?  
 Probe: How does the use of VPs compare to other E&T methods? 
 Probe: What are your feelings towards VP use in practice? 
Probe: What sort of impact do you think the VP intervention could have on patients? 
 
e) VPs: The Technology 
     - Describe your thoughts regarding the intervention program 
Probes: Is there anything you want to discuss about the program,  
Are there any good points or advantages you want to highlight? 
              Are there any improvements you can suggest?  
Are there any negative points or disadvantages to raise? 
Are there any changes you would make to the program? 
     - Do you have any further comments regarding the technology, case or program? 
     - What are your feelings towards the VP technology and case? 
     - Do you think that by using the program you are better prepared to counsel NOAC taking AF    
patients? …. Why? 
     - Do you think that you are more likely to conduct these counsellings? …. Why? 
Prompt: Do you think your practice will change as a result of using the program?  
 
f) Further comments 
     - Is there anything else you would like to tell me or discuss?  
Prompt: Any other comments you wish to add or any further feedback on the program? 

































































































































































































































































































































Community Occasionally Occasionally Quite Extremely Quite Quite Not at all Quite Quite Quite 












































































































































































































































































































































Community Agree Agree Agree Agree Agree Agree Agree Agree Agree Agree Agree 
Hospital Agree Agree Agree Agree Agree Agree Agree Agree Agree Agree Agree 
Table 1. Responses to questions on the frequency of NOAC counselling, confidence and the interest and usefulness of the VP and of the usability and 

































































































































































































































































































































Qualified Occasionally Quite Quite Extremely Quite Quite Not at all Quite Quite Quite 
Pre-registration 
trainee 
Once in a 
while 









































































































































































































































































































































Qualified Agree Agree Agree Agree Agree Agree Agree Agree Agree Agree Agree 
Pre-registration 
trainee 
Agree Agree Agree Agree Agree Agree Agree Agree Agree Agree Agree 
Table 1. Responses to questions on the frequency of NOAC counselling, confidence and the interest and usefulness of the VP and of the usability and 
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